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Samenvatting
De verwezenlijkingen binnen het genoomonderzoek, met ondermeer de publicatie van de volledige
sequentie van het menselijke genoom, bieden een schat aan informatie voor het biochemisch
en biomedisch onderzoek. Naarmate echter de genetische kennis completer werd verschoof de
wetenschappelijke aandacht meer en meer naar de biologische interpretatie van deze informatie.
Het onderzoeksveld ’proteoomanalyse’ omvat het grootschalig identificeren en kwantificeren
van de uiteindelijke genproducten, de eiwitten, maar ook de analyse van hun modificaties. De
studie van het proteoom is bijzonder uitdagend gezien de grote dynamische verschillen waarmee
eiwitten tot expressie gebracht worden en de grote variabiliteit in de finale structuur van de
eiwitten; ’splice’-varianten, N- en C-terminale processing, co- en post-translationele modificaties
(PTMs) [1]. N- en C-terminale splitsingen in de gevormde polypeptidenketen behoren tot de
meest voorkomende types van PTMs in eiwitten. Hoewel deze modificaties een grote impact
kunnen hebben op de biologische activiteit van eiwitten, wordt hier nog relatief weinig aandacht
aan besteed en is er nood aan de ontwikkeling van bijkomende technieken die een systematische
analyse van proteolytische processing toelaten.
Het systematisch bepalen van de eiwittermini kan bovendien ook bijdragen tot een meer accurate
en betrouwbare genoomannotatie. Om meer betrouwbare voorspellingen uit te voeren wordt
momenteel voor de annotatie van genen gebruik gemaakt van een combinatie van verschillende
algoritmes voor gen-predictie en similariteitsanalyse. In proteogenomics wordt data afkomstig
uit proteoomanalyse gebruikt als extra parameter om de theoretisch voorspelde genen te kunnen
bevestigen of corrigeren [2–6]. De correcte C-terminus van het finale genproduct bepalen is een
van de grootste uitdagingen binnen dit onderzoeksdomein.
In de loop der jaren zijn verschillende methodes ontwikkeld om de C-terminale sequentie van
een eiwit te bepalen. De oorspronkelijke benaderingen omvatten chemische sequentiemethoden,
complementair aan de Edmandegradatie, maar deze waren minder gevoelig en betrouwbaar
[7]. Nadien werden een aantal massaspectrometrische technieken ontwikkeld, waaronder het
uitvoeren van een beperkte eiwithydrolyse [8] of de analyse van in-source decay fragmenten
in een MALDI-TOF massaspectrometer uitgerust met LIFT-concept [9]. Eveneens werden
een aantal technieken ontwikkeld die toelaten om het C-terminale peptide te isoleren of se-
lectief te merken; voorbeelden hiervan zijn het gebruik van anhydrotrypsinekolommen [10] en
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de merking van tryptische peptiden met 18O isotopen [11]. Meer recent werden een aantal
LC-MS gebaseerde technieken beschreven waaronder het gebruik van een ionenuitwisseling om
N-terminaal geblokkeerde peptiden en C-terminale peptiden aan te rijken [12] alsook het gebruik
van de COFRADIC technologie om specifiek N- en C-terminal peptiden te selecteren via diago-
nale chromatografie [13]. Geen van deze methodes is echt doorgebroken als standaardtechnologie
voor C-terminale sequentiebepaling en er is dus nog steeds nood aan eenvoudige, gevoelige, en
robuuste analysetechnieken.
Het laboratorium voor Eiwitbiochemie en Biomoleculaire Engineering (L-ProBE) heeft een rijke
geschiedenis in het ontwikkelen van methoden voor C-terminale sequentieanalyse. In 2005 werd
een C-terminale sequentieanalyse techniek ontwikkeld die gebruik maakt van carboxypeptidasen
om C-terminale sequentieladders te genereren in peptidefragmenten bekomen na behandeling
van eiwitten met cyanogeen bromide (CNBr) [14, 15]. Tijdens de splitsing van eiwitten met
CNBr worden alle peptidebindingen C-terminaal van methionine verbroken en wordt het termi-
nale methionine omgezet naar een homoserinelacton. Het C-terminale peptide is het enige dat
een carboxyl terminus heeft en gedegradeerd kan worden door carboxypeptidasen. Het doel van
dit project was deze techniek verder te verfijnen door enkele van de belangrijkste beperkingen
weg te werken en zo een geautomatiseerd C-terminale sequentieanalyse platform te ontwikkelen.
De voornaamste beperkingen van de techniek waren verbonden aan het gebruik van carboxypep-
tidasen. De enzymatische activiteit van carboxypeptidasen is immers sterk afhankelijk van
zowel het af te splitsen C-terminaal aminozuur als van de volgorde van de aminozuren van het
peptide, waardoor de snelheid waarmee de C-terminale degradatie gebeurde zeer sterk afhing
van de aard van het peptide. Sommige aminozuren worden zelfs helemaal niet afgesplitst. We
hebben nu een strategie voor chemische selectie ontwikkeld die het gebruik van carboxypepti-
dasen overbodig maakt. Door de homoserine lacton ringen gedeeltelijk te openen in een licht
basische bufferoplossing worden alle interne en N-terminale peptiden tijdens MALDI TOF
MS analyse geobserveerd als een doublet, met 18 Da massa verschil, terwijl het C-terminaal
peptide als enige als singlet geobserveerd wordt. De sequentie van dit C-terminale fragment
wordt vervolgens eenvoudig en met verhoogde gevoeligheid bepaald met behulp van MS/MS
analyse. De techniek werd zowel voor eiwitten in oplossing als gel gescheiden eiwitten geop-
timaliseerd. Om de throughput van de technologie te verhogen werd de staalvoorbereiding
ge¨ımplementeerd op een Tecan Freedom Evo 150 robot platform. Als proof-of-concept werden
96 2D-PAGE gescheiden eiwitten van de bacterie Shewanella oneidensis, zowel met de manuele
CPase gebaseerde techniek, als de geautomatiseerde chemische selectie techniek geanalyseerd.
Met de geautomatiseerde chemische selectie technologie werden drie keer meer eiwitten ge¨ıdenti-
ficeerd dan met de manuele CPase techniek, terwijl de staalvoorbereiding 10 maal sneller verliep.
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De resultaten van de manuele chemische selectie techniek zoals toegepast op eiwitten in oplossing
en gel gescheiden eiwitten werden in 2010 gepubliceerd in het tijdschrift Journal of Proteomics
[16]. De automatisatie van de techniek en de resultaten van de vergelijkende studie op 96
S. oneidensis stalen werden in 2014 gepubliceerd in het open access tijdschrift EuPA Open
Proteomics [17].
Bij deze chemische selectie technologie wordt een MALDI TOF/TOF MS instrument gebruikt
voor de massaspectrometrische analyse. Uit analyse van de S. oneidensis dataset is gebleken
dat slechts een beperkt aantal C-terminale peptiden een massa hebben die optimaal is voor een
goede MS en MS/MS detectie. C-terminale CNBr peptiden zijn typisch te groot. Door aan het
CNBr-reactiemengsel een kleine hoeveelheid KI toe te voegen treedt een splitsing op na zowel
Met als Trp [18]. Tijdens deze oxidatie wordt Trp omgezet tot een Cγ-O-spirolactonderivaat.
Omdat dit spirolactonderivaat chemisch gelijkaardig is aan het homoserinelactonderivaat, kon
verondersteld worden dat de lacton functies zich in de chemische selectie technologie gelijk
zullen gedragen. De reactieparameters voor de splitsingsreactie werden geoptimaliseerd en de
reactieproducten en zijreacties gekarakteriseerd. Tijdens de splitsingsreactie worden eveneens
alle disulfidebruggen verbroken en de cyste¨ınes geoxideerd tot cyste¨ınezuur. Hierdoor wordt
het mogelijk om de gebruikelijke reductie-, alkylatie en ontzoutingsstap over te slaan. De
gecombineerde partie¨le spirolacton- en homoserinelactonring opening werd getest bij twee
eiwitten, waarbij het C-terminale peptide in het PMF mengsel kon ge¨ıdentificeerd worden
en bij e´e´n eiwit de sequentie via de novo sequencing bepaald kon worden. Ondanks het feit
dat tryptofaan ook een laag abundant aminozuur is (1.25 %), stijgt de theoretische aantal
eiwitten waarvan de C-terminale sequentie kan worden bepaald met de novo sequentieanaly-
se met een kleine 10 % tot ongeveer 42 % van het totale aantal eiwitten in een bacterieel genoom.
De chemische selectie strategie kan enkel toegepast worden op eiwitten die vooraf met 2D-PAGE
gescheiden zijn. 2D-PAGE is een methode met veel intrinsieke beperkingen, waardoor men
steeds meer overgaat tot LC-MS gebaseerde terminale sequentie analyse technieken [12, 13, 19].
In dit proefschrift wordt een nieuwe LC-MS compatibele techniek voorgesteld. In onze methode
worden de vrije carboxylgroepen van een eiwit (zijketens en C-terminus) gederivatiseerd met
piperazine groepen, waarna de eiwitten gedigereerd worden met trypsine (of een protease met
een andere specificiteit). Vervolgens worden de interne peptiden met een vrije carboxylgroup
gekoppeld aan een resin, waarbij enkel het C-terminale peptide in oplossing blijft en geanalyseerd
kan worden met (LC-)MS. Door de aanwezigheid van een piperazine groep op de C-terminus
kunnen echte termini tijdens de MS analyse van vals positieven onderscheiden worden. De
initie¨le resultaten, optimalisatie van derivatisatie en koppeling van interne peptiden aan de
resin, worden hier voorgesteld.
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Door de ontwikkeling van de chemische selectie techniek en de uitbreiding ervan met splitsing
C-terminaal na methione en tryptofaan, is nu een platform ontwikkeld dat intrinsiek een
eenvoudige, robuste en snelle C-terminale sequentie bepaling toelaat. Bovendien werd de basis
gelegd voor een methode die niet langer afhankelijk is van 2D-PAGE technologie. Deze methoden
kunnen in de toekomst gebruikt worden ter ondersteuning van genoomannotatieprojecten. De
technieken kunnen ook leiden tot de identificatie van proteolytische processing van eiwitten,
een proces waarvan eerder is aangetoond dat het een belangrijke impact kan hebben op de
functie van een eiwit en in verband is gebracht met neurologische en hart-en vaatziekten [20].
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Summary
The achievements in genome research, e.g. the completion of the Human Genome Project, pro-
vided a treasure of valuable biochemical and biomedical information. In the meantime the focus
shifted towards the biological interpretation of this genome information. Proteomics entails the
large scale identification, quantification and characterization of the final gene products, i.e. the
proteins and their post-translational modifications. Monitoring protein expression profiles and
protein modifications remains a very challenging task because of the wide dynamic range of
expressed levels of proteins and the variability of gene products due to the presence of splicing
variants, N- and C-terminal processing, and co- and post-translational modifications (PTMs)
[1]. Truncations of the nascent polypeptide chain at the N- or C-terminus are by far the most
common types of PTMs found in proteins. Although these modifications are known to alter
the biological activity of a protein, relatively little attention has been paid to the development
of approaches for the systematic analysis of proteolytic processing events.
Systematic analysis of protein termini could also contribute to more accurate and reliable
genome annotation. Currently, multiple algorithms for gene prediction and gene homology are
combined to provide more reliable gene annotations. In proteogenomics, proteomics data is used
as an additional factor to confirm or correct theoretically predicted genes [2–6]. Determining
the exact C-terminus of the final protein product is one of the major challenges in this field.
Over the years, multiple methods have been developed to determine the C-terminal sequence
of proteins. Initially chemical sequencing methods, complementary to Edman degradation,
were developed. The derivatization of the much less chemically reactive carboxylic acid group
proved to be exceedingly more challenging, limiting the sensitivity and robustness of these
methods [7]. Later, several mass spectrometry based techniques were reported including limited
protein hydrolysis [8] or the analysis of in-source decay fragments using a MALDI TOF mass
analyzer equipped with a LIFT module [9]. In some techniques, C-terminal peptides were
selectively enriched or labelled; e.g. enrichment using anhydrotrypsin columns [10] and labelling
with 18O isotopes during proteolysis [11]. Recently, a number of LC-MS based methods have
been developed to determine protein termini. Ion exchange separations were used to enrich
N-terminally blocked and C-terminal peptides [12], the COFRADIC technology was applied to
specifically select N- and C-terminal peptide through diagonal chromatography [13]. None of
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these methods entered into a mature state of wide scale usage, so there is still a demand for
simple, sensitive and robust sequencing technologies.
The Laboratory for Protein Biochemistry and Biomolecular Engineering (L-ProBE) has a
history in developing new methods for C-terminal sequence analysis. In 2005, a new method
was reported in which carboxypeptidases (CPase) are used to selectively generate C-terminal
sequence ladders in a mixture of cyanogen bromide (CNBr) cleaved proteins [14, 15]. During
CNBr cleavage, all Met-Xxx peptide bonds are cleaved and all methionine residues are converted
to homoserine lactone. During digestion with carboxypeptidase, only the original C-terminal
fragment is accessible to enzymatic degradation and forms a ladder. The main goals of this
project were to further improve the technique by eliminating some of its limitations and to
automate the improved method, so that it can be applied to complex biological samples in a
high-throughput setup.
We have now developed a strategy to chemically select the C-terminal peptide, eliminating the
use of CPases. In this chemical selection method, all homoserine lactone residues, present in
internal and N-terminal peptides generated by CNBr cleavage, are partially opened in a slightly
basic buffer and are observed as a doublet, with 18 Da mass difference, during MALDI TOF
MS analysis. This allows discriminating the C-terminal peptide, observed as singlet, which can
then be identified by MS/MS. The protocol was optimized both for proteins in solution and
gel-separated proteins. The sample preparation throughput was improved by implementing the
technology on a Tecan Freedom Evo 150 robotic platform. As a proof-of-concept 96 2D-PAGE
separated Shewanella oneidensis proteins were analyzed using both the manual CPase based
protocol and the automated chemical selection procedure. We identified three times more
proteins using the chemical selection technology, while sample preparation was 10 times faster.
The results obtained by applying the manual chemical selection technology on proteins in
solution and gel-separated proteins were published in 2010 in Journal of Proteomics [16]. The
implementation of the technology on an automated platform and the results of the differential
study on 96 S. oneidensis samples were published in 2014 in the open access journal EuPA
Open Proteomics [17].
In the chemical selection technology, a MALDI TOF/TOF instrument is used for MS analysis.
The S. oneidensis dataset showed that only a limited number of C-terminal peptides have a
mass in the optimal MS and tandem MS range. The peptides generated after CNBr cleavage
are often relatively large. Adding KI to the CNBr cleavage mixture induces cleavage C-terminal
of both methionine and tryptophan [18]. During this oxidative halogenation Trp is converted
to a Cγ-O-spirolactone tryptophan. The structural resemblance between the reaction products
SUMMARY 9
offered the likelihood of a similar behavior during chemical selection incubations. We optimized
the protocol and characterized the reaction products and the side reactions. During protein
cleavage, also disulfide bridges were cleaved and cysteine residues were oxidized to cysteic acid.
This allows to eliminate the standard reduction, alkylation and desalting step. Using two test
proteins, we were able to identify both C-terminal peptides in a PMF mixture after combined
partial spiro- and homoserinelactone ring opening. In one of the cases we were also able to
obtain the C-terminal sequence after de novo interpretation of the fragment spectrum. Even
though tryptophan is also a low abundant amino acid (1.25 %), the theoretical number of
proteins that can be identified by de novo sequencing is raised by 10 % to around 42 % of the
total protein complement of a bacterial genome.
The chemical selection technology requires proteins to be separated by 2D-PAGE prior to ana-
lysis. To circumvent the limitations associated with 2D-PAGE, recently, several LC-MS-based
terminal sequencing technologies have been presented [12, 13, 19]. We also present a new LC-MS
compatible technology. In our method free carboxyl groups of a protein (both side chains and
C-terminus) are derivatized using piperazine groups followed by digestion with trypsin (or
any other protease with different specificity). Next, the internal peptides, containing a free
carboxylgroup are coupled to a resin. The C-terminal peptide remains in solution and can be
analyzed using (LC-)MS. The presence of the piperazine group at the C-terminus of the proteins
allows differentiating real protein termini from false positives. The initial results, optimizing
the derivatization reaction and coupling of internal peptides to the resin, are presented here.
By combining the initial chemical selection technology with the cleavage C-terminal of methio-
nine and tryptophan, a platform has been developed that allows C-terminal sequence analysis
in a simple, robust and high-throughput way. In the future this sequencing platform can be
applied to support genome annotation projects. It can also be used to study proteolytical
processing events, a process that can significantly alter the function of a protein and has recently
been connected to neurological or cardiovascular diseases (Petrera 2014). To circumvent the
limitations associated with 2D-PAGE separations the initial results of an alternative LC-MS
compatible sequencing strategy has been presented [20].
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Part I
General Introduction

Chapter 1
Proteomics and mass spectrometry
1.1 Introduction
The Human Genome Project was completed a decade ago [1] and resulted in 20.135 annotated
unique genes, a lot less than the anticipated 100.000 [2]. This led to a paradox; why are there
so few genes in the human genome compared to organisms that are considered less complex?
The cabbage genome, for instance, encodes twice as many genes compared to humans, 41.174.
Many other organisms have a similar number of genes as humans. The Drosophila genome
contains 15.016 genes and Caenorhabditis elegans contains 20.470, so where does the extra
information come from that makes humans distinct from other organisms [3]?
It soon became clear that organism complexity is generated by a complex proteome rather than
by a complex genome. The estimated number of protein forms encoded by these genes is two
to three orders of magnitude higher. The proteome is defined here as the time- and cell-specific
protein complement of the genome. It encompasses all proteins that are expressed in a cell
at a certain moment, including isoforms and protein modifications. Whereas the genome is
constant for one cell, largely identical for all cells of an organism, and does not vary a lot within
species, the proteome is very dynamic with time and in response to external factors, and differs
substantially between cell types and subcellular localizations [4]. At the DNA, RNA and protein
levels, complexity can arise from allelic variations, from alternative splicing of RNA transcripts
and from many post-translational modifications, respectively. These events create distinct
protein molecules that modulate a wide variety of biological processes, from cell signaling inside
or between cells to gene regulation and activation of protein complexes [5]. The successor of
the Human Genome Project, the Human Proteome Project was launched in 2010 by HUPO
(Human Proteome Organization) to identify and understand the function of all proteins in the
human body and to map the human proteome on a disease- and chromosome-centric basis [3].
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1.2 Information flow in Biology
The central dogma of molecular biology describes, in its simplest form, the information flow
in biological systems from deoxyribonucleic acid (DNA) to DNA during replication or DNA
via ribonucleic acid (RNA) to a synthesized protein during respectively transcription and
translation [6] (Figure 1.1). While DNA forms a catalogue of the biomolecular information of an
organism, mRNA serves as a messenger to transfer that information in the cell. Proteins form
the functional entities of an organism, although several processes are known where RNA is the
effector molecule, e.g. tRNA, rRNA and different forms of small RNAs. Both transcription and
translation are regulated quantitatively and qualitatively, and together provide a quick protein
response to environmental changes. A single DNA sequence can encode multiple proteins due to
a variation in translation start and stop sites, translational frame shifting, and in eukaryotes also
by alternative splicing, the use of alternative promoters and RNA-editing. Mainly in eukaryotes,
the proteins can also undergo a wide range of co- and post-translational modifications. The
different processing steps and quantitative regulation steps explain why no simple correlation
can be made between the expression levels of genes and proteins [7, 8].
Figure 1.1: Overview of the different information flows according to the central dogma of molecular
biology. Flows in green only appear in certain organisms. Reverse transcription is typical for retroviruses,
like HIV. RNA replication is common in RNA viruses [9].
Several different scientific disciplines focus on the different steps in the central dogma, genomics
(study of the genome) [10, 11], transcriptomics (study of transcriptome) [12, 13], proteomics
(study of the proteome) and metabolomics (global study of the metabolites) [14, 15]. By
combining data from different omics technologies, system biologists are able to get a holistic
view on the complexity of biological systems.
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1.3 Proteomics: definition, challenges and technology
The original definition of the term “protein complement encoded by a genome” does not reflect
the dynamic properties of what is currently known as the proteome [16]. A more comprehensive
definition could be “proteomics is the study of all proteins expressed at a given moment under
given circumstances by a specific type of cell or tissue”.
The enormous complexity of the proteome makes the development of appropriate technology
for its analysis extremely challenging. Proteins are not only distributed over all cell structures,
some are water-soluble cytoplasmic proteins and others are membrane-associated or integral
membrane proteins, requiring different extraction and purification methods. Protein expression
levels differing by 12 orders of magnitude in biological samples have been observed, asking
for techniques with a very large dynamic range [17]. Post-translational modifications can
result in significant activity difference, but often affects only a small fraction of the total
amount of an expressed protein. Unlike for oligonucleotides, no amplification technique is
available for proteins to overcome the problem of detection limits. Proteomic methods are
typically biased to the more abundant proteins. Several affinity based depletion techniques
have been reported. Up to 20 of the most abundant proteins from blood serum samples can be
depleted, but even if the depletion is 99.9% successful, those 20 proteins are still 109th-fold more
abundant than many of the important signaling proteins [18]. Therefore, extensive separations
prior to analysis are necessary to characterize the total protein complement of a biological sample.
The introduction of two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) in 1975
by O‘Farrell can be considered as the birth of proteomics [19]. Proteins are first separated
according to their pI value during an iso-electric focusing step in the first dimension. In the
orthogonal second dimension the proteins are separated on the basis of their molecular weight
by sodium dodecylsulfate polyacrylamide gel electrophoresis. Although the power of large
2D-PAGE gels has been demonstrated by separating thousands of proteins, the approach has
some serious limitations [20, 21]. Hydrophobic and low abundant proteins, as well as those
with extreme pI values are often missed. In addition, the technique is labor intensive and is
not amenable for automatic high-throughput analysis. Alternatively, complex protein mixtures
can be separated using liquid chromatography and capillary electrophoresis. Although multiple
types of resins are available for protein chromatography, none provides sufficient resolution to
be considered as an alternative to 2D-PAGE for protein-based separations [22].
Two fundamental breakthroughs facilitated protein identification of unknown protein mixtures,
i.e. the complete sequencing of genomes and the development of two mass spectrometric
(MS) ionization techniques. Prior to these achievements separated proteins were identified
using Edman sequencing, a method that lacks the sensitivity and throughput to systematically
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characterize 2D-PAGE separated protein spots.
Due to these fundamental developments, proteomic approaches were focusing on mass spectro-
metry based gel-free peptide-centered methods. Techniques in which peptides are separated and
analyzed using MS are called ’bottom-up’ or ’shotgun’ proteomics approaches, as opposed to
’top-down’ approaches where intact proteins are separated and characterized by MS. In shotgun
proteomics experiments, proteins are enzymatically cleaved and the resulting complex peptide
mixture is chromatographically separated prior to MS analysis. These separation steps are
necessary to reduce the sample complexity, because even high-resolution mass spectrometers are
unable to handle the large amount of peptides generated after digestion of thousands of proteins.
Trypsin is typically used as protease in bottom-up approaches. It cleaves C-terminal of Arg and
Lys residues, and due to the natural abundance of these two amino acids in proteins, peptides
are generated that fit the m/z range of mass analyzers [23]. Recently the use of multiple
proteases has gained attention (LysC, ArgC, AspN, GluC). They are complementary to trypsin
as they increase the proteome coverage of the identified peptides [24]. In order to separate
these complex mixtures a combination of multiple and/or different LC methods is required.
The group of John Yates III first developed an online method coupling two-dimensional liquid
chromatography to tandem mass spectrometry. In this method a microcapillary column was
packed with two independent chromatographic phases, strong cation exchange phase (SCX)
and C18 reverse phase (RP) (Figure 1.2). The technique was called Multidimensional Protein
Identification Technology (MudPIT)[25]. Together with the protein identification algorithm
SEQUEST, it constituted the first automated platform for proteome analysis [26, 27]. Aside
from SCX-RP, several other 2D-LC setups have been found to provide sufficient orthogonality
[28]. Combining two reverse phase separations, the first one at pH 10, the second one at pH
3, have been described [29]. Although peptide hydrophobicity remains the major separation
parameter, sufficient orthogonality is achieved using RP-RP LC. Depending on the conditions
(pH <pI or pH >pI) certain residues (Arg, His, Lys, Asp, Glu) either gain a charge and become
hydrophilic, or lose their charge and become hydrophobic. During ’off-line’ coupled separations,
the eluent of the first chromatographic separation is collected and re-injected for the second
separation. In ’online’ techniques, the samples are directly transferred from the first dimension
column to the second dimension column.
1.4 Mass spectrometry
Mass spectrometry has become the method of choice for the analysis of complex protein samples.
MS-based proteomics is a discipline made possible by the availability of gene and genome
sequence databases and technical and conceptual advances in many areas, most notably the
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Figure 1.2: A schematic overview of the MudPIT approach. Both SCX and RP resin are loaded into
an ESI needle. By alternating increasingly stronger salt pulses with reverse phase gradients, peptides
are eluted from the material [30].
discovery and development of soft ionization techniques, as recognized by the 2002 Nobel Prize
in chemistry [31].
A mass spectrometer generally consists of three compartments, an ion source, a mass analyzer
and a detector. In the ion source, analyte molecules are charged and transferred into the
gas-phase before being passed onto the mass analyzer. Using an electrical or magnetic field, a
mass analyzer separates the gas-phase ions according to their mass to charge (m/z) ratio. A
detector registers the ions in a quantitative way.
Multiple mass analyzers can be put in series, usually with a fragmentation unit in between them.
This setup allows to perform so called ’tandem MS’. The precursor ion is selected by the first
mass analyzer, is fragmented in the fragmentation unit, and the second mass analyzer separates
the newly formed fragment ions. A peptide sequence can be determined from the generated
MS/MS spectrum. In hybrid instruments multiple types of mass analyzers are combined, e.g.
Q-TOF.
Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) are the
two techniques most commonly used to volatize and ionize the proteins or peptides for mass
spectrometric analysis [32–34]. ESI ionizes the analytes out of a solution and is therefore readily
coupled to liquid-based (for example, chromatographic and capillary electrophoresis) separation
tools. MALDI sublimates and ionizes the samples out of a dry crystalline matrix using laser
pulses. MALDI-MS is normally used to analyze relatively simple peptide mixtures, whereas
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Figure 1.3: Workflow of a typical proteomic experiment. First the proteins are extracted from a
sample and subjected to fractionation, before being enzymatically digested into a peptide mixture and
identified by mass spectrometry. This reduction in complexity can either be achieved by using gel-based
separation methods, such as two-dimensional gel electrophoresis (A) and geLC (B), or by using multiple
HPLC separations of the proteins (C) or peptides (D) before MS identification.
integrated liquid-chromatography ESI-MS systems (LC-MS) are preferred for the analysis of
complex samples. There are five basic types of mass analyzers currently used in proteomics
research: the ion-trap, time-of-flight (TOF), quadrupole, orbitrap and Fourier transform ion
cyclotron resonance (FT ICR-MS) analyzers. They are very different in design and performance,
each with its own strengths and weaknesses [35].
AB Sciex 4800 plus MALDI TOF/TOF
All our experimental work was designed for and performed on a MALDI TOF/TOF instrument.
Therefore, in this introduction we restrict the technical part on an outline of this specific set-up.
In our work, an Applied Biosystems SCIEX 4800 Plus Proteomic analyzer was used (Figure
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1.4). The MS was operated in two different modes, the reflector MS and the tandem MS mode.
In the tandem MS mode, the MALDI-generated analyte ions are separated in the first TOF
analyzer. A time-ion selector is used to isolate and transfer the precursor ion into the collision
cell, where the selected ion is fragmented. The fragment ions are then reaccellerated by the
second source and separated by the second TOF analyzer. In the reflector MS mode the analyte
ions are not fragmented and both TOF analyzers are used in series, resulting in a longer flight
path and higher resolution. The different elements of a MALDI TOF/TOF instrument are
discussed in more detail below.
Figure 1.4: Schematic overview of the 4800 Plus MALDI TOF/TOF analyzer.
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1.4.1 Matrix-Assisted Laser Desorption/Ionization (MALDI)
In the Matrix-Assisted Laser Desorption/Ionization (MALDI) process, the sample is mixed with
a solution of low-molecular weight matrix molecules and spotted on a solid metallic MALDI
target plate. The matrix and analyte molecules co-crystalize on the plate [36]. Ionization
is achieved by irradiating the target with a pulsed laser, typically an Nd-YAG or N2 laser
generating light in the UV-spectrum. The matrix molecules (e.g. α-cyano-4-hydroxycinnamic
acid for peptide analysis and 3,5-dimethoxy-4-hydroxycinnamic acid for protein analysis [37, 38])
have an absorption maximum at or near the wavelength of the laser and are sublimated from
the target plate along with the analyte molecules. Analyte molecules are ionized in the gas
phase by proton transfer from the matrix to the analyte. Although well studied, the precise
nature of the ionization process in MALDI remains under discussion [39–41]. After ionization
the, mostly single, charged ions are accelerated by a voltage applied to a grid and extracted
from the source towards the mass analyzer (Figure 1.5).
Figure 1.5: Principles of the Matrix-Assisted Laser Desorption/Ionization (MALDI) process.
1.4.2 Time of Flight (TOF) Analyzer
A Time of Flight analyzer is essentially a long vacuum tube with an ion-source at one end and
a detector at the other (Figure 1.6) [42]. The ions, typically generated by the MALDI process,
are accelerated towards the field-free region by an electric field Ve generated by the applied
grid voltage at the source. The kinetic energy (Ekin =
1
2mv
2) of an ion in the field-free TOF
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tube equals the acceleration energy it has received during the extraction (Eacc = zVe). The
flight time of an ion (t) therefore depends on the mass-to-charge ratio (m/z) of the ion and the
length of the flight tube (x), according to formula 1.1;
t =
(
m
z
· x
2
2Ve
) 1
2
(1.1)
According to this equation, ions with a lower m/z ratio reach the detector earlier than ions
with a higher m/z ratio, so separating them. Despite the simple concept, early TOF analyzers
achieved poor resolution. As not all ions are formed simultaneously and at the same distance
from the grid, they obtain a different kinetic energy, causing a broadening effect. This can be
countered by adding a reflector to the flight tube and by so called ’delayed extraction’ of the
ions from the source [43–45]. The use of a reflector unfortunately lowers the sensitivity and
imposes an upper m/z limit [46].
Figure 1.6: Overview of a TOF analyzer.
1.4.3 Collision cell
In a collision cell peptide ions are typically fragmented by collision-induced dissociation (CID),
also referred to as collisionally activated dissociation (CAD). The precursor ions enter the
collision cell at high kinetic energy and collide with neutral gas (He, N2, Ar or Air). The loss
of kinetic energy during the impact is converted into internal energy, resulting in bond cleavage
and the formation of smaller fragment ions. On the AB MALDI TOF/TOF, depending on the
mode, the collision cell is operated at 7 or 6 kV, respectively causing a 1 or 2 kV potential
difference between the source (8 kV) and the collision cell. This potential difference causes
the analyte molecules to fragment. Additionally neutral gas can be added to the collision cell,
mainly resulting in the fragmentation of side chains and the formation of internal peptide ions.
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Fragmentation mainly occurs along the peptide backbone, and the most labile bond in gas
phase peptides is the peptide bond. The different fragment ions formed are named according to
a standardized nomenclature (Figure 1.7)[47]. The generated fragment ions form a (sometimes
interrupted) series of masses, each representing a peptide fragment differing from the next
by one amino acid. As such, peptide sequences can be determined from the tandem mass or
MS/MS spectra.
Figure 1.7: Nomenclature for the product ions generated after peptide fragmentation by tandem mass
spectrometry. E.g. when the peptide bond is fragmented, the peptide fragement ion containing the
N-terminus is called a b-ion, the fragment ion containing the C-terminus is called a y-ion.
1.5 Identification of proteins from peptide maps and MS/MS data
Besides de novo sequencing, where sequence tags are (manually) derived from tandem MS
spectra and searched against protein databases using BLAST algorithms, two strategies are
commonly used to identify proteins from MS-generated data, Peptide Mass Fingerprint (PMF)
and Peptide Fragment Fingerprint (PFF). Both techniques require a protein database of the
analyzed species or at least of a very closely related species. During PMF, a 2D-PAGE or
chromatographically separated protein is proteolytically digested and the resulting peptide
mixture is analyzed by MS. Every protein digested by an enzyme with known specificy will
produce a specific series of peptide masses, called a ’mass fingerprint’. A protein can be
identified by matching the experimentally obtained mass list against in silico generated PMFs
of all proteins in the database. A scoring algorithm ranks the hits according to plausibility.
Today, different database search algorithms are available that are differing mostly at the level
of the scoring algorithm; examples are: MASCOT [48], SEQUEST [49], X!Tandem [50] and
Paragon [51].
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Similarly, in peptide fragment fingerprinting (PFF) the experimental MS/MS spectra of peptides
are searched against a protein database. The search algorithm first selects all peptides in
the database that are isobaric to the precursor after cleavage with a selected enzyme. These
peptides are then in silico fragmented and the resulting peptide fragment fingerprints are
compared with the experimental MS/MS spectrum. The most commonly used PFF search
algorithms are MASCOT [48] and SEQUEST [49]. PFF analysis is used in shotgun proteomics
experiments because PMF information is lost by the enzymatic cleavage of the proteins carried
out prior to separation.
1.6 Alternative fragmentation techniques and Top-down Proteomics
Besides the very common combination of CID with an ion-trap or TOF analyzer, other tandem
MS techniques are available for protein identification and characterization. Although these
techniques can be used to characterize peptide mixtures, their main application lies in top-down
proteomics studies. Currently both the FT-ICR and orbitrap analyzers are capable of determi-
ning the mass of intact proteins with high resolution and mass accuracy [52–54]. Although the
intact protein mass can be used to confirm the structure of proteins with a known sequence, the
information remains insufficient to identify unknown proteins and proteins containing different
co- and post-translational modifications.
Fragmentation of the intact protein and interpretation of the fragmentation spectra provides
additional information than the determination of the intact mass alone. To obtain this infor-
mation, electron capture dissociation (ECD) and electron transfer dissociation (ETD) are two
fragmentation techniques often implemented in high resolution mass analyzers. During ECD
the analyte ions are bombarded with low energy electrons in the ICR cell. The interaction of
the multiple charged analyte ions and the electrons results in the formation of odd electron
ions that fragment into product ions. A similar process occurs in ETD, where radical anions of
anthracene and azobenzene are used to transfer an electron to the multiple charged analyte
ions. The ETD process is typically performed in a linear ion trap coupled to a high resolution
analyzer. Whereas during CID, peptide bonds are fragmented after introduction of vibrational
energy and intramolecular rearrangements, while ECD and ETD use a faster, non-ergodic
process to fragment bonds more uniformly along the peptide backbone and predominantly
generate c- and z-ions as opposed to b- and y-ions in CID [55–59].
In bottom-up proteomics approaches, C-terminal peptides are often not observed. Internal
tryptic peptides always contain at least one positive charge, C-terminal peptides are often very
small or have no positivly charged residue, limiting their detection in MS. The uniform frag-
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mentation along the protein backbone by ECD and ETD allows deriving continuous sequence
information, including the terminal regions, from tandem MS spectra. Some post-translational
modifications, such as phosphorylations and glycosylations, are typically lost during the CID
fragmentation process, but remain intact during ETD and ECD fragmentation. Multiple
tandem mass analyzers have been used to obtain post-translational modification and terminal
sequence information of small proteins; ESI-ECD-FTICR [55, 60, 61], ESI- Infrared multiphoton
dissociation (IRMPD)-FTICR [62], ESI-IRMPD+ECD-FTICR [63–65], ESI-ETD-LTQ [66].
Besides the described post-source fragmentation techniques, also in-source fragmentation tech-
niques have been applied to study protein sequences; for example the T3-sequencing approach
on a MALDI LIFT-TOF/TOF [67, 68].
Most of the techniques can only be applied on relatively large amounts of small purified proteins
and generate very complex datasets. Currently, the high cost and the difficulties accompanied
with the purification of intact proteins prevents top-down approaches to compete with the
existing bottom-up approaches. We will therefore focus on bottom-up approaches.
1.7 Quantification
Besides proteomic profiling, where a list of identified proteins is generated, most proteomic
studies compare multiple environmental or disease states of an organism. The oldest differen-
tial proteomic method uses 2D-PAGE profiles to determine changes in protein abundance by
comparing spot intensities. The intensities of Coomassie- or silver-stained protein spots can be
compared, or proteins can be differentially stained with fluorescent dyes prior to 2D-PAGE
separation (difference gel electrophoresis, DIGE) to determine the relative protein abundance
in multiple samples using protein image analysis software [69].
Bottom-up MS-based proteomics, GeLC-MS/MS and MudPIT, can also be employed to deter-
mine differences in protein expression levels across samples. Relative or absolute quantification
of peptides involves either label-free or label-incorporated approaches to discern differences in
protein abundance among different biological conditions. Many reviews discuss the different
label and label-free methods currently available; an overview is given in Table 1.1 [70–73].
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1.8 Terminomics
C- and N-terminomics can be defined as the proteome wide-analysis of protein C- and N-termini
and their modifications.
In solution due to solvation, most protein termini are exposed at the protein surface and
often serve as recognition sites for receptors. Several protein domains have been reported to
specifically interact with protein C-terminal regions, e.g. PDZ and tetratricopeptide repeat
(TPR) domains [86, 87]. The interactions of these protein domains with various terminal
epitopes plays an important role in a broad range of physiological functions. Some of these
functions include protein trafficking, subcellular anchoring of proteins, targeted protein degra-
dation, and formation of macromolecular complexes. These interactions are often regulated by
post-translational modifications (PTM) of the terminal regions [88].
While N-termini, e.g. due to the presence of an initiator methionine and the presence of a signal
sequence for protein targeting, are often redundant, C-termini are very specific. Wilkins et al.
evaluated the possibility to identify 2D separated proteins on the basis of short N- or C-terminal
protein tags. C-terminal tags of 4 amino acids were found to be unique in up to 97% of the
proteins, depending on the species studied [89]. While studying terminal sequences of all open
reading frames in yeast, Li et al. showed that both previously characterized and new terminal
sequences are conserved with the same frequency as functionally important, experimentally
confirmed signals. This was also found in other organisms. It was shown that proteins can even
be functionally classified based on their termini [88, 90].
Several modifications specific to protein termini are reported in Unimod, an online database of
known protein modifications (www.unimod.org) [91]. These modifications are known to change
protein interactions and alter the turn-over rate of proteins, e.g. causing deviation of the N-end
rule that links protein half-life to the N-terminal amino acid [92]. 11 amino-terminal PTMs
are defined including acetylation, mono-, di- and trimethylation, formylation, carbamylation,
succinylation, cyclization, propionylation, palmitoylation and myristoylation. N-acetylation
and cyclization have been studied in depth at the mechanistic and proteome-wide level [93–95].
The C-terminus of a protein is inherently less reactive than the N-terminus, resulting in fewer
PTMs. C-methyl-esterification is the most frequently annotated modification of the carboxyl
terminus, but with only 17 cases reported in human, 6 in mouse and 7 in yeast, it remains
underexplored [96]. C-terminal isoprenylation, cholesterol-esterification and addition of gly-
cophosphatidylinositol (GPI) anchors are involved in membrane targeting and trafficking. The
limited number of described and observed C-terminal modifications might not reflect reality,
but may rather be due to the lack of appropriate technologies [97].
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The ‘Termini-oriented protein Function Inferred Database’ (TopFIND http://clipserve.clip.ubc.
ca/topfind) acts as central repository and information resource to combine the information on
protein termini, limited proteolysis and protein interactions via termini [98].
1.9 Proteogenomics
Proteogenomics has emerged as a field at the intersection of genomics and proteomics. The
aim of the field is to improve and verify gene prediction and gene annotations using proteomic
data. Several bioinformatics tools have been developed to improve the matching of MS/MS
derived peptide sequences to genomic loci in pro- and eukaryotes [99–104]. Proteomic data has
been used to confirm translation, determine reading-frames, identify gene and exon boundaries,
provide evidence for post-translational processing, identify splice-forms including alternative
splicing, and predict completely novel genes [99].
Traditionally, proteomic studies could only be performed on organisms with a sequenced
genome, or on evolutionary close relatives. Nowadays, using next-generation sequencing, draft
genomes can be generated at low cost for any organism. Proteogenomic software tools allow
to identify tandem MS data using these draft genomes, eliminating the need for expensive
and time-consuming gene annotation. In 1995, Yates et al. already presented a software tool
to search un-interpreted mass spectra against a six-way translated nucleotide database [105].
However, the true added value of the current proteogenomic studies comes from the use of
these peptide identifications in gene finding [99].
Since the initial studies [106, 107], numerous proteogenomic reannotations of genomes have been
reported [108–112]. To improve gene annotation, genome sequencing of bacteria and archaea is
often performed in parallel with proteogenomic studies: Mycoplasma mobile [107], Thermococcus
gammatolerans [113], Campylobacter concisus [114], and Acholeplasma laidlawii [115]. The
exact translation initiation codon and the signal peptide maturation sites can be deducted from
protein N-terminal sequences. Multiple N-terminal sequencing technologies have been applied in
proteogenomics studies [109, 116]. In a study on Deinococcus deserti, 664 N-terminal peptides
were observed, leading to the correction of 63 translation initiation codons in the genome [117].
Similar results have been reported for other bacteria, such as for Salmonella typhimurium [118],
Shigella flexneri [119], Ruegeria pomeroyi [120], and Pseudomonas fluorescens [121], indicating
10% incorrectly predicted initiations of translation.
The genomic structure of genes differs between prokaryotes and eukaryotes. In prokaryotes,
related genes are clustered in operons. They share the same promotor and are transcribed
into a single mRNA. Regulation of the individual expression levels occurs at the translation
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level. Programmed frame-shifts can produce alternative or truncated proteins and are nearly
impossible to predict solely from genomic data. In most eukaryotic genes, the coding regions
(exons) are interrupted by non-coding regions (introns). During RNA-splicing, introns are
removed and exons are joined and form mature mRNA. In many cases, the splicing process
can create multiple unique proteins by combining the exons in different ways, a process called
’alternative splicing’.
Currently, most sequenced genomes are annotated using automated annotation pipelines without
manual curation. Gene finding algorithms try to identify the operons in prokaryotes, and
the genomic coordinates of exons and the splicing patterns in eukaryotes. They combine
evidence from multiple orthogonal sources [122]; ab initio gene predictors, large scale transcript
sequencing projects and evolutionary conservation among related species. Predicting translation
start sites remains a major challenge [123]. Genes that differ in GC composition change coding
signals, to the point that the tools have to be ’retrained’ for each new genome [124].
The most commonly used start codon is AUG, coding for the amino acid methionine during
translation. Several codons are indicators of the translation stop of which TGA, TAA and TAG
are the most common. To be able to determine the correct translation stop site, the frame of
the terminal exon needs to be correctly predicted first. Both in pro- and eukaryotes, alternative
start codons have been reported, e.g. GUG and UUG of the lac-operon in Escherichia coli.
During proteogenomic studies, many non-standard start sites have been observed and used for
reannotation of existing genomes [117, 125].
Despite cDNA evidence, 4000 genes in human do not translate into protein [126]. Currently
most gene prediction algorithms are only being trained using transcript sequencing data.
The data collected in proteogenomic experiments can be used to improve the performance of
self-learning gene annotation algorithms. Since C-terminal peptides are underrepresented in
standard proteomics data sets, C-terminal sequencing technologies are very useful to generate
data sets of protein termini for proteogenomic purposes.
1.10 Degradomics
Limited proteolysis, also known as protein processing, is one of the many known post-
translational modifications. Proteases hydrolyze protein substrate bonds at the protein termini
(exoproteases) or inside (endoproteases) their protein substrate targets. Proteolysis can be
divided into two general classes: sequential maturation and protein partitioning. During
sequential maturation a functional protein part is formed by cleavage of a propeptide. The
propeptide is often degraded. During protein partitioning two new protein species are formed
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with usually unrelated properties [127]. In either way, new protein termini are formed that
are susceptible to further modification, such as acetylation [128]. Given the irreversible nature
of proteolysis, proteases require tight regulation. In vivo, interactions with natural protease
inhibitors, post-translational modifications (including removal of propeptides) and subcellular
substrate/protease compartmentalization are important regulatory mechanisms for protease
activity. Many physiological processes (e.g. food processing and blood clotting) are controlled
by proteolytical processing, often interconnected in a protease web [129]. During a large
scale evaluation of thirteen terminomics datasets from Homo sapiens, Mus musculus, and
Escherichia coli show that >30% of all N-termini and >10% of all C-termini originate from
post-translational proteolytic processing other than classical protein maturation (removal of
the initiator methionine, signal peptide and pro-peptide) [130]. More recently, in skin, for 50%
of the >2000 identified proteins evidence was found for the presence of stable cleavage products
in vivo [131]. Infectious microorganisms, viruses and parasites also use proteases as virulence
factors. Animal venom often contains proteases to evade host responses and degrade tissue
[132]. Many human diseases are associated with uncontrolled proteolytic activities, including
cancer [133, 134]. Therefore, proteases represent attractive drug targets.
In 2002 Lopez-Otin defined degradomics as all genomic and proteomic investigations and
techniques regarding the genetic, structural and functional identification and characterization of
proteases, and their substrates and inhibitors, that are present in an organism. The definition of
a degradome is twofold: the complete set of proteases that are expressed at a specific moment,
or circumstance, by a cell, tissue or organism. Hence the degradome of a protease is defined as
the complete natural substrate repertoire of that enzyme in a cell tissue or organism [135].
In MEROPS (http://merops.sanger.ac.uk), the protease database, all information regarding
proteases and their inhibitors is combined [136]. Proteases represent a large enzyme family,
with 567 members in humans, but more than half of these proteases have no annotated substrates.
In 2008, Schilling et al. presented a procedure called Proteomic Identification of protease
Cleavage Sites (PICS) to determine both the prime (C-terminal) and non-prime (N-terminal)
side residue preferences of endoproteases, using database searchable proteome-derived primary
amine protected peptide libraries. After incubation with a protease, prime side cleavage prod-
ucts are tagged with biotin, isolated and identified by MS. The corresponding non-prime side
sequences are derived from databases using bioinformatics [137].
Specific analysis of cleavage sites in denatured peptides does not allow to identify native
substrates. The COFRADIC technology developed by the group of Gevaert and the TAILS
technology developed by the group of Overall allow to differentially study the effect of a protease
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on a proteome. These approaches generate terminal sequence information by ’negative’ selection
of terminal peptides [97, 138, 139]. The TAILS technology was used to study skin inflammation
using protease knock-out and wild type mice [131]. A four-way cross-comparison of healthy and
inflamed skin revealed a mechanistic insight on the role of proteolysis in inflammation. Several
terminal modifications, in particular pyroglutamate formation and an alternative translation
initiation site, were also observed.
Proteolytic cleavage also creates novel substrate C-termini, and analyzing these is complementary
to N-terminal proteome studies, given that not all protein N-termini can be identified because
of problems related to retention on RP columns and peptide ionization and fragmentation.
Further, protein neo-C-termini directly point to substrates of the largely unexplored family
of carboxypeptidases. Positional proteomics on protein C-termini remains very challenging,
mainly because of the lower reactivity of carboxyl groups versus amino groups [139].
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Chapter 2
Terminal sequencing technologies
2.1 Introduction
Techniques for sequencing terminal protein regions are a crucial element of terminomics, pro-
teogenomics and degradomics studies. Due to the difference in reactivity of the functional groups,
N-terminal sequencing techniques have always been more successful than C-terminal sequencing
techniques. Indeed, most methods start with a specific chemical or enzymatic reaction to modify
the terminal amino acid that is subsequently released and identified. However, N-terminal
labelling is not possible when the N-terminus is ’blocked’, e.g. by acetylation, which occurs
in as many as 85% eukaryotic cytosolic proteins and which plays an important role in protein
stability and protein turnover [1–4]. Furthermore, protein N-termini are highly susceptible
to ’trimming’ by various aminopeptidases, resulting in proteins that have N-termini missing
one, two, or three N-terminal amino acids [5, 6]. This can be problematic when attempting to
identify proteolytic cleavage sites, since the N-terminal residue of a neo-N-terminal peptide may
not reflect the initial cleavage, but may reflect subsequent trimming events. These drawbacks
are less prominent in C-terminal labelling approaches because protein C-termini are rarely
blocked compared to N-termini [7] and are not as susceptible to trimming [8].
In the early 50s the first entire protein sequences were determined by chemical sequencing,
using paper electrophoresis and spot staining, and later also liquid chromatography and UV
detectors, to separate and identify amino acids, mostly in the form of derivatives. With the
introduction of soft ionization techniques a new range of mass spectrometry-based sequencing
methods was introduced, rapidly followed by the launch of positional proteomics. Below is a
detailed overview of these strategies with some examples of N-, but mainly C-terminal sequence
determination.
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2.2 Chemical sequencing techniques
2.2.1 Sanger sequencing
Frederick Sanger was the first to elucidate the sequence of an entire protein, insulin. After
performic acid oxidation of the cystine bridges, the two subunits were characterized [9–11]. The
primary structure of these subunits was determined using a mixture of partial acid hydrolysis,
2D-paper chromatography and N-terminal labelling using fluorodinitrobenzene (Sanger-reagent).
In 1958 Sanger was awarded the first of his two Nobel prices for the structural work on insulin.
2.2.2 N-terminal Edman degradation
Pehr Edman from Lund University in Sweden introduced the chemistry for the automated
N-terminal amino acid sequence determination in 1950 [12]. To submit a protein to Edman
sequencing, the protein must first be immobilized on a support. Nowadays, the sample is
typically electroblotted from a gel onto a porous polyvinylidene fluoride (PVDF) membrane.
The Edman chemistry cycle consists of three stages; a coupling, cleavage and conversion stage
(Figure 2.1). In the coupling step, phenylisothiocyanate (PITC, Edman reagent) is attached
under mildly basic conditions (pH 9) to the uncharged α-amino function at the N-terminus
of the protein. The newly formed phenylthiocarbamyl (PTC) moiety is cleaved off by adding
neat trifluoroacetic acid (TFA). During this cleavage step an unstable cyclic anilinothiazolinone
(ATZ)-derivative of the N-terminal amino acid is released from the rest of the unaltered protein.
The ATZ-amino acid is extracted from the support and transferred to a conversion flask while
the remaining polypeptide can undergo a new coupling step. In the conversion stage the ATZ-
amino acid converts into a stable phenylthiohydantoin (PTH)-derivative after treatment with
25% TFA in water. At the end of each cycle of Edman degradation, the PTH-amino acid is sepa-
rated from reaction by-products and identified by its retention time using C-18 reversed-phase
HPLC, combined with UV-absorbance detection. Although not part of the Edman degrada-
tion cycle per se, the PTH amino acid analysis step is essential in the protein sequencing process.
The success of the Edman chemistry depends largely on the actual sequence of the peptide of
interest. During the reactions, cysteine residues are degraded and therefore, in order to be
detected, they need to be modified prior to analysis [13–16]. N-terminally blocked proteins
(acetylated, formylated or pyroglutamyl ending) have no free amino group to react with the
PITC reagent and have to be ’deblocked’ prior to analysis [17, 18].
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Figure 2.1: The three steps of Edman degradation. Step 1: Coupling of PITC to N-terminal amino
acid under basic conditions (trimethylamine) forming a PTC-peptide. Step 2: Cleavage under acidic
conditions generates a free amino terminus on the polypeptide and an ATZ-adducted amino acid. Step
3: Conversion of the ATZ-derivative to a PTH-amino acid after treatment with TFA (25%) [19].
The efficiency of the Edman degradation chemistry performed by automated protein sequencers
is typically at or above 95%. This allows 30 up to 50 amino acids to be determined in a single
run experiment typically starting from 1-50 pmol of separated peptide or protein. A single
cycle takes about 30-60 minutes making it possible to run these reactions over multiple days.
In order to obtain entire protein sequences, the proteins have to be cleaved and the resulting
peptides have to be separated and sequenced individually.
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Several by-products are reducing the efficiency. They are formed by reaction of PITC with
oxygen, water and dimethylamine, a degradation product of trimethylamine. To prevent the
formation of these by-products all reactions are performed under constant argon flow and
using ’sequencing-grade’ reagents. Besides these by-products masking the PTH separation and
interpretation, several other factors limit the reaction efficiency and sensitivity. The cleavage
reaction requires a balance between complete cleavage of the ATZ-amino acid from the peptide
and unwanted acid cleavage at the other sites along the peptide chain. Each time a non-specific
cleavage of the peptide chain occurs, a new N-terminus is formed which can react with PITC,
causing the PTH-amino acid background to increase. Also contaminating proteins and free
amino acids present in the sample react with PITC, lowering the detection limit.
2.2.3 C-terminal chemical sequencing
The search for a chemical method for stepwise removal of amino acids from the C-terminal
end of proteins began early in the 20th century when Schlack and Kumpf applied the method
of Johnson and Nicolet, for conversion of acylamino acids to acylthiohydantoins, to a small
peptide. The thiohydantoin was then cleaved from the molecule with 1 M sodium hydroxide
[20, 21]. Although several methods for chemical sequence analysis have been developed, none
have reached the level of efficiency that is achieved using the N-terminal Edman degradation [22].
The nucleophilic α-amino group of the N-terminal amino acid residue permits a facile chemical
reaction with PITC under mild reaction conditions, resulting in high repetitive yields (95-99%).
The derivatization of the much less chemically reactive carboxylic acid group of the C-terminal
amino acid residue proved to be exceedingly more challenging. In several methods the poorly
nucleophilic carboxylic group is converted to a more reactive electrophilic functionality. The
almost indistinguishable chemical properties of main and side chain carboxyl groups limit the
possibilities for selective C-terminal modification. An oxazolone represents one of the very
few reactive intermediates that derive solely from the C-terminal carboxyl group of a protein [23].
Acetic anhydride is typically used to activate the carboxyl group forming mixed anhydrides.
The activation of the C-terminal carboxyl groups with acetic acid under basic conditions results
in the formation of an oxazolone, except for proline [24]. Under strong basic conditions or
in the presence of an acylation catalyst (pyridine), the C-terminal oxazolone can react with
excess activating reagent to form a less reactive O-acetylated oxazolone. This reaction is known
as the first step of the Dakin-West reaction. Lutidin is commonly used as weak base during
activation with acetic anhydride [25]. Mixed anhydrides tend to undergo aminolysis unless
counteracted by steric hindrance [26]. For this reason, trifluoroacetic anhydride is attractive for
the generation of oxazolones with very little possibility of activating the side-chain carboxyl
groups to amidation, but well promoting the sequential degradation of peptides [27]. The side
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chain carboxyl groups of C-terminal Glu and Asp residues are known to form cyclic anhydrides
[28]. Besides carboxyl groups, acetic anhydride also reacts with other functional groups, causing
unwanted side reactions. Amino and hydroxyl groups are acetylated, Ser and Thr side chains
are dehydrated and form an unsaturated oxazolinone. Phenol can be added to the reaction
to convert the oxazolone to a more stable ester and avoid the side-chain acylation of tyrosine
hydroxyl groups by oxazolone-activated carboxyl groups. In turn, the ester can effectively react
with a nucleophile amine [29].
Figure 2.2: Thiocyanate chemistry: Reaction scheme for the sequential C-terminal degradation of
peptides using the thiocyanate chemistry. During the activation step, the C-terminal carboxylic group is
converted under basic conditions (lutidin) to a reactive electrophilic mixed anhydride or oxazolone. This
oxazolone is then derivatized to a thiohydantoin using a thiocyanate reagent under acidic conditions.
During the cleavage step, the thiohydantion is cleaved off generating a thiohydantoin derivatized amino
acid [30].
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The so-called thiocyanate degradation proved to be the most successful chemical C-terminal
sequencing method. Traditionally, the steps necessary for one complete cycle of the thiocyanate
chemistry have been referred to as the activation, derivatization, and cleavage steps (Figure
2.2). During the activation step the C-terminal carboxylic group is converted to a reactive
electrophilic mixed anhydride or oxazolone. This activated carboxylic group is then derivatized
to a thiohydantoin using a thiocyanate reagent under acidic conditions. Finally the thiohy-
dantoin derivative of the C-terminal amino acid is specifically cleaved off. Similar to Edman
degradation the thiohydantoin derivatives are identified using RPLC analysis. Since thiohy-
dantoin derivatives are more hydrophilic than phenylthiohydantoin derivatives, the separation
of the more polar amino acids remains challenging. Applied Biosystems and Hewlett-Packard
have automated two variations on the thiocyanate degradation using different activation and
cleavage reagents.
DPP-ITC method of Hewlett-Packard
The automated C-terminal sequencer from Hewlett-Packard combines the activation and deriva-
tization step, eliminating the use of acetic anhydride. Diphenyl phosphoroisothiocyanatidate
(DPP-ITC) and pyridine are used to convert the C-terminal amino acid of a peptide to a
peptidylthiohydantoin. The thiohydantoin is subsequently released through reaction with
potassium trimethylsilanolate [24]. The thiohydantoin derivative of the C-terminal amino acid
residue is separated and identified by RPLC analysis [31](Figure 2.3).
The use of DPP-ITC to form thiohydantoins was first reported in 1953, but due to slow kinetics
(several days) the reaction was abandoned [32]. The addition of pyridine to the reaction mixture
allows a complete conversion to a thiohydantoin in less than one hour at 50 ◦C [33]. After
reaction with DPP-ITC, pyridine is delivered in the gas phase resulting in the rearrangement
of the pentavalent acylphosphoryl isothiocyanate to the acyl isothiocyanate that rearranges to
a thiohydantoin under acidic conditions.
It is claimed that using this chemistry, all natural occurring amino acids can be converted to a
thiohydantoin. Proline forms a quaternary ammonium salt containing thiohydantoin. Unlike
formation of peptidylthiohydantoins with the other 19 commonly occurring amino acids in
which cyclization to a thiohydantoin is concomitant with loss of a proton from the amide
nitrogen, proline has no amide proton and, as a result, the newly formed proline thiohydan-
toin contains an unprotonated ring nitrogen. This cyclic structure, if left unprotonated, will
regenerate C-terminal proline during the cleavage reaction. By the addition of acid, the proline
thiohydantoin ring is protonated and stabilized. It can be hydrolyzed by the addition of water
vapor or sodium trimethylsilanolate to proline thiohydantoin and a shortened peptide. Since
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the TFA/water steps have no effect on peptidylthiohydantoins formed from the other 19 amino
acids, the additional steps required for proline can readily be integrated into the automated
sequencing program [34].
Because PVDF was not stable during the degradation reaction, Zitex (porous teflon) was
introduced as support to which the proteins were non-covalently bound. Due to the low initial
yield (10-50%) and the low repetitive yield, the sequence analysis of proteins is limited to about
5 C-terminal amino acids starting from nanomolar amounts of purified protein [35].
Figure 2.3: Hewlett-Packard chemistry: The detailed reaction scheme of the HP thiohydantoin C-
terminal sequence chemistry in which the activation and derivatization step are combined. The chemical
coupling reactions with diphenyl phosphorylisothiocyanate (DPP-ITC) generate a mixed anhydride
followed by the extrusion of phosphate with ring formation to yield the peptide thiohydantoin. The
subsequent chemical cleavage reaction with potassium thimethylsilanolate (KOTMS, a strong nucleophilic
base) releases the C-terminal amino acid thiohydantoin derivative from the shortened peptide [31].
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Alkylation chemistry method of Applied Biosystems
In 1992 a new method was described for C-terminal degradation, which was implemented,
on an automated sequencer by Applied Biosystems (Figure 2.4). The sequencing procedure
consists of converting the C-terminal amino acid into a thiohydantoin derivative, followed by
transformation of the TH into a good leaving group by alkylation of the sulfur atom with
2-bromomethyl naphthalene. The alkylated thiohydantoin is cleaved mildly and efficiently with
thiocyanate, which simultaneously converts the penultimate amino acid to a thiohydantoin [36].
The concomitant cleavage and derivatization implies that the activation must be performed only
once. The peptidyl-TH can form a resonance stabilized anion with a low pKa-value (around 7).
Therefore it can be alkylated rapidly in basic conditions.
Certain amino acid side chains such as Cys and Lys residues need to be modified prior to
analysis and the protocol was expanded with some additional chemical modification cycles
[37–39]. Besides the standard activation cycle, a second activation cycle was added. In the
first activation cycle, the carboxylterminus of the proteins is converted to an oxazolinone using
acetic anhydride and 2,6-dimethylpyridine. The oxazolone is then converted to a thiohydantoin
with tetrabutylammonium thiocyanate in the presence of TFA. During the second activation
cycle the side-chain carboxylgroups of Asp and Glu are selectively amidated to improve their
detectability, using piperidine thiocyanate in the presence of lutidine [25, 40]. To increase the
initial yield, the first cycle is repeated once more after the second activation cycle. Following
the activation cycles the proteinyl thiohydantoin is S-alkylated and in the same cycle an
acetylation is performed on the hydroxyl groups of Ser and Thr using acetic anhydride and
N-methylimidazole as catalyst. This cycle is called the ’OH-capping and sequencing cycle’ and is
followed by the cleavage of the alkylated thiohydantoin using tetrabutylammonium thiocyanate
and TFA vapors. The subsequent cycles only require alkylation and cleavage reactions, and the
ATH-products are analyzed using RPLC.
The inability to sequence through proline is one of the main problems in the use of this alkylation
chemistry. It was shown that the derivatization of N-acetylproline to proline thiohydantoin is
possible with a 100% yield [41].
Both sequencers are discontinued and no longer supported by their manufacturers, although
they certainly served a function in the characterization of protein termini of relatively pure,
mainly recombinant, proteins. The chemical sequencing techniques lack the sensitivity and
throughput to be succesfull on most biological samples.
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was formed using a 140C micro gradient system (Perkin-Elmer,
Applied Biosystems Division, Foster City, California) with the
following solvents: Solvent A (35mM sodium acetate buffer/3.5%
tetrahydrofuran/MQ-water) and Solvent B (100% ACN). The ATH
derivatives were monitored using a 785A absorbance detector set
at 254 nm and quantified relative to a 100 pmol ATH amino acid
standard. The methyl naphthyl thiohydantoin (mnth) amino acid
standards were obtained from the supplier (Perkin-Elmer, Applied
Biosystems Division, Foster City, California). The following
derivatives were included: acetyl-Tyr mnth, !-phenylcarbamoyl
Lys-mnth, piperidineamide Asp-mnth, piperidineamide Glu-mnth,
and 2-cyanothiomethylnaphthalene (ctmn).
RESULTS AND DISCUSSION
Description of the Automated C-Terminal Protein Se-
quencing Chemistry. C-terminal sequence analysis was per-
formed on a specially configured Procise sequencing platform
using the C-terminal sequencing chemistry (Figure 1) first
described by Boyd4 and most recently reviewed in 1995.5
In the first activation cycle, the C terminus of the immobilized
protein is derivatized with acetic anhydride and 2,6-dimethylpy-
ridine to a C-terminal oxazolinone (Figure 1, steps 1 and 2). This
oxazolinone is then converted to a thiohydantoin (TH) with
tetrabutylammonium thiocyanate in the presence of trifluoroacetic
acid (TFA) vapor (Figure 1, step 3). In a second activation cycle
the side-chain carboxyl groups of Asp and Glu are selectively
amidated using piperidine thiocyanate (Figure 2A). During the
first activation cycle, the side-chain carboxyl groups form mixed
anhydrides when reacted with acetic anhydride. Delivery of
piperidine thiocyanate generates piperidine which, under mildly
basic conditions (due to the presence of lutidine), selectively
amidates all Asp and Glu side chains. Since the proteinyl-
oxazolinone as well as the proteinyl-thiohydantoin are ionized
under basic conditions, these derivatives are less reactive toward
the nucleophile.11 To increase the initial yield, the first activation
(11) Boyd, V. L.; Bozzini, M.; Guga, P. J.; DeFranco, R. J.; Yuan, P.-M. J. Org.
Chem. 1995, 60, 2581-2587.
Figure 1. General scheme for the alkylation sequence chemistry. Reactions 1-2: Formation of C-terminal oxazolinone through reaction of
the C-terminal carboxyl group with acetic anhydride in the presence of 2-6-dimethylpyridine (lutidine). Reaction 3: Derivatization of the oxazolinone
with tetrabutylammonium thiocyanate in the presence of TFA vapors resulting in the formation of a proteinyl isothiocyanate which cyclizes to the
C-terminal thiohydantoin. Steps 1-3 are performed in the so-called “C-terminal activation 1” cycle. Reaction 4: Alkylation of the C-terminal
thiohydantoin with 2-bromomethylnaphthalene under basic conditions (2% DIEA/n-heptane). Reaction 5: ATH cleavage with tetrabutylammonium
thiocyanate in the presence of TFA vapors. Steps 4 and 5 are performed in the so-called “sequencing 1” cycle which is the default cycle during
sequence analysis. Reaction 5ʹ′: Since the cleavage generates the thiohydantoin of the penultimate C-terminal amino acid, the subsequent
cycles require only alkylation and cleavage reactions.
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Figure 2.4: Alkylation chemistry: The reaction sche e of the alkylation chemistry as aut mated by
Applied Biosystems. During the cleavage step, the penultimate amino acid is simultaneously converted
to form a thiohydantoin. During the activation steps (1 & 2) the C-terminal carboxyl is converted to an
oxazolone that in turn is derivatized by the thiocyanate reagent (step 3). During the alkylation step (4)
2-(bromomethyl) aphthalen is coupled to the thiohy toin under basic conditions forming a good
leaving group. Cleavage is induced by thiocyanate reagent under acidic conditions reforming an peptide
thiohydantoin [39].
2.3 MS-based sequencing techniques
In the early 90s MS analyzers were introduced as detectors in chemical sequencing setups
[34, 42]. When compared to the classic RPLC and UV characterisatio of ami o acids and thei
derivatives, MS analyzers offered advantages that included speed, sensitivity and the ability to
analyze post-tran lational modified amino acids [19]. However, they evidently did not overcome
the issues relating to the chemical sequencing strategies (increasing background after a certain
number of cycles, side reactions) and were never routinely used.
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The currently reported terminal sequencing methods are all based on a few strategies to obtain
that sequence. In the so-called ’ladder sequencing’ approaches a series of sequentially truncated
polypeptides is generated. Other techniques selectively target functional groups in order to
label, select or enrich the terminal peptide. Recently, LC-MS based methods were reported that
enrich terminal peptides using their physicochemical properties. The actual terminal sequence
of the protein is obtained in two ways: fragment spectrum analysis of the terminal peptide or
interpretation of polypeptide ladders observed in MALDI-MS.
2.3.1 Ladder sequencing techniques
In 1993, Chait et al. described the ladder generating chemistry as the controlled generation
of a family of sequence-defining peptide fragments from a polypeptide chain, each differing
from the next by one amino acid. The resulting sequencing ladder is analyzed by MALDI-MS.
Each amino acid is identified by the mass difference between successive peaks and the position
in the data set defines the sequence of the original peptide chain [43]. The initial chemical
ladder generating techniques were based on the known chemical degradation techniques. Chait
used a mixture of 95% PITC and 5% PIC during successive N-terminal degradation cycles
without intermediate separation or analysis of the released amino acid derivates. PIC serves as
a terminating reagent forming stable phenylcarbamyl peptides and so blocking a small portion
of the peptides at each cycle.
The group of Tsugita developed a chemical C-terminal ladder generating method using vapors
of fluorinated organic acids or their corresponding anhydrides. An oxazolinone is postulated
to be an intermediate [44]. However, the incubation of peptides in acids also results in the
cleavage of acid-labile bonds (i.e. at the C-terminal side of aspartic acid and the N-terminal
side of serine) [44]. The truncation with perfluoric acid anhydrides suppresses the cleavage of
internal peptide bonds and, as such, allows more specific C-terminal sequence analysis [27].
Due to the high reactivity of this reagent and the extremely low reaction temperatures required,
the truncation with perfluoric acid anhydride is not easy to perform. Reactive groups can
be protected from side reactions through acetylation prior to the truncation reaction. This
approach was used to determine the C-terminal sequence of intact proteins, like myoglobin, but
requires a lot of pure starting material [45, 46]. Controlled acid hydrolysis was used to generate
both N- and C-terminal peptide ladders [47, 48].
Whereas methods for N-terminal ladder sequence analysis are mainly based on chemical ladder-
generating procedures [43], proteolytic digestion is the preferred method to generate C-terminal
sequence ladders. Carboxypeptidase Y and P are the most common serine exopeptidases that
are used for this technique. In the initial carboxypeptidase (CPase) based techniques the
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sequence was obtained by analysis of the released amino acids. With the advancement of MS
techniques, it became possible to perform direct mass analysis on the peptide fragment ladders
formed by incubation of peptides and small proteins with CPase [49, 50]. In 2005, Samyn et al.
reported a method to selectively form C-terminal peptide sequence ladders from a mixture of
CNBr-generated peptides using CPase (Figure 2.5)[51, 52]. During CNBr cleavage, all Met-Xxx
peptide bonds are cleaved and all methionine residues are converted to a homoserine-derivative.
CPase does not cleave the homoserine lactone ending internal and N-terminal peptides. When
a mixture of CNBr generated peptides is incubated with CPase, only the carboxyl ending
C-terminal peptide will be degraded. The method has successfully been applied on a proteomic
scale and used to study proteolytic processing of procardosin A. CPases cleave off different
amino acids at different rates, while certain amino acids are not cleaved off at all [53]. Therefore,
to obtain optimal results, the digestion protocol should be specifically optimized for every
peptide. A detailed overview of the cyanogen bromide reaction mechanism, enzymatic ladder
sequencing techniques and their limitations are given in Chapter 3.
Figure 2.5: Schematic representation of the different steps in the CPase-based C-terminal sequencing
method. After reduction, proteins are cleaved by CNBr, generating homoserine lactone ending internal
peptides. Only the C-terminal sequence (Xxx-Yyy-Zzz) is accessible for enzymatic degradation by
(CPase) and forms a ladder that is analyzed by MALDI mass spectrometry. CPX represents a CPase or
mixture of CPases [52].
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2.3.2 Selective labelling of functional groups to distinguish terminal pep-
tides
Most of the currently reported techniques, chemically or enzymatically, target specific functional
groups in order to label, select or enrich the terminal peptide from the protease digest mixture.
The sequence of the terminal peptides is then determined by de novo interpretation of tandem
mass spectra. The carboxylic and α-amino groups are the obvious groups that are targeted
in these approaches. Several reagents and coupling resins have been reported to modify or
bind these functional entities. Some reagents discriminate between terminal and side-chain
functional groups. Before the different terminal techniques are discussed, the most commonly
used modification reagents are brought to mind.
Overview of commonly used reagents for amino and carboxyl group modification
Several reagents are available to modify the primary amino groups in proteins. As dis-
cussed above, the Edman reagent (PITC) can be used to modify all primary amino groups.
N-hydroxysuccinimide (NHS) and sulfo-N-hydroxysuccinimide (S-NHS) are commonly used
activating reagents for carboxyl groups (Figure 2.6). The formed (S)-NHS-esters react with
primary amino groups. Because the pKa of the α-amino group (pKa = 8.9) is considerably
lower than that of the -amino group of lysine (pKa = 10.5), it is possible to selectively label
the α-amino groups. Performing the reaction at lower pH ensures that the lysine amines are
rarely in the unprotonated state that allows them to react [54].
Under basic conditions (7 N NH4OH) O-methylisourea selectively modifies all lysines to ho-
moarginine residues [55–59]. Homoarginines have a higher pKa which has a positive effect on
MS detection. During chemical transamination, α-amino groups are selectively converted into
a carbonyl group [60, 61]. The selectivity is achieved by the direct participation of the adjacent
carbonyl oxygen. P-phenylene diisothiocyanate (DITC) glass originally used as new support
during solid phase Edman degradation, can be used to selectively bind free amino groups in a
mixture [62].
In peptide synthesis, carboxyl groups are traditionally coupled to amines using carbodiimides
as coupling reagents. The diimides react with both side chain and terminal carboxyl groups.
The reaction mechanism and conditions are discussed in detail in Chapter 5. Selective labeling
of the C-terminal carboxyl group is particularly challenging, since carboxyl groups have a
lower reactivity relative to amino groups, and the carboxyl group in aspartate and glutamate
residues exhibits a similar reactivity and moreover, is approximately 50 times more abundant
in a typical protein [63]. As was discussed in Chapter 2.2.3, an oxazolone represents one of
the very few reactive intermediates that derive solely from the C-terminal carboxyl group of
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a protein [23]. To limit undesired modification of Tyr side chains and hydrolysis in aqueous
solution, Yamaguchi et al. converted the oxazolone to a stable active ester by addition of
(pentafluoro)phenol. These active esters can in turn effectively react with a nucleophile sich as
NH2-Y [29, 64](Figure 2.7).
Figure 2.6: NHS and EDC coupling: formation of activated carboxylgroups using carbodiimide and
formation of amine reactive sulfo-NHS ester [65].
our approach has had substantial success in specifically enhancing
the MALDI response of leucine (Leu)-enkaphalin with an ap-
pended arginine methyl ester, it became apparent that improve-
ments in the generation of oxazolones were required along with
maximal suppression of side reactions. In particular, the method
had to be applicable to proteins dissolved in aqueous solutions at
very low concentrations, in which hydrolysis tends to compete
against the desired aminolysis of oxazolone, thereby reducing
reaction efficiency.
While treating Leu-enkephalin with acetic anhydride at 110 °C,
we unexpectedly found that the oxazolone-activated carboxyl
group reacted with the side chain of the tyrosine residue. The
resulting O-acylated peptide was identified as a minor MALDI peak
with about twice the molecular mass of Leu-enkephalin.9 This
suggested that oxazolones are potent enough to compete with
acid anhydrides for acylation of the phenolic hydroxyl group. Ac-
cordingly, we added a phenol to convert oxazolone into the more
stable ester. This approach avoided the side-chain acylation of
tyrosine residues and kept the R-carbonyl group susceptible to
aminolysis necessary for C-terminal modification. Some other side
reactions might also be suppressed by this approach because the
lifetime and, consequently, the concentration of oxazolone are
minimized. Based on these assumptions, we investigated in detail
a new method for C-terminal modification of proteins, a method
in which an oxazolone is converted to the corresponding active
ester, which in turn could effectively reacts with a nucleophile
(Scheme 1).
In this paper, we report the optimization of this method for
the application to proteins in aqueous media. Considering the sub-
sequent proteolysis of the modified protein, we examined the use
of 2-hydrazino-2-imidazoline (Imz-NHNH2) in place of the arginine
derivative as a nucleophile (Y-NH2 in Scheme 1) to avoid formation
of ordinary peptide linkages, which are susceptible to hydrolysis
by proteases. The hydrazine derivative can serve not only as a
nucleophile to react with the active ester but also as a potent
deacylating agent to recover the side-chain hydroxyl groups of
serine, threonine, and tyrosine. This approach simplifies the mass
spectra, making it easier to recognize the peak representing the
C-terminal peptide. The method was applied to a few short pep-
tides and small proteins in a variety of reaction conditions, the
goal being substantial simplification of MALDI spectra, ideally
consisting of only the peak of interest. The results led us to
suggest extension of the method for de novo protein sequencing.
EXPERIMENTAL SECTION
Materials. Synthetic Leu-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-
OH) and δ sleep-inducing peptide (DSIP: H-Trp-Ala-Gly-Gly-Asp-
Ala-Ser-Gly-Glu-OH) were purchased from Peptide Institute Inc.
(Osaka, Japan). Soybean trypsin inhibitor (STI), "-lactoglobulin,
ribonuclease A (RNase A; bovine pancreas), chymotrypsin (bovine
pancreas), and Glu-C protease (Staphylococcus aureus) were
obtained from Sigma. Other reagents, all reagent grade, were used
without further purification. The reduced and carboxymethylated
(RCM) proteins were prepared using dithiothreitol for the reduc-
tion of cystine and 2-iodoacetic acid for S-carboxymethylation of
cysteine residues as described in the literature.10
Mass Spectrometry (MALDI-TOF MS and MALDI-PSD
MS). MALDI-TOF mass spectra were recorded using an Axima
CFR-plus V2.3.2 (Shimadzu/Kratos, Manchester, UK) instrument.
A nitrogen laser (337 nm) was used to irradiate the sample for
ionization. The accelerating voltage of the instrument was set to
20 kV using a gridless-type electrode. Each spectrum was obtained
by accumulating the responses obtained from 150 to 250 laser
shots using the reflectron mode set to detect positive ions. We
chose R-cyano-4-hydroxycinnamic acid (CHCA) as the matrix,
which was saturated in 50% aqueous acetonitrile containing 0.05%
TFA. A portion (0.5 µL) of each sample solution was mixed with
0.5 µL of matrix solution on the MALDI target and analyzed after
drying. The m/z values of spectra were externally calibrated with
CHCA and angiotensin II.
MALDI-PSD spectra were obtained by focusing all the product
ions in a single spectrum by the curved field reflectron. External
PSD calibration used selected product ions generated from
angiotensin II. The spectra were obtained by collecting 500 laser
shots. To generate sufficiently abundant product ions in PSD
mode, we used somewhat increased laser power compared with
that employed in reflectron mode.
Derivatization of a Protein and Detection of the C-Termnal
Peptide. A protein (0.1-10 nmol) was dissolved in 200 µL of a
1:1 (v/v) mixture of acetic anhydride and formic acid together
with pentafluorophenol (Pfp-OH; 100 µmol), warmed at 60 °C for
20 min. After evaporation to dryness under reduced pressure, the
residue was dissolved in 200 µL of a solution containing 100-200
µmol of a nucleophile such as H-Arg-OMe or Imz-NHNH2, which
was neutralized by a slight excess of triethylamine, and allowed
to stand for a few hours at room temperature. The modified protein
(10) Crestfield, A. M.; Moore, S.; Stein, W. H. J. Biol. Chem. 1963, 238, 622-
627.
Scheme 1. Reactions of the C-Terminal Amino Acid of a Peptide (n Amino Acid Residues) To Be
Derivatized with an Amine (Y-NH2) through an Active Ester (COOX) Containing an
Electron-Withdrawing Group X
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Figure 2.7: Active ester formation via oxazolone: The C-terminal carboxyl group of a peptide reacts
with acid anhydride (acetic anhydride in formic acid, in this example) to form an oxazolone via a
mixe nhydride. The oxazolone is converted to a more stabl active ester COOX) containing an
elec ro -withd wing group X. The active ester in turn reacts with a nucleophilic reagent (Y-NH2) [29].
Labelling with a mass tag
Several methods have been reported to identify the terminal peptide in MS by the prese ce
o absence of c rtain isotopic distributions or mass differences. By selectively coupling a
Br-containing group to the C-terminal carboxyl function, a Br-isotopi signature is observed at
the C-terminal peptide in the MS spectrum. A Br-isotopic signature shows a doublet structure
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with 2 Da mass difference due to the unique isotopic distribution of bromine (50,7% Br-79;
49,3% Br-81). All y-ions in the fragment spectrum also show the same distribution, simplifying
the de novo sequence determination [64, 66, 67].
Several isotopic labelling strategies have been reported to allow identifying the C-terminal
peptide in a peptide digest mixture. The use of 50% 18O-labeled water during proteolytic digest
results in partially heavy labelled internal and N-terminal peptides. Multiple groups have used
the technique, although some with mixed success [68, 69]. The labelling efficiency is found to
be dependent on both the relative ratio H2
16O/ H2
18O in the digest buffer and on the nature of
the peptide formed in a y=x2 relation (y= labelling efficiency and x = relative H2
16O/ H2
18O
ratio). Once the free peptide is formed, back-exchange can occur where the peptide-trypsin
ester complex is reformed and subsequently hydrolysed. Depending on the ratio of 16O /18O
labelled water, this can induce the formation of doubly 16O- or 18O-labelled C-terminal groups.
Low pH buffer solutions can also induce back-exchange due to chemical hydrolysis. For trypsin
digests typical storage conditions are pH 3-4, low enough to keep the protease inactive and
high enough to limit chemical back-exchange [70]. Acylation and esterification using partially
d6-labeled reagents of respectively LysC and GluC generated carboxyl groups have also been
used to identify C-terminal peptides [69].
Mass tags can also be introduced by chemical modification of other groups. CNBr cleaves
C-terminal of methionine, converting methionine under acidic conditions to homoserine lactone.
Incubation of the peptide mixture with acidic methanol results in methanolysis of hsl, adding
32 Da to the peptide. The original carboxyl terminus is converted to a methyl ester, adding 14
Da to the peptide. By comparing the spectra before and after modification, the C-terminus
can be identified [71]. Nakazawa et al. developed a series of techniques that selectively modify
the C-terminal peptide using the oxazolone and the active ester of the oxazolone to specifically
introduce chemical groups at the C-terminus. Arginine methyl ester, 2-hydrazino-2-imidazoline
and 3-aminopropyltris-(2,4,6-trimethoxyphenyl)phosphonium bromide (TMPP-propylamine)
were introduced to enhance the response of the C-terminal peptides during MALDI-ionization
[26, 29, 72].
Labelling and enrichment
Since α- and -amine groups can selectively be modified, multiple techniques have been reported
to label and enrich the N-terminal peptide. In 2005, Beynon et al. reported a technique to
selectively recover N-terminal proteolytic peptides (Figure 2.8 b). All available amino groups
are blocked by acetylation using acetic anhydride. Subsequently, the protein is tryptically
digested and the newly generated amino groups are biotinylated. The biotinylated internal
peptides are removed by recovery onto immobilized avidin or streptavidin, leaving the acetylated
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N-terminal peptides in solution. If isotope-labeled acetic anhydride would have been used in
the initial labelling, it would have been possible to identify and discriminate between naturally
and chemically acetylated peptides [73]. Alternatively, all lysine -amine groups can be guani-
dinylated prior to N-terminal amine labelling with a NHS-SS-biotin group. After proteolytic
digestion the labelled N-terminal peptides can be positively selected using avidin (Figure 2.8 c)
[74, 75]. Variations have been presented where DITC is used to bind the newly formed α-amino
groups after selective introduction of a TMPP group at the protein N-terminus (Figure 2.8 e) [76].
In a strategy called N-terminalomics by Chemical Labeling of the α-Amine of Proteins (N-
CLAP), the Edman reagent (PITC) is used to label all amino groups. Reaction with TFA
selectively unblocks the N-terminus by removal of the N-terminal amino acid. Labelling of
the new amino group with Sulfo NHS-SS-Biotin allows affinity enrichment and elution with a
reducing agent [6]. In a technique called Dimethyl Isotope-Coded Affinity Selection (DICAS)
all amino groups are reductively aminated with formaldehyde, after trypsin digest the newly
formed amino groups are depleted using POROS-AL [77, 78] (Figure 2.8 d).
Similar methodologies have been developed where C-terminal peptides are isolated after α-amino
group modification combined with LysC digests. DITC glass was used to couple the -amine
groups and, together with the α-amino group labelling, MALDI response enhancing groups
were coupled to the C-terminal peptides [72, 79, 80]. The same group recently reported the use
of an Arginine-capturing material (m-aminophenylboronic acid-agarose) that, in combination
with ArgC, results in isolated C-terminal peptides [81].
Recently, a number of methods have been reported that combine mass and enrichment tagging
in multiple derivatization steps. The sequential derivatization reactions are performed while
the peptides are bound to the solid phase extraction support (C18 ZipTip). The reagents are
sequentially exchanged directly on the resin bed, eliminating intermittent sample purification
[82, 83].
Similar to ladder sequencing, enzymes can be used to selectively target peptide backbone
carboxyl functions. Anhydrotrypsin is a catalytically inert derivative of trypsin that binds
peptides containing lysine or arginine residues at their C-terminus without cleaving them.
Immobilized anhydrotrypsin can be used to bind all internal and N-terminal peptides generated
by Lys-C digest. The C-terminal peptides remain in solution and are analyzed by LC-MS [84].
Under certain reaction conditions carboxypeptidase Y (CPY), besides proteolysis, exhibits also
transpeptidase activity, in which an exogenous nucleophile, such as an amino acid, is added
to a protein. In the Profiling Protein C-Termini by Enzymatic Labeling (ProC-TEL) CPY
was used to couple a biotin group to the C-terminal carboxylgroup. After trypsin digestion
56 TERMINAL SEQUENCING TECHNOLOGIES
the C-terminal peptide could be targeted by avidin agarose [8]. A similar positive selection
N-terminal sequencing technique exists. A genetically constructed variant of the subtilisin
protease, subtiligase, is used to selectively biotinylate unblocked protein α-amines with absolute
selectivity over -amines of lysine side chains. Using 50 mg of starting material, 333 cleavage
sites in 292 proteins were characterized when the technique was used to study substrates
targeted by caspase-like proteolysis in Jurkat cells following induction of apoptosis [85].
Most of the previously described techniques use a negative selection step to identify the C-
terminal peptide. When a negative selection is made, the non-terminal peptides are the ones
that are targeted during the enrichment or MS step. The peptides that are not targeted are
the ones of interest. Because terminal peptides are far less abundant in a protein digest, the
enrichment steps need to be very performant to result in a sample that exclusively contains
terminal peptides. Some enrichment techniques using negative selection include an extra
modification step to incorporate a mass tag to give a second, positive identification argument
during MS/MS analysis. ProC-TEL was the first positive selection technique using enzymatic
labeling. The mass tag generated by TMPP serves to exclude false positive identifications. The
performance of most techniques depends largely on the length of the generated terminal peptide.
MALDI-based techniques cannot detect molecules below 1 kDa and above 5 kDa. Trypsin
is used in most techniques, but due to the relatively high amount of charged amino acids in
termini, mainly small terminal peptides are generated. Most techniques that use proteases
can also not be used when the terminal amino acid is the target of the modification. Proteins
ending on Arg and Lys also get 18O-labeled C-terminally by trypsin, Arg-ending peptides also
get linked to the m-aminophenylboronic acid agarose matrix.
2.4 LC-MS based proteome wide techniques for terminal sequencing
Similar to standard bottom-up strategies, all terminal sequencing strategies using MS as detector
suffer from sample complexity. By introducing an LC separation prior to MS analysis, more
complex samples can be analyzed. Several terminal sequencing techniques have been reported
to use chromatography as part of the terminal peptide enrichment and identification procedure.
Being able to identify 263 annotated and 87 unpredicted acetylated N-termini and 168 annotated
and 193 unpredicted C-termini in the crude membrane fraction of human embryonic carcinoma
cells, Heck et al. showed that a SCX separation results in the selective enrichment of acetylated
N-terminal tryptic peptides and C-terminal peptides [86]. In general, ignoring missed cleavages,
tryptic peptides have a lysine or arginine residue at the C-terminus and one free amine group at
the N-terminus. At low pH, most acidic residues will be neutral and thus the bulk of the peptides
generated will possess two positive charges and will co-elute under SCX chromatography.
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296 Techniques
Figure 3
Current Opinion in Microbiology 2009, 12:292–300 www.sciencedirect.com
Figure 2.8: Five approaches to specifically enrich N-terminal peptides are shown: COFRADIC
(a), acetylation and biotinylation (b), guanidinylation and biotinylation (c), DICAS (d) and TMPP
modification (e). N-terminal peptides analyzed by MS/MS are shown with a yellow background. The
first step common to all these strategies, consisting in reduction and alkylation of cysteines is not shown.
Depending on the strategy used, naturally blocked N-terminal peptides are depleted, enriched and
detected or directly analyzed. Alternatives (B1 and B2 and C1 and C2) have been proposed to deplete
internal peptides or enrich labelled peptides. In the COFRADIC method (a), eluted fractions 1 and 2
(more retained) from both reverse-phase chromatographies are schematized [87].
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Peptides formed from the protein C-terminus will lack a terminal lysine or arginine residue
and thus will contain a single positive charge. Peptides corresponding to the blocked (i.e.
N-acetylated) N-terminal peptide will also possess a single positive charge. C-terminal peptides
and blocked N-terminal peptides can thus be distinguished from other tryptic peptides on basis
of the difference in positive charge [88]. Gorman et al. first reported the isolation of terminal
peptides using cation exchange chromatography in 1993, but the technique was mainly used to
enrich tryptic posphopeptides [89, 90].
The group of Gevaert et al. set up one of the most successful proteomics platforms using
their COFRADIC technology. The approach is based on two papers describing the use of
diagonal paper electrophoresis and diagonal chromatography [91, 92]. Diagonal chromatography
essentially consists of two identical peptide separation steps with a chemical or enzymatic
reaction applied to the fractions in between. This reaction specifically alters the side chain of a
specific type of amino acids, thereby changing the chromatographic properties of the peptides
holding the targeted (altered) amino acids. The diagonal electrophoresis in combination with
Edman sequencing was used to identify the C-terminal peptide sequence of several test proteins
and of a Bacillus toxin [93, 94].
Gevaert et al. increased the throughput of the technique by combining several altered primary
fractions prior to secondary separations, hence the acronym Combined FRActional Diagonal
Chromatography [95]. Changing the reaction selects different classes of peptides. Similar to Iso-
tope coded affinity tag (ICAT) (see Table 1.1), the initial application of the technique focussed
on reducing the sample complexity by affinity isolation of a specific class of peptides prior to
analysis, the general idea being that when mass spectrometers are not flooded by peptides,
more peptide ions are finally fragmented and identified [96]. In the initial COFRADIC setup,
controlled oxidation of the side chain of methionine to its sulfoxide counterpart was used to
introduce a hydrophillic shift during the second chromatographic separation. Besides the initial
Met and Cys labelling techniques [95, 97], different procedures were later developed to study
different PTMs: phosphorylations [98], N-glycosylated peptides [99], sialylated N-glycopeptides
[100], as well as peptides holding conjugated ATP-derivatives [101] and, more recently, protein
ubiquitination identifying over 7500 endogenous ubiquitination sites in human Jurkat cell lysates
[102].
In 2003 the COFRADIC N-terminal peptide sorting protocol was presented [5]. After initial
alkylation of cysteines and acetylation of all free amino groups, the proteins were tryptically
digested (only C-terminal of Arg) and chromatographically separated. Twelve peptide fractions
were collected of this primary run and treated with 2,4,6-trinitrobenzenesulfonic acid (TNBS),
blocking all free amines. When the TNBS-treated fractions were individually rerun on the same
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column under identical conditions, the internal (trinitrophenyl)peptides had shifted to later
elution times (hydrophobic shift), whereas the unaltered N-terminal peptides eluted within
the same time interval and were collected in a number of secondary fractions. Proline and
pyroglutamate residues do not react with TNBS and are detected as false positives, together
with the N-terminal blocked peptides. Two additional steps were therefore added to the protocol
to eliminate these false positives, a SCX step and an enzymatic step liberating pyro/-glu/-
ta/-myl peptides. The SCX step reduces the complexity of the analyte mixture by enriching
N-terminal peptides and depleting α-amino free internal peptides, as well as proline-starting
peptides. Combined glutamine cyclotransferase (Qcyclase) and pyroglutamyl aminopeptidase
(pGAPase) incubation removes all pyroglutamyl residues. Using the improved protocol, 95% of
the COFRADIC sorted peptides were found to be α-amino acetylated [103].
In 2010 a slightly modified protocol was applied in a degradomics study to screen for human
protein substrates of granzyme B and carboxypeptidase A4 in human cell lyates (Figure 2.9).
Cell lysates, metabolically labeled with heavy amino acids were incubated with a protease,
or left untreated. Both samples were then treated as mentioned above, except for the use of
trideutero-acetylation to differentiate between in vivo and in vitro acetylation, and the use
of heavy and light NHS-C4-butyrate instead of TNBS (Figure 2.10). The two samples were
pooled prior to the secondary COFRADIC runs. Since the flow through of SCX at pH 3
should only contain α-amino blocked peptides and C-terminal peptides, all peptides that are
hydrophobically shifted after butyrate labelling can be identified as C-terminal peptides. Using
this approach 965 protein C-termini, 334 neo-C-termini resulting from granzyme B processing
and 16 neo-C-termini resulting from carboxypeptidase A4 processing were identified, besides
1621 protein N-termini [104]. Important to note is the complexity of the protocol and the data
sets generated: analysis of one sample results in a total of 52 RPLC runs (Figure 2.11). To
improve the peak capacity and protein identifications, multiple columns have been coupled and
ran at elevated temperatures, resulting in long runs and GC like resolution [105].
Figure 2.9: Outline of the COFRADIC based positional proteomics procedure using SILAC labeled cell
lysates. After protein S-alkylation, reduction and trideutero-acetylation of primary amines, the proteome
is digested with trypsin, which now only cleaves after arginine residues. Following pyroglutamate residue
removal amino-blocked and C-terminal peptides are enriched during SCX separation. Two parallel
RP-HPLC runs with equal amounts of peptide material from the control and the protease-treated
proteome are performed. Fractionated peptides containing α-amines (C-terminal peptides) are labeled
with different isotopic variants of the amine-reactive NHS-butyrate. Corresponding fractions in time
are pooled and reseparated by RP-HPLC, upon which butyrylated C-terminal peptides segregate from
the N-terminal peptides. In this way, N-terminal peptides, C-terminal peptides or both are selected for
LC-MS/MS analysis. Ac(D3) indicates in vivo free, thus in vitro trideutero-acetylated peptides, But
indicates butyrylated C-terminal peptides [104].
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BRIEF COMMUNICATIONS
We used this COFRADIC-based complementary positional 
proteomics approach to study processing by the human endo-
protease granzyme B (hGrB) in K-562 cell lysates. A stable isotope 
labeling by amino acids in cell culture (SILAC; ref. 7) 13C6-l-
Arg–labeled cell lysate served as a hGrB substrate pool, and a 
12C6-labeled proteome served as control, allowing quantifica-
tion of N-terminal peptides and of peptides with new N termini 
generated by protease activity (neo–N-terminal peptides) that all 
end in arginine. We also differentially tagged protein C-terminal 
peptides using N-hydroxysuccinimide (NHS) esters of 12C4 or 
13C4 butyric acid (Figs. 1 and 2a). After LC-MS/MS analysis, we 
identified 1,621 database-annotated N termini and 760 database-
annotated C termini (Supplementary Table 1a,b). In addition, 
we identified 248 neo–C-terminal peptides after processing at 
aspartic acid, 38 neo–C termini generated by cleavage after a P1 
glutamic acid and 48 neo–C termini generated upon process-
ing at other residues. Together, these 334 neo–C termini were 
found in 294 proteins (Supplementary Fig. 1 and Supplementary 
Table 1c). Furthermore, we identified 622 hGrB cleavage–
 generated neo–N termini in 498 proteins (Supplementary 
Fig. 1 and Supplementary Table 1d). The number of proteins 
identified by both their database-annotated terminal peptides 
was only 202 (we identified 2,516 proteins in total based on their 
(neo-)terminal peptides; Supplementary Fig. 1), whereas we 
identified only 45 cleavage sites (911 different cleavage sites iden-
tified) by both of their neo-terminal peptides (Supplementary 
Table 2), illustrating that higher proteome coverage resulted from 
the simultaneous analyses of both N- and C-terminal peptides.
The zinc-finger HIT domain-containing protein 2, cleaved at 
Asp150 was an example of a protein for which we obtained com-
plementary processing information. We identified the database-
annotated N and C termini of this protein as isotopic doublets, in 
addition to the neo–C terminus and neo–N terminus proteolytic 
signature peptides that we identified as singletons (Fig. 2b–f). The 
potential of using neo–C termini to identify protease substrates 
was exemplified by caspase-3: owing to its size, high hydrophobi-
city and the presence of a SCX-nontolerated histidine, processing 
of this well-established hGrB substrate at its activation site was 
not identified in a previous N-terminal proteomics screen8, but 
in this work, we documented it by identifying its complementary 
neo–C terminus, GTELDCGIETD (amino acids 165–175) 
(Supplementary Table 1c). Additionally, we identified 176 cleav-
age sites (53% of all sites identified by neo-C-terminal peptides) 
that were technically not assessable with the N terminus–only 
approach, highlighting the benefit of analyzing both termini (Fig. 2g 
and Supplementary Table 1c). iceLogo9 analysis identified nearly 
identical hGrB recognition motifs, independent of whether they 
originated from neo–N or neo–C termini (Fig. 3), indicating 
that no notable biases were introduced when delineating the 
hGrB consensus cleavage motif by analyzing any of the two types 
of peptides.
We used a similar setup to identify the substrate repertoire of 
the carboxypeptidase, human metallocarboxypeptidase CPA4, 
which is upregulated by histone deacetylase inhibitors during 
differentiation of prostate epithelial cancer cells10. We subjected 
a PC3 cell lysate to proteolysis by recombinant human carboxy-
peptidase A4 (hCPA4). By analyzing protein terminal peptides, 
we identified database-annotated N and C termini of 1,750 and 
687 human proteins, respectively (Supplementary Table 1e,f), 
leading to the identification of 2,238 proteins, for which we identi-
fied both termini of only 199 proteins. In addition, we identi-
fied 16 neo–C termini exclusively in the hCPA4-treated setup 
(Supplementary Table 3). For all neo-C termini identified, the 
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Figure 1 | Outline of the COFRADIC-based complementary positional 
proteomics procedure. SILAC-labeled cell lysates are incubated with a 
protease of interest (13C6-L-arginine sample) or left untreated (
12C6- 
L-arginine sample). After protein S-alkylation, reduction with tris 
(2-carboxyethyl)phosphine (TCEP) and trideutero-acetylation of primary 
amines, the proteome is digested with trypsin, which now only cleaves 
after arginine residues. Pyroglutamate residues are enzymatically removed 
by the combined action of glutamyl cyclase and pyrolidone-carboxylic 
acid peptidase (pGAPase). Then, SCX enrichment for amino-blocked 
and C-terminal peptides is performed. Two parallel RP-HPLC runs with 
equal amounts of peptide material from the control (fractions labeled 
1a–na) and the protease-treated proteome (fractions labeled 1b–nb) are 
performed. (“Ac” indicates in vivo acetylated N-terminal peptides, and 
Ac(D3) indicates in vivo free, thus in vitro trideutero-acetylated peptides. 
The dashed lines indicate the applied gradient of organic solvent to 
elute peptides.) Fractionated peptides containing A-amines (C-terminal 
peptides) are labeled with different isotopic variants of the amine-
reactive NHS-butyrate. Corresponding fractions in time (for example, 
fractions labeled 6a and 6b) are pooled and reseparated by RP-HPLC,  
upon which butyrylated (But) C-terminal peptides segregate from the  
N-terminal peptides. In this way, N-terminal peptides, C-terminal peptides 
or both are selected for LC-MS/MS analysis.
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ultimate residue corresponded to the penultimate residue of the 
protein sequence, indicating that hCPA4 acts as a monocarboxy-
peptidase. The fact that these 16 hCPA4 sites were picked up in 
a background of over 2,000 database-annotated protein termini 
highlights the sensitivity of our method, enabling the detection 
of rare processing events. In general, we found hydrophobic 
amino acids such as phenylalanine, isoleucine and leucine at the 
amino acid C-terminal to the scissile bond (P1` site), in agree-
ment with the known specificity of the hydrophobic S1` pocket 
of hCPA4, which accommodates the substrate’s P1` site (ref. 11). 
Furthermore, 11 neo-C termini had a lysine residue at one of the 
two positions N-terminal to the scissile bond (at P1 or P2 sites 
but never at both sites), and no lysine residue occupied the P3 
site, indicating that this carboxypeptidase most likely displays 
an extended specificity profile as observed in the case of peptidic 
substrates for metallocarboxypeptidase enzymes12 and is thereby 
likely to be highly specific in substrate processing. We also iden-
tified database-annotated C termini of 13 CPA4 substrates; for 
11 of these, we could calculate the extent of CPA4 proteolysis 
(Supplementary Table 3), information that is often lacking in 
protease studies. We observed efficient processing, indicated by 
ratio values of C termini differing significantly (P a 0.01) from the 
mean, for the substrates glutaminyl- and valyl-tRNA synthetase 
a
No hGrB
With hGrB
100
1,044.95
1,047.96
1,045 1,047
m/z m/z m/z
1,049
R
el
at
iv
e 
in
te
ns
ity
0
12C6L-Arg SCX COFRADIC
Butyrylation
12Arg
13Arg
13Arg
13Arg
12Arg
13butyrate
13butyrate
LC-MS/MS
analyses
12butyrate
13Arg
13C6L-Arg
b
f
g
Indentified
Identifiable
Not identifiable
C termini
13%
51%
36%
Complement of
N-terminal peptides
N termini
27%
40%
33%
Complement of
C-terminal peptides
Neo–C termini
6%
38%
56%
Complement of
neo–N-terminal peptides
Neo–N termini
11%
37%
52%
Complement of
neo–C-terminal peptides
100 878.93
876 878 880
R
el
at
iv
e 
in
te
ns
ity
0
c
100 546.31
543.28
543 545 547
R
el
at
iv
e 
in
te
ns
ity
0
d
100 486.27 488.28
486 488
m/z
490
R
el
at
iv
e 
in
te
ns
ity
0
e
Figure 2 | N- and C-terminal peptides provide  
complementary data. (a) Protein processing  
with hGrB yielded protein neo–N and neo–C 
termini (versus only N and C termini in the 
unprocessed sample), which we isolated by  
SCX and COFRADIC, and identified by LC-MS/MS.  
N-terminal, C-terminal, neo–N-terminal and 
neo–C-terminal peptides are colored in black, 
gray, blue and orange, respectively. Proteolytic 
processing events were assigned after  
differential-mass tagging. (b) Mass spectrum of 
the database-annotated protein N terminus of  
the zinc-finger HIT domain–containing protein 2,  
identified as Ac-MEPAGPCGFCPAGEVQPAR 
(residues 1–19; Ac, in vivo A-acetylation),  
and the ion intensities of the differentially 
labeled forms were about equal (ratio = 1.05) 
indicating that this peptide was not affected  
by hGrB treatment. (c) Mass spectrum of the 
neo–C terminus, But13C4-AGPQLLEELDNAPGSD 
(residues 134–150; But13C4, A-amino group 
modified by 13C4 butyric acid), which was only 
generated in the hGrB-treated sample. (d) Mass  
spectrum of the neo-N terminus Ac(D3)-
AAELELAPAR (residues 151–160; Ac(D3), 
A-trideutero-acetylated amino group), which 
was only generated in the hGrB-treated sample. 
(e) Mass spectrum of the C terminus of the zinc 
finger HIT domain-containing protein 2, identified as differentially butyrylated TLIEELPS (residues 396–403) peptides with about equal intensities  
(ratio = 0.96), indicating that this peptide was not affected by hGrB treatment. (f) The amino acid sequence of human zinc finger HIT domain–containing  
protein 2 (Swiss-Prot identifier Q9UHR6) with the identified peptides are indicated. (g) Summary of the contribution of the ‘identified’, ‘identifiable but 
unidentified’ and ‘unidentifiable’ complements of the identified N termini, C termini and hGrB treatment–specific neo–N termini and neo–C termini.
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Figure 3 | Sequence analysis of identified hGrB cleavage sites.  
(a,b) IceLogo representations of the 334 hGrB cleavage sites identified  
by analysis of neo–C termini (a) and the 622 hGrB cleavage sites 
identified by analysis of neo–N termini (b). Peptide sequences were 
aligned such that cleavage occurred between position P1 and P1`. 
Statistically significant residues (P < 0.01) were plotted, and amino acids 
heights are indicative for the degree of conservation at the indicated 
position. The frequency of the amino acid occurrence at each position in 
the sequence set was compared with that of the human protein sequences 
stored in the Swiss-Prot (version 56.0) database. Residues that were 
completely absent in the identified terminal peptides are shown in pink.
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Figure 2.10: Overview of isotopic labels used in COFRADIC for positional proteomics of granzyme B
(hGrB) treated and untread samples. N-terminal, C-terminal, neoN-terminal and eoC-terminal peptides
and spectra are presented in black, gray, blue and orange respectively. The database annotated N- and
C-termini are observed as is topic d ubl ts of 6 and 4 Da difference resp ctively (b and e), whereas the
neoC terminus and neoN terminus proteolytic signature peptides are identified as singletons (c, d) [104].
©
20
11
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
PROTOCOL
1138 | VOL.6 NO.8 | 2011 | NATURE PROTOCOLS
41| To obtain a final number of 36 samples for LC-MS/MS a al sis, secondary fractions (diffe ing 12 min in retention time) 
are combined during fraction collection. In Figure 2, for instance, the secondary fractions of C2, C3 and C4 are pooled.
M CRITICAL STEP Pooling the secondary fractions in combination with an increased orthogonality by switching from pH 
5.5 to 3 results in a busier chromatogram during LC-MS/MS analysis, thereby making more efficient use of the analysis time 
on the mass spectrometer45. This pooling also results in time gain of 75% of LC-MS/MS analysis; however, note that a more 
extensive pooling scheme will lead to suppression of peptide ionization and thus to less peptide identifications. As fractions 
are collected in vials suitable for the autosampler of the nano-LC, sample losses are minimized.
42| Dry all fractions completely.
J PAUSE POINT The dried samples can be stored at  − 20 °C for several weeks.
LC-MS/MS analysis L TIMING 39 h
43| Redissolve the secondary fractions in 20 Ml of nano-LC solvent A.
44| Analyze eluting peptides by using LC-MS/MS. In our hands, the use of an LTQ Orbitrap XL hybrid mass spectrometer with 
top 6 settings, in combination with the nano-LC gradient depicted in Table 2, on the indicated nano-RP-HPLC column has 
proven to be sufficient for the analysis of these samples.
M CRITICAL STEP Typically only one-tenth of each pooled fraction is loaded, as higher amounts can lead to column overload.
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Figure 2 | Examples of primary and secondary COFRADIC RP-HPLC runs. UV absorbance (at 214 nm) chromatograms of the primary (top) and secondary COFRADIC 
runs (middle) of a Jurkat T-cell proteome are shown (SCX flow-through peptide frac ion). During he primary separation, peptides are collected in 15 fractions 
of 4 min each (fraction C5 to A1, top). Every TNBS-modified primary fraction is then reseparated during 15 secondary separations, starting with fraction A1. 
During every secondary separation, peptides eluting 1 min before and 1 min after the primary collection interval are also collected to correct for possible peak 
broadening. Chromatograms of secondary runs are shown for prim ry fractions C2, C3 and C4 with the primary collection interval shown i  dark gray. In this way, 
12 secondary fractions of 30 s each are collected during every secondary separation. Fraction collection is such that all secondary ‘AXy’ (X, from 1 to 5, and y 
from 1 to 12) are collected together (similar for the ‘BXy’ and ‘BXy’ fractions) into fractions Ay, By and Cy, resulting in 36 samples for LC-MS/MS analysis. Bottom, 
fractions C2y, C3y and C4y are pooled into frac ion Cy. Ea h Cy fraction will also contain C1y and C5y, which, for the sake of clarity, are not shown here.
Figure 2.11: Exa ples f primar a d seco dary COFRADIC RP-HPLC runs. During the primary
run, 15 fractions f 4 minutes ach ar g ne ted. After modificatio , th se fraction are rerun. During
every secondary run, peptides eluting 1 mi ute before and 1 minute after the primary collection interval
are also collected to correct for possible peak broadening (light grey). That way 12 fractions of 30
seconds each are collected during every econdary separation. Multiple fractio of different secondary
separations are pooled as illustrated, resulti g in a total of 36 samples to be analysed on LC-MS/MS
[106].
62 TERMINAL SEQUENCING TECHNOLOGIES
In 2010, Overall et al. presented a C-terminomics procedure, a strategy for the specific isolation
and analysis of C-terminal peptides from complex proteomes [107] (Figure 2.12). After reduction
and alkylation of protein thiol groups, all amino groups are reductively methylated. All car-
boxylgroups are then protected by carbodiimide-mediated and N-hydroxysuccinimide-assisted
condensation with ethanolamine. Tryptic digestion yields a C-terminal peptide with a protected
carboxyl group, which differs from the internal and N-terminal peptides that have free C-termini.
These free C-termini are then coupled by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)
mediated condensation to the primary amines of a high-molecular weight linear polyallylamine
polymer. The blocked original C-terminal peptides remain unbound and are readily separated
from the polymer by ultrafiltration and analyzed by LC-MS/MS. The ethanolamine label serves
as positive identification criterium after the negative selection step. Prior to the coupling
step the newly generated N-termini of tryptic and C-terminal peptides are protected via a
second reductive methylation step. This prevents cross-reactivity, peptide concatamerization or
cyclization.
To quantify cleavage events specific to the protease of interest and to distinguish these from
proteolysis products present in an untreated sample, the group also introduced two stable isotope
label-based techniques to determine the relative abundances of peptides in protease-treated
and control samples, Terminal Amine Isotopic Labeling of Substrates (TAILS) and C-Terminal
Amine-based Isotope Labeling of Substrates (C-TAILS) [107, 108]. In TAILS, half of the staring
material is treated with a protease to form both a control and a protease-treated sample (Figure
2.13). In a reductive methylation step using light and heavy formaldehyde, all amines are
labeled prior to enzymatic digestion. All newly formed internal peptides are captured using an
amine-reactive polymer and the blocked N-terminal peptides are recovered by centrifugation
in a negative selection step and can be analyzed by LS-MS/MS. Similar to TAILS, a stable
isotope is incorporated in the tryptic peptides during the second reductive methylation step of
C-TAILS using the heavy isotopic form of formaldehyde [107]. An additional SCX step has
also been implemented to pre-enrich the acetylated N-terminal peptides prior to analysis, and
multiple proteases (trypsin, Lys-C and Lys-N) have been combined to cover a larger part of the
N-terminal proteome [109]. As part of the chromosome-centric Human Proteome Project, the
TAILS protocol has recently been applied to the human erythrocyte proteome identifying 1369
natural and 1234 neo-N-termini [110].
Overall et al. use in-house generated polymers to couple the peptides. To bind all free amines
in TAILS a dendritic hyperbranched polyglycerol aldehyde polymer of 100-600 kDa is used and
a 56 kDa linear carboxyl reactive polyallylamine polymer is used in C-TAILS. These polymers
have a binding capacity of 2.5 mg peptide/mg of polymer, a more than 10 fold improvement in
capacity over previous non-specific reactive resins. The improved sample recovery allows to
reduce the sample amount to around 100 µg [108].
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with ethanolamine, yielding a 1,532.8-Da species. We detected both 
peptide variants, when mixed, as single protonated ions ([M+H]+) 
by matrix-assisted laser desorption ionization (MALDI)–time of 
flight (TOF) mass spectrometry (Fig. 1b and Online Methods). 
After polymer-based enrichment, however, we detected only the 
C terminus–protected peptide by MALDI-TOF (Fig. 1b).
In a more complex setting, we selectively recovered the C-terminal 
peptides from bovine serum albumin (BSA) and B-casein and 
analyzed them by mass spectrometry (Fig. 1c,d). Before polymer 
enrichment, the C-terminal peptides were overshadowed by more 
intense tryptic-peptide ions and thus were in the lower third 
in terms of intensity (Fig. 1c). After polymer enrichment, the 
C-terminal peptides ranked as the two most intense ions in the 
mass spectrum (Fig. 1d) with Mascot scores of 128 for BSA and 
30 for B-casein after MS/MS analysis (Supplementary Fig. 1).
We then applied our C-terminomics approach to Escherichia 
coli lysates. We determined that carboxyl protection was >95% 
complete by dataset searches for unblocked aspartate or gluta-
mate residues after LC-MS/MS analysis. Before polymer enrich-
ment, two independent experiments both yielded ~98% internal 
tryptic peptides with free C termini (Fig. 1e and Supplementary 
Tables 1 and 2). After polymer enrichment, we identified 460 
peptides, of which >72% had a protected C terminus, from 196 
proteins in two separate experiments by MS/MS analysis (Fig. 1e 
and Supplementary Tables 3 and 4). Overall, the original 
protein C termini represented ~60% of the C-terminally protected 
peptides identified, whereas ~40% of the peptides originated 
from internal positions owing to proteolytic processing in the 
cell generating stable cleavage products (Fig. 1e). The exact dis-
tinction between ‘original’ and ‘proteolytically generated’ protein 
C termini depends on functional proteome annotation, which for 
protein start and termination sites is incomplete14. The amount 
of C-terminal processing was surprisingly high, yet similar to 
the ~50% of N-terminally processed proteins (excluding initia-
tor methionine removal) previously found in E. coli proteomes6.
Compared with previous C terminus–labeling approaches, 
such as aniline benzoic acid labeling analysis of Lactococcus 
lactis, which identified 188 proteins12, we identified a greater 
number of C-terminal peptides owing to the selective removal 
of internal tryptic peptides. Using trypsin normally ensures that 
peptides have a C-terminal basic residue that aids in LC-MS/MS 
detection and identification. However, semitryptic C-terminal 
peptides can have any terminal residue, leading to charge reduc-
tion as well as potential incompatibility with LC-MS/MS analysis 
and with analysis using search engines that are optimized for 
fully tryptic peptides.
In addition to routine matching of isolated C-terminal pep-
tide sequences with those annotated in databases by Mascot, 
in our method the presence of the C-terminal label allows for 
orthogonal validation of original protein C-terminal peptides. 
For neo–C-terminal peptides with sequences from within the 
protein generated by proteolysis, it is crucial to have orthogonal 
validation to ensure that these are part of the proteolytic signa-
ture of the sample and are not due to cleavage during sample 
processing. The presence of the C-terminal label, incorporated in 
the intact proteins before digestion by typsin, provides a reliable 
means of orthogonal validation that is not possible when rely-
ing on chromatographic separation alone. We identified cases of 
C-terminal truncations resulting from processive proteolysis, also 
known as ragging (Fig. 1f). Of the cleavage sites we identified, 
62% were located in the C-terminal half of proteins. However, 
cleavage sites within 10 residues of either the original mature 
N or C terminus may not be identified by mass spectrometry 
if the neo-peptides are redundant as a result of being too short. 
This is lessened by a key feature of our approach whereby lysine 
residues are blocked, preventing trypsin cleavage. Hence, pep-
tides are generated with ArgC-like specificity producing longer 
sequences, which considerably improves identification rates by 
mass spectrometry. Other cleavage sites occurred deep inside 
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Figure 1 | C-terminomics workflow. (a) To enrich C-terminal peptides 
for mass spectrometry analysis, protein amine and carboxyl groups are 
first chemically protected. After trypsination, peptide N termini are 
also protected. N-terminal and internal tryptic peptides are coupled to 
polyallylamine via their free C terminus. The original protein C-terminal 
peptides remain unbound and after separation by ultrafiltration are 
analyzed by LC-MS/MS. (b) Polymer-based enrichment of the peptide 
AFQVWSDVTPLR with protected carboxyl groups (theoretical [M+H]+ =  
1,533.8, measured [M+H]+ = 1,534.0) from a variant with free  
carboxyl groups (theoretical [M+H]+ = 1,446.7 measured [M+H]+ =  
1,446.9) before and after polymer coupling. (c,d) Mass spectra of a 
sample of C-terminal peptides of B-casein (812.6 Da, [M+H]+ = 813.6) 
and BSA (1,725.1 Da, [M+H]+ = 1,726.1) before enrichment (c) and 
after enrichment (d; corresponding sodium-adduct ions (+22 Da) are 
indicated). The BSA C-terminal peptide originates from a chymotryptic 
cleavage, indicating the presence of chymotryptic impurities or partially 
autolysed trypsin18. (e) Summary of data averaged from two experiments 
for isolation of protein C termini from E. coli. (f) Examples of processive 
proteolysis of protein C termini detected after enrichment of E. coli 
protein C termini.
Figure 2.12: C-terminomics workflow. Panel A: overview of the protocol as described in the text.
Panel B: Polymer-based enrichment of a peptide with and without protected carboxyl group before and
after polymer coupling. Panel C and D: MS spectra of sample of C-terminal peptides of β-casein (812.6
Da) and BSA (1726.1 Da) before (C) and after (D) enrichment [107].
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Next, TAILS uses a new class of highly water-soluble (concentrations 
of ~100 mg/ml are routinely feasible) polymers to selectively enrich 
the blocked N-terminal peptides by negative selection. We synthe-
sized a series of hyperbranched polyglycerols (HPGs) with molecular 
weights in the range of 100–600 kDa and narrow polydispersity14 and 
converted them to dendritic HPG-aldehydes (ALDs) by periodate oxi-
dation of their 1,2-diol groups using HIO4 (Fig. 1b). The HPG-ALD 
polymer readily reacts with all unblocked internal and C-terminal 
tryptic peptides through their free N-termini in sodium cyanoboro-
hydride. However, along with the dimethylated lysines, acetylated, 
cyclized and isotopically labeled protein N-terminal peptides and the 
neo-N-terminal peptides of their cleavage products are unreactive, 
remaining unbound for recovery by ultrafiltration. Binding of tryptic 
peptides occurs at up to 2.5 mg peptide/mg polymer, a more than 
tenfold improvement in capacity over amine-reactive resins, with no 
nonspecific interactions with peptides (Supplementary Results 1). 
This reduces the number of false-positive peptides identified and 
improves sample recovery, thereby reducing the sample size for analy-
sis to 100 Mg, compared to >50 mg in a recently described procedure10. 
Due to the massive sample simplification and high recovery, proteome 
coverage using TAILS is excellent, even without sample prefractiona-
tion before a single tandem mass spectrometry (MS/MS) analysis 
using a high mass accuracy LTQ-Orbitrap, unlike other approaches 
which can require up to 150 analyses per sample11. However, cover-
age can be increased with prefractionation by strong cation exchange 
chromatography and ten MS/MS analyses.
Confident protein assignment from a single peptide is critical for 
the successful application of a N-terminal positional proteomics 
technique. However, since protein identification confidence increases 
with the detection of two or more peptides per protein and this is 
not always possible in a successful N-terminal positional proteomics 
experiment, we applied a combination of highly accurate MS mea-
surements, orthogonal validation and stringent data analysis criteria to 
address this issue. Using Mascot and X! Tandem to search for peptide 
sequences against protein and peptide databases15, those identified 
by both search engines are compiled. Next, we used an orthogonal 
validation approach that involves further evaluation of only 
N-terminally dimethylated peptides within 5 p.p.m. of their expected 
mass for high-confidence N-terminal peptide identification. 
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Figure 1 Schematic diagram of TAILS and the polymer developed for 
proteomics. (a) The TAILS workflow and scheme for bioinformatics analysis. 
Unfractionated proteins from control (blue)- and protease (green)-treated 
samples are labeled on the primary amines of the N-termini (NH2) and 
lysines (K) by dimethylation using light (d(0)C12)-formaldehyde (blue 
spheres) or heavy (d(2)C13)-formaldehyde (green spheres), respectively. 
Gray pentagons represent a naturally blocked protein N-terminus. Protease 
cleavage (scissors) generates fragments cleaved on the nonprime (P	 side 
(for naturally blocked peptides; shown in orange) and fragments cleaved 
on the prime (P`	 side (neo-N-terminal peptides; shown in red). The high 
protease/control ratio peptides (q3.0 or heavy singleton) correspond to 
protease-generated neo-N-termini (peak C). These are distinguished from 
background proteolysis products and original mature N-terminal peptides 
that have an isotope ratio of ~1.0 because they are equally abundant in 
both samples. Two examples of peptide pairs with 6.0 $ m/z (bracketed) 
due to the differential labeling are shown. Mature protein N-terminal 
peptides or background proteolysis products are shown in peak A. In peak B,  
naturally blocked N-terminal peptides (Ac, but this includes all forms 
of blocked N-termini) are labeled if lysines (K) are present. Cleavage 
close to a labeled N-terminus results in loss of such tryptic peptides 
and hence in a low isotope ratio (a3.0 or light singleton), as the tryptic 
peptide that spans the protease cleavage site is only present in the control 
sample (peak D). Cleavage in naturally blocked peptides can also be so 
analyzed when lysine labeled (appearing like peak D). A time line indicating 
approximate duration of the various steps in a typical TAILS protocol is shown. 
Data analysis time varies based on the number of samples, labeling strategy 
and sample requirements. (b) Chemical structure of HPG-ALD polymer.
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Figure 2.13: Schematic overview of the TAILS technology. Protease treated and control sample are
differentially labeled using light and heavy formaldehyde during a reductive methylation step, blue
and green circles respectively. The grey pentagons represent N-terminally blocked peptides. An amine-
reactive polymer is used to capture all free amino group containing tryptic peptides, resulting in the
enrichment of neo and native N-terminal peptides[108].
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Recently, a method for absolute quantification of proteolytical processing has been presented
that can be applied on a proteome-wide scale. The strategy can be used to monitor both the
proteolytic activation of some proteases and the proteolytic cleavage of substrates [111]. Two
peptides need to be characterized and chemically synthesized prior to analysis; one tryptic
peptide containing the cleavage site of the substrate (Proteolytic Signature Peptide (PSP))
and one peptide common to both the processed and the mature form of the protein substrate
(STandard of Expressed Protein (STEP)). The peptides of a digested proteome are labeled with
Isobaric tags for relative and absolute quantitation (iTRAQ) and the two standard peptides are
labeled with a different form of the iTRAQ reagent. Mixing of the two samples allows selecting
one peptide mass with 2 different iTRAQ labels for MS/MS. The ratio of the precursor ions
113 Da and 114 Da allows to determine the ratio of test peptide and proteolytically digested
PSP, hence determining the activity of the studied protease on the substrate (Figure 2.14).
Partial activation of MMP-2 by PMC treatment is observed by
zymography (Fig. 5a) where ~30–45% of the protein has under-
gone proteolytic autoactivation, as determined by replicate
densitometry of reversed gel images. As predicted the common
STEP peptides do not significantly change in concentration upon
PMC treatment. Using the neopeptide PSP as a standard, 150 pM
active MMP-2 is present in the PMC-treated sample (Table 1 and
Fig. 5b). Conversely, the intact PSP reveals adecreaseof proMMP-2
from 390 to 250 pM upon PMC-induced autoactivation (Fig. 5b).
The total amount of pro and active MMP-2 thus calculated is
~400 pM (150 + 250 pM), which is in close agreement with that
calculated from the average of the two STEP peptides, 410 pM.
3.7. Protein family-wide quantification of proteolysis
Many proteins are cleaved by more than one protease and
many proteases cleave more than one substrate. Therefore to
obtain a family-wide picture of proteolysis we analyzed
tryptic digests of other collagenolytic MMPs: MMP-1 (also
known as interstitial collagenase) and MMP-8 (also known as
neutrophil collagenase). We BLAST searched the sequences to
confirm unique PSPs and of tryptic peptides with the highest
ion counts to select STEP peptides that would render the
analysis the most sensitive possible (Table 1). TIMPs regulate
MMP activity in vivo so we also designed standard peptides for
TIMP-1 and TIMP-2 as listed in Table 1. Since the mass
spectrometer readily monitors many peptides during a single
LC–MS/MS analysis a mixture of 25–50 nM of each PSP and
STEP peptide was included to quantify these family members
in the 30-h conditioned medium of HT1080 cells. Measured
concentrations of the proteins in conditioned media range
from 0.4 nM (MMP-2) to 1.5 nM (MMP-1). Both MMP-1 and
MMP-2 are observed as zymogens with no active forms
detected. After mild PMC-induced activation, MMP-1 and
MMP-2 were determined to be 22% and 38% activated,
respectively. MMP-8 was included as a negative control since
its expression is polymorphonuclear (neutrophil) leukocyte
specific [46]. TIMP-1 and TIMP-2 were also quantified using
two different standard peptides for each protein to demon-
strate the compatibility of monitoring proteolysis with more
conventional targeted proteomic methods. Peptide quantifi-
cation for all peptides for each protein before and after MMP
activation, which does not modify either TIMP protein, was
very consistent and revealed that proteins in complex
proteomes could be quantified to high pM concentrations
with minimal enrichment and purification to provide a
family-wide analysis of proteolysis in a proteome.
4. Discussion
We present a targeted proteomic technique for the simulta-
neous analysis and absolute quantification of proteolytic
cleavage of proteins present in a complex proteome in both
their intact and protease-cleaved forms. Proteolytic signature
peptides uniquely characterize the uncleaved form of the
protein. By quantifying the amount of the tryptic peptide that
spans a known protease cleavage site the amount of intact
protein at this site is determined. The amount of cleaved
protein can then be determined in two ways. The amount of
protein hydrolyzed at the cleavage site can be directly
measured by quantification of the semi-tryptic neopeptides
that are only present in the tryptic digest of proteomes in
which the protein was cleaved by the protease. Such cleavage
also causes a reciprocal reduction in the amount of the
spanning tryptic intact PSP and so provides a second, indirect
method for the quantification of the cleaved forms. The
amount intact PSP is then related to the mole amounts of the
protein determined by quantifying STEP tryptic peptides
common to both the intact and protease cleaved forms from
which the amount of cleaved protein can be calculated. Using
MMP-2 proteolytic activation as an example we show tight
concordance of the calculated amounts of cleaved and
uncleaved proMMP-2 present in a complex proteome sample
calculated by both methods.
In this study we provide experimental proof of concept
using MMP-2, that was identified by Massague's group [46] as
Fig. 4 – Analysis of proteolysis in a complex mixture. (a)
Purified human proMMP-2 (10 nM) and active MMP-2 (10 nM)
were combined (see gel insert) and added to the secreted
proteins isolated from conditioned media of Mmp2 -/-
embryonic fibroblasts. The samplewas digestedwith trypsin
and labeled with iTRAQ-113 (i113) and then combined with
PSP and STEP peptide standards labeled with iTRAQ-114
(i114). Final samples consisted of 20 nM tryptic-digested
MMP-2 and 50 nM of each peptide standard. (b) Reporter ions
upon MS/MS analysis of the intact PSP
102CGNPDVANYNFFPR115 and STEP 147AFQVWSDVTPLR158
peptides. The relative 113/114 reporter ion ratios of 0.18 and
0.4 for the PSP and the STEP peptides respectively, are in
close agreement with the predicted ratios of 0.2 and 0.4.
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Figure 2.14: Quantitative analysis of proteolysis in a complex mixture. Panel A: Two proteases
proMMP-2 and MMP-2 were added to the secreted proteins isolated from conditioned media of Mmp2 -/-
embryonic fibroblasts. The sample was digested with trypsin and labeled with iTRAQ-113 and combined
with PSP and STEP peptide standards labeled with iTRAQ 114. Panel B: Reporter ions upon MS/MS
analysis of the intact PSP and STEP peptides. The relative 113/114 reporter ion ratios and the known
concentrations of both peptides allows to determine the concentration of the cleaved substrate. [111].
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Rationale and aims
When this project was started in 2007, the ladder sequencing approach introduced in section
2.3.1, using carboxypeptidase (Cpase) digestion on CNBr generated peptides, was the only
C-terminal sequencing method that had successfully been applied at a proteomic scale and
that was used to study proteolytic processes in biological samples [1, 2]. Unfortunatly, the
technique has some important limitations. The main goals of this research were to overcome
those limitations and to automate the improved method, so that it can be applied to complex
biological samples in a high-throughput setup.
The first aim was to develop a chemical method to identify the C-terminal peptide in a mixture
of CNBr generated peptides, as an alternative to the use of CPase. CPase cleaves off different
amino acids at different rates, while certain amino acids are not cleaved off at all. Therefore, to
obtain optimal results, the digestion protocol must be specifically optimized for every peptide.
In our chemical selection method, CNBr-generated peptides are incubated in a slightly basic
buffer. All homoserine lactone residues, present in internal and N-terminal peptides, are
partially opened and form homoserine, and are displayed as a doublet in mass spectra. This
allows to discriminate the C-terminal peptide that can then be identified by MS/MS. This
allowed us to set up the first fully automated C-terminal sequencing platform that has been
tested in a traditional proteomic setting on Shewanella oneidensis MR-1. The development,
automation and application of the chemical selection technique will be discussed in Chapter 3.
Since C-terminal fragments are identified using a MALDI TOF/TOF setup, the C-terminal
fragments have to be smaller than 5 kDa in order to be detected with sufficient resolution. Since
methionine only accounts for 2.59% of the amino acids in Shewanella oneidensis MR-1, the
peptides generated after CNBr cleavage are often relatively large. Generating smaller fragments
results in a higher number of proteins for which the C-terminal peptide can be analyzed. The
second goal of our study was to generate smaller C-terminal peptides using a new chemical
method that still retains the capability to select the C-terminal peptide in the mixture. We
present a new cleavage method that cleaves C-terminal of Met and Trp simultaneously by
adding KI to the standard CNBr cleavage mixture. During the cleavage reaction all Trp residues
are converted to Cγ-O-spirolactone tryptophan. We further showed that the chemical selection
technique to discriminate the C-terminal peptide can also be applied to CNBr and KI generated
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digest mixtures. The alternative cleavage reaction increased the theoretical coverage of the
Shewanella oneidensis MR-1 proteome to 58%, almost 10% higher than can be achieved using
any other standard cleavage methods. The generation of smaller C-terminal fragments by
cleavage after Met and Trp using a CNBr and KI mixture are discussed in Chapter 4.
In the course of 2010 the groups of Gevaert and Overall reported two new proteome-wide
LC-MS based C-terminal sequencing techniques [3, 4]. The techniques were applied in multiple
degradomics and terminomics studies identifying a few hundred new C- and N-termini for
each study. This increase in identification and the low ionization and fragmentation efficiency
of C-terminal peptides by MALDI TOF/TOF forced us to develop a completely new setup,
that can be analyzed on any (LC-)MS platform, to become competitive in high-throughput
terminomics. In this new approach all carboxyl groups of the intact protein are derivatized
using 1-(2-pyrimidyl)piperazine (PP), a method originally developed to improve the ionization
efficiency in phosphopeptides. This carbodiimide-mediated coupling reaction is followed by a
proteolytic digest step. After digestion, the free carboxyl groups of the internal and N-terminal
peptides are bound to a polymer, leaving the C-terminal peptides in solution. The PP-group at
the original C-terminus serves as a positive selection procedure to eliminate false positives, and
should at the same time improve their ionization efficiency. The preliminary results obtained
using the PP derivatization and enrichment are presented in Chapter 5.
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Part II
Results

Chapter 3
Chemical selection of C-terminal
peptide after CNBr digest
3.1 Introduction
In the carboxypeptidase (CPase) based ladder sequencing technique, already introduced in
section 2.3.1, proteins are chemically cleaved using cyanogen bromide (CNBr). During CNBr
cleavage, all Met-Xxx peptide bonds are cleaved and all methionine residues are converted
to a homoserine-derivative, which is in equilibrium with its lactone form. During digestion
with carboxypeptidases only the original C-terminal fragment (having a free carboxyl group)
is accessible to enzymatic degradation and forms a ladder. We present here a novel chemical
selection method where a slightly basic buffer treatment is used to partially open the homoserine
lactone forming homoserine. This results in the formation of m/z doublets (∆m = 18 Da) for
all internal peptides and allows to identify the C-terminal peptide, which appears as singlet
in the mass spectrum. The sequence of the C-terminal peptide is determined by tandem MS
using a MALDI TOF/TOF instrument.
3.1.1 CNBr cleavage of proteins
In 1962, Gross and Witkop first proposed the use of CNBr as cleavage agent for peptide bonds
in proteins [1]. The selectivity of the reaction depends on the pH. In neutral and alkaline
conditions, CNBr reacts with basic groups in proteins [2]. At acidic pH only Met and free Cys
are attacked by CNBr, and cysteine is oxidized to cysteic acid [3]. At low pH the cleavage
yield is nearly 100%, except if the residue C-terminal of methionine is serine or threonine
[4]. The hydroxyl function of these amino acids can interfere with the cleavage reaction by
acting as nucleophile and competes with water in the cleavage reaction (Figure 3.1). This side
reaction can be avoided by performing the reaction in a solution containing a higher percentage
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of water [5]. Incubation with 70% TFA is preferred, as formylation of reactive side chains is
observed if 70% formic acid is used [6, 7]. Despite the harsh reaction conditions, in situ CNBr
cleavage of proteins in-gel has been demonstrated [8, 9]. It is important to note that oxidation
of methionine totally impairs the reaction.
Figure 3.1: CNBr cleavage reaction. Incubation of proteins with CNBr results in cleavage of peptide
bonds C-terminal to methionine. During the cleavage reaction methionine is converted to a homoserine
lactone. The acid stable homoserine lactone is in equilibrium with its open form (homoserine). In the
first step, the sulfur function of methionine displaces the polarized bromide anion of cyanogen bromide
forming a bromide-stabilized S-cyanide methionine derivate. In the second step the nucleophilic attack
of the peptide bond carbonyl function results in the formation of a five membered ring structure and the
release of methylisothiocyanate. This iminolactone ring is resolved by nucleophilic attack from water,
resulting in peptide bond cleavage and the formation of homoserine lactone [5].
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The equilibrium between the homoserine lactone and its open form is pH sensitive. In acidic
environment the lactone form is preferred over the open form [10]. Under CNBr cleavage
reaction conditions (70% TFA) and CPase incubation buffer (10 mM ammonium acetate pH
5.4) the equilibrium is almost completely shifted to the lactone form.
The specific reactivity of the lactone function has been used in different approaches. The
first report on homoserine lactone aminolysis with aryl and alkylamines dates back to 1964
[11]. In solid-phase Edman degradation the lactone ring is used to couple the CNBr-generated
peptides to an insoluble amino resin [12]. More recently, the same chemistry was used to
conjugate amino group containing affinity tags to homoserine lactone ending peptides, as a
method to identify disulfide bridges and chemical cross-linking sites [13]. Likewise the addition
of tris(hydroxymethyl)aminomethane (Tris) was used in order to improve the mass accuracy
determination of high molecular mass CNBr generated peptides [14].
The homoserine lactone fragments have also been used to identify the C-terminal frag-
ment in a CNBr-generated peptide mixture. Lactonization and amination with radioactive
[14C]ethylenediamine of CNBr-generated fragments allowed to identify the C-terminal peptide
after peptide separation [15]. Reaction of acidic methanol with homoserine lactone causes a 32
Da mass shift for all internal peptides. The C-terminal peptide can be identified when the pre-
and post-derivatization MS spectra are compared [16].
3.1.2 Carboxypeptidase methodology
Two carboxypeptidases, P and Y, are used to determine the C-terminal peptide in a CNBr
digest. They are both serine exoproteases with a broad substrate specificity [17–19]. CPY is
a vacuolar protease isolated and characterized from Saccharomyces cerevisiae, and CPP was
isolated from Penicillium janthinellum [20]. A unique feature of these enzymes is their wide pH
optimum and, in particular, their high activity at acidic pH: between 2.5 and 5.7 for CPP and
between 5.5 and 7.5 for CPY [21]. This is in contrast to members of the trypsin or subtilisin
families of serine endopeptidases, which are essentially inactive at pH <7 [22, 23].
Structural studies of CPY show that the catalytic mechanism resembles that of typical serine
proteases, which hydrolyze peptide and ester substrates in a two-step reaction using a catalytic
triad (Figure 3.2). A key feature of this mechanism is the ability of the catalytic histidine to
abstract a proton from the catalytic serine prior to, or simultaneously with, the nucleophilic
attack on the scissile bond. Several models explain how the catalytically essential histidine
is maintained in its active deprotonated state through perturbation of its pKa-value in the
enzyme-substrate complex [24, 25]. One model involves the polarization of the scissile peptide
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bond through H-bond formation with the α-carboxylate group. According to a second model
an apolar environment can be formed in the catalytic site upon binding of the substrate [19].
CPY has six substrate binding sites S1’ to S5, of which S1 is the most selective one and a binding
site for the carboxylate group [26]. This explains why despite their broad specificity, preferences
for both the C-terminal and the penultimate amino acid exist. Hydrophobic residues are
preferred at the penultimate position; Phe>Leu>Ala>Ile>>>Lys for both carboxypeptidases
[21]. CPP has a lower cleavage rate for Ser and Gly as C-terminal residue, while incubation with
CPY alone results in a slower cleavage rate when Asp and Gly are the C-terminal amino acids.
Incubation with a combination of CPP and CPY overcomes the specificity of the individual
carboxypeptidases. Longer stretches of sequence can be obtained if a combination of these
carboxypeptidases is used [27].
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the amide nitrogen is raised. The required distortion of the
peptide bond may result from stabilization of the specific
tautomeric form of the substrate.
The chief difference between the charge-relay systems of
CPY and serine endopeptidases lies in the fact that the
geometrical positionings of Serl46, His397, and Asp338
are not identical. In CPY, the carboxylate of Asp338 and
the imidazole of His397 are not coplanar, and this geomet-
ric arrangement is far from ideal for proton transfer (47).
In addition, the spatial relationships between the aspartic
acid and serine of endopeptidases and CPY are different, so
that the overall orientation of the three catalytic residues
cannot be superimposed.
Substrate binding properties. Two substrate binding
sites, the Si and S/ subsites, accommodate amino acid side
chains of the substrates, Pi and P / . There is also a binding
site for the C-terminal carboxylate group of peptide sub-
strates. CPY has an oxyanion hole to accommodate a
tetrahedral intermediate where the oxyanion in the transi-
tion state is stabilized. The presence of additional substrate
binding subsites, S2-S5, has been shown (48). By fillingthese additional substrate binding pockets, extensive
enhancements in the catalytic efficiency are observed: a
heptapeptide is hydrolyzed 52,000-fold faster than a
dipeptide (49).
Oxyanion hole. The three-dimensional structure shows
that the oxyanion hole is located just above Serl46 and
consists of the backbone amides of Gly53 and Tyrl47.
Si substrate binding site. The Si subsite is a deep
pocket mainly constructed of hydrophobic residues,
Tyrl47, Leul78, Tyrl85, Tyrl88, Trp312, Ile340, and
Cys341. This pocket actually determines the Pi substrate
preference (50). When Leul78, located at the bottom of
the Si binding pocket, was replaced by charged residues,
the hydrolytic preference was altered to the oppositely
charged P, side chains (51, 52). When Trp312, located in
the upper wall of the Si binding pocket, was changed to
asparagine, the hydrolytic activity for basic PL side chainsincreased dramatically (53).
Cys341 is the only residue considered to be a polar amino
acid in the Si subsite. Because this single cysteinyl residue
is conserved in the vicinity of the active site in serine
carboxypeptidases, the role of this residue has been a focus
of research since the discovery of the enzyme. Chemical
modification and mutagenic approaches have shown that,
although Cys341 is not essential for the enzyme activity, it
exerts a large effect on the catalytic efficiency (37, 50, 54,
55). The involvement of Cys341 in the correct positioning
of His397, and also in the shielding of Asp338 from the
solvent, has been suggested (32). Recently, the role of
Cys341 was re-investigated by combining site-directed
mutagenesis and a high-pressure technique. Six enzymes
with mutations at Cys341, C341G, C341S, C341V, C341F,
C341D, and C341H, were prepared and their activities
toward Fua-Phe-Phe and Fua-Ala-Phe were measured
under moderately high pressure. It was found that Cys341
plays a role in the catalytic reaction, especially of large
hydrophobic substrates, by controlling the cavity size of the
Si substrate binding pocket during the hydrolytic transition
state (56).
Si' substrate binding site. The S,' subsite of CPY is
constructed mainly of hydrophobic residues, Thr60, Phe64,
Tyr256, Tyr269, Leu272, and Met398. Unlike the S,
subsite, the S/ subsite exhibits wide substrate preference
by recognizing both hydrophobic and hydrophilic amino
acids, alcohols, amides, and anilides. This unique property
is probably explained by the fact that the S i' binding pocket
is sufficiently large to allow a multiple binding mode.
Another explanation has recently been proposed that the
flexible side chain of Met398 may contribute to the wide
substrate preference by adjusting the distance to the
hydrophobic portion of the P,' residue or the hydrophilic
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Figure 3.2: The catalytic mechanism of CPY (typical for serine proteases), which hydrolyzes peptide
and ester substrates in a two-step reaction. In the first reaction, a tetrahedral intermediate is formed as
a result of the nucleophilic attack of the essential serine hydroxyl on the carbonyl carbon atom of the
substrate. The histidine residue assists in this step by accepting the proton from the serine hydroxyl and
stabilizing the tetrahedral intermediate. This proton is then transferred to the newly generated amino
half of the peptide bond in an acylation step. The amino half of the peptide is now free to dissociate.
Hydrolysis of the acyl-enzyme intermediate then produces a product in a deacylation step [19].
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Because CPases cleave off different amino acids at different rates, with certain amino acids
not being cleaved off at all, the digestion protocol should be specifically optimized for every
peptide. In order to obtain a full sequence ladder, analysis at multiple time points or at different
concentrations of CPase need to be acquired, and MS spectra need to be combined. This makes
the approach labor intensive. Since the peptide of interest is distributed over multiple experi-
ments and present in multiple ladder forms simultaneously, the sensitivity of the technique is low.
Therefore, we designed a novel strategy to make the C-terminal sequencing method less de-
pendent on CPase activity. We designed a chemical selection method where a slightly basic
buffer is used that partially opens the homoserine lactone, forming homoserine. This results in
the formation of m/z doublets (∆m = 18 Da) for all internal peptides and allows to identify
the C-terminal peptide, which appears as singlet in the mass spectrum. The sequence of the
C-terminal peptide is determined by tandem MS using a MALDI TOF/TOF mass spectrometer.
The techniques can both be applied on purified proteins in solution and in gel (1D and 2D
PAGE). Since all the homoserine lactone residues open under the same conditions, one protocol
can be applied to all samples. This allows automation of the technique. Here we present results
of proof-of-concept experiments and an automation of the procedure on a robotic Tecan platform.
In this study the entire cell lysate of Shewanella oneidensis MR-1 was used as a test case. S.
oneidensis is a Gram-negative γ-proteobacterium isolated from freshwater lake sediment [28].
The organism is an aerotolerant anaerobe, able to reduce heavy metal ions, making it a potential
agent for bioremediation. The S. oneidensis MR-1 genome has been sequenced in 2002 [29] and
has been reannotated in 2003 [30]. Multiple proteomics studies have attemped to use LC-MS
and LC-MS/MS data to improve the annotations of S. oneidensis [31–34] and to detect post-
translational modifications such as proteolytical processing [35]. Recently a large mutant study
was performed in order to improve the annotation of gene function of S. oneidensis proteins [36].
This chemical selection technique has recently been used to determine the C-terminal sequence
of the recombinant protein α-1-antitrypsin (A1PI) after expression in a human cell line. α-
1-antitrypsin is a plasma protein with the function to protect lung tissues from proteolytic
destruction by enzymes from inflammatory cells. A1PI deficiency is an inherited disorder
associated with pulmonary emphysema and a higher risk of chronic obstructive pulmonary
disease [37].
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3.2 A new chemical approach to differentiate carboxy terminal pep-
tide fragments in cyanogen bromide digests of proteins.
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3.2.1 Abstract
We present a novel approach to perform C-terminal sequence analysis by discerning the C-
terminal peptide in a mass spectral analysis of a CNBr digest. During CNBr cleavage, all
Met-Xxx peptide bonds are cleaved and the generated internal peptides all end with a homoserine
lactone (hsl) derivative. The partial opening of the hsl derivatives, by using a slightly basic
buffer solution, results in the formation of m/z doublets (∆m = 18 Da) for all internal peptides,
and allows to identify the C-terminal peptide which appears as a singlet in the mass spectra.
Using two model proteins we demonstrate that this approach can be applied to study proteins
purified in gel or in solution. The chemical opening of the hsl derivative does not require
any sample clean-up and therefore, the sensitivity of the C- terminal sequencing approach is
increased significantly. Finally, the new protocol was applied to characterize the C-terminal
sequence of two recombinant proteins. Tandem mass spectrometry by MALDI-TOF/TOF
allowed to identify the sequence of the C-terminal peptides. This novel approach will allow to
perform a proteome-wide study of C-terminal proteolytic processing events in a high-throughput
fashion.
3.2.2 Introduction
Proteomics is one of the fastest growing areas of biological research. Its objective has moved
beyond simple cataloguing to the study of functional and regulatory aspects of proteins. The
monitoring of protein expression profiles remains a very challenging task because of the wide
dynamic range of expressed proteins and the variability of gene products due to the presence of
splicing variants, N- and C-terminal processing, and co- and post-translational modifications
(PTMs). Truncations of the nascent polypeptide chain at the N- or C-terminus are by far
the most common types of PTMs found in proteins. Although several approaches have been
developed that allow proteome-wide PTM analysis of phosphorylation and glycosylation events,
relatively little attention has been paid to the development of approaches for the systematic
analysis of proteolytic processing events [38]. Recently, a number of methods have been devel-
oped to characterize N-terminal proteolytic processing, such as e.g. the COFRADIC [39] and
the positional proteomics approach [40]. In contrast, considerably less attention has been spent
on the study of C-terminal processing [41].
Recently, we developed a new technique that enables the more systematic identification of
C-termini from intact proteins. This MS-based, enzymatic, ladder sequencing approach can
be applied on the unseparated peptide mixture generated by cleavage of the protein with
cyanogen bromide (CNBr), either in solution or in gel. Under acidic conditions, CNBr cleaves
after every Met in the sequence, generating internal peptides with a C-terminal homoserine
lactone (hsl) derivative. During incubation with carboxypeptidases (CPase) only the original
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C-terminal fragment (having a free carboxyl group) is accessible to enzymatic degradation
and forms a ladder. Ladder readout is typically performed using MALDI-TOF MS as this
technique produces predominant ladders of singly charged ions. Application of this method
on complex mixtures has verified its vital role for the determination of C-termini of proteins
at a proteomic scale [42]. A positive identification of the C-terminus will first depend on the
length and ionization capacity of the generated CNBr fragments. In our approach, MS analysis
was performed using MALDI ionization which generates predominantly singly charged ions.
The use of the α-cyano-4-hydroxycinnamic acid matrix produces interference in the low Mw
mass range and therefore presents a challenge for the analysis of peptides with a Mw below
0.7-1.3 kDa. In our experience, the upper mass limit for the analysis of ladder sequences in
RE-MALDI-MS, providing enough resolution and accuracy to identify amino acids by 0.1 Da
weight difference, is restricted to C-terminal fragments with a Mw of ±4 kDa.
In its current form the use of CPase limits the sensitivity and the specificity of this approach
[43]. The use of exopeptidases has regained interest with the introduction of improved methods
for MS readout. For C-terminal sequence analysis, carboxypeptidases Y and P (CPY & CPP)
are chosen most often because of their broad amino acid specificity [44]. However, the rate at
which amino acids are cleaved by CPase depends to a great extent on the amino acid sequence
of the substrate. Additionally, the cleavage rate depends on reaction conditions such as pH, ion
strength and substrate concentration. During digestion with CPase we observed, according to
the known specificity, a slow cleavage of C-terminal Gly. Unexpectedly, the presence of Phe,
Thr, or Lys also slowed down or inhibited ladder generation (unpublished results). Finally,
it should be noted that most exopeptidases have a Km-value in the range of 5-50 µM, which
means that they are operating at 50% maximum velocity when a protein concentration of 5
pmol/µl is used [45]. At lower concentrations (sub picomole), the proteolytic activity toward
the substrate will be minimal.
Therefore, the main goal of the present study was to eliminate the use of CPase and develop a
novel chemical approach that allows to differentiate between internal CNBr fragments and the
C-terminal peptide fragment. Incubation of the CNBr mixtures in a slightly basic buffer results
in a partial opening of the homoserine lactone derivatives to the corresponding homoserine
derivative (∆m = + 18 Da). Therefore, all internal peptides appear as doublets in the MS
spectrum, whereas the C-terminal fragment appears as the only singlet and can be selected for
MS/MS analysis. The feasibility of this approach was evaluated using two test proteins and
demonstrated with two recombinant proteins purified in solution or by SDS-PAGE. We further
demonstrate that, in contrast to the CPase method, the sensitivity of this approach is in the
lower fmol range (150 fmol).
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Previously, we have demonstrated that C-terminal sequence information is useful to study C-
terminal processing events, but that its positional bias can also be used to improve the correctness
of protein identification by mining protein databases [42]. As the N- and C-terminal sequences
are highly specific characteristic features, this information can also be used to mine annotated
as well as un-annotated genome sequences to identify ORFs. It has been demonstrated earlier
that proteomic data information is an excellent tool to mine genome sequences, eliminating
problems associated with standard techniques for gene prediction, especially with eukaryotic
data [46]. So far, only high-throughput tandem MS based proteomics has been used to improve
the quality of genome annotations [47]. Recently, the group of Heck has demonstrated that
there are a significant number of unknown protein N- and C-termini in the human genome,
suggesting the existence of a high degree of novel transcription, independent of annotated gene
boundaries and/or specific protein processing [48]. The C-terminal sequence information will
allow integrating proteomic MS data with current genomic annotations and thus improve the
quality of gene prediction.
3.2.3 Materials and methods
Materials
Yeast alcohol dehydrogenase (gel filtration purity) and horse heart cytochrome c (purity
99%) were purchased from Sigma (Bornem, Belgium). Elongation factor Tu (EF-Tu or TufA)
(Shewanella oneidensis MR-1) and glycerophosphodiester phosphodiesterase (Haemophilus
influenzae) were expressed and purified in house. Stock solutions (0.5 nmol/µl water) were
prepared for all proteins and further diluted prior to use. HPLC- grade acetonitrile (ACN) was
obtained from BioSolve (Valkenswaard, The Netherlands). Trifluoroacetic acid (TFA) (purity
>99.9%) was from Beckman Instruments (Palo Alto, CA, U.S.A.). Ammonium hydrogen
carbonate (NH4HCO3) (purity >99.5%), ammonium citrate (purity 98%), cyanogen bromide
(CNBr) (purity 97%) and α-cyano-4-hydroxycinnamic acid were purchased from Sigma. 12%
Tris-HCl precast SDS-gels were purchased from Bio-Rad (Nazareth, Belgium). C-18 ZipTips
were from Millipore (Billerica, MA, USA). Water was purified using a MilliQ water filtration
system (Millipore). SDS- PAGE gels were performed as described previously [42, 43].
CNBr Cleavage
CNBr cleavage of gel/gel-free separated proteins was basically performed as described before
[42, 43]. Briefly, after visualization and destaining, the bands or spots containing the protein
were excised from the gels. Before cleavage with CNBr, the gel pieces were washed twice with
150 µl 50% ACN/MQ, dehydrated with 40 µl ACN and reswollen in 5 µl MQ. CNBr cleavage
was started by adding 5 µl 5.0 M CNBr/ACN (Sigma, Bornem, Belgium) and 15 µl TFA
(Applied Biosystems, Foster City, CA). CNBr and TFA are highly toxic and corrosive products
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which must, at any time, be manipulated under a fumehood by skilled personnel wearing
protective clothing! After incubation overnight (4 ◦C) the supernatant was collected and the
peptides were extracted twice with 50 µl 70% ACN/0.1% TFA for 30 min at 37 ◦C. All fractions
were pooled and dried in a SpeedVac. Care must be taken during sample manipulation to avoid
oxidation. Artefactual oxidation of methionine to sulfoxide means that CNBr is inhibited from
reacting with the sulfur of the methionine residue, which may explain the abscence of certain
CNBr fragments.
Chemical opening
Before chemical opening, the dried samples were desalted using C-18 micro purification tips
(ZipTip). The ZipTip protocol was performed as described by the manufacturer. A 50% ACN/
0.1% TFA solution was used as activation and elution solvent. A 0.1% TFA solution in MQ was
used as equilibration and washing solvent. After elution the samples were dried in a SpeedVac
instrument. The partial opening of the homoserine lactone to homoserine was performed by
redissolving the sample in 10 µl 12.5 mM NH4HCO3 (pH 8.0), and incubation at 37
◦C for 30
min. Care was taken during the redissolving steps to thoroughly vortex the samples for 30
seconds.
Mass spectrometry
All mass spectrometric analysis were performed on an Applied Biosystems 4800+ Proteomics
Analyzer with TOF/ TOF optics (Applied Biosystems, Foster City, CA). This mass spectrome-
ter uses a 200-Hz frequency tripled Nd:YAG laser operating at a wavelength of 355 nm. For
MS/MS, ions generated by the MALDI process are accelerated at 8 kV through a grid set
at 7.3 kV into a short, linear, field-free drift region. In this region, the ions pass through a
timed-ion selector device that is able to select one peptide, from a mixture of peptides, for
subsequent fragmentation in the collision cell. After a peptide at a given m/z is selected by
the timed-ion-selector, it passes through a retarding lens, where the ions are decelerated and
then pass into the collision cell, which is operated at 7 kV. The collision energy is defined
by the potential difference between the source and the collision cell (1 kV). After passing
through the collision cell, the ions (both intact peptide ion and fragments) are accelerated in
the second source region at 15 kV, pass through a second, field- free, linear drift region, into
the reflector, and finally, to the detector. The detector amplifies and converts the signal to
electric current, which is observed and manipulated on a PC-based operating system. For high
resolution analysis, the instrument is operated in the reflector mode. After the MALDI process
generates the peptide ions, they are accelerated at 20 kV through a grid at 15.6 kV into the first,
short, linear, field- free drift region. After this point, the rest of the instrument can be treated
as a continuation of this region until the ions enter the reflector and finally reach the detec-
tor where, as before, the signal at the detector is amplified and converted to an electrical current.
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Samples were prepared by applying 0.6 µl of the sample to a stainless steel 384-well target
plate and adding 0.6 µl matrix solution (25 mM α-cyano-4-hydroxycinnamic acid + 10 mM
ammonium citrate solution in 50% ACN containing 0.1% TFA). They were allowed to dry at
room temperature and were then inserted into the mass spectrometer. All MS and MS/MS
experiments were performed twice on the same sample (two spots) and were run in duplicate.
Prior to analysis, the mass spectrometer was externally calibrated with a mixture of Angiotensin
I, Glu-fibrino-peptide B, ACTH (117), and ACTH (1839). For MS/MS experiments, the
instrument was externally calibrated with fragments of Glu-fibrino-peptide.
Interpretation Mascot parameters
For protein identification, a database search was performed, using a local MASCOT server,
against the entire NCBI database, to be found at www.ncbi.nlm.nih.gov. Both for PMF and
MS/MS searches, the 50 most intense ions were loaded to the server. Search parameters were
50 ppm peptide tolerance and 0.5 Da MS/MS tolerance. CNBr was selected as cleavage reagent
and zero miss cleavages were allowed. Conversion of methionine to homoserine lactone or
homoserine was allowed as variable modification.
3.2.4 Results and discussion
Optimization of homoserine lactone opening
In order to differentiate the internal CNBr fragments from the C-terminal peptide we developed
a chemical approach in which all homoserine lactone derivatives are partially opened (∆m = 18
Da). The complete CNBr mixture was therefore incubated under basic conditions. Parameters
explored were (i) the buffer: N,N’-diisopropylamine (DIEA), lutidine (dimethylpiperidine),
NH4HCO3; (ii) the concentration of the reagent; (iii) the duration of the reaction; and (iv) the
reaction temperature. We found that the use of 12.5 mM NH4HCO3 (pH 8.0) at 37
◦C for
30 min were the best conditions to partially open the homoserine lactone derivatives. Under
these conditions, no side reactions were observed for the internal peptides or the C-terminal
peptide, therefore the C-terminal peptide appears as the only singlet in the mass spectrum. As
the homoserine lactone derivative and the homoserine derivative will probably be detected at
different sensitivities, the partial opening was studied in a heuristic fashion. We could also not
exclude that a part of the homoserine derivative closes again under the acidic conditions of
the MALDI matrix. The partial opening of the homoserine lactone derivative was monitored
by MALDI-MS analysis. The relative intensities of both peaks in the doublets varied between
30/70 to 70/30.
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Chemical opening in solution
The optimized ring opening was first tested on two model proteins in solution. Therefore, two
stock solutions of cytochrome c (horse heart) and alcohol dehydrogenase (yeast) (15 pmol) were
prepared and incubated in 12.5 mM NH4HCO3 as indicated above. Figure 3.3 A shows the
CNBr fingerprint of cytochrome c after chemical opening. The peak at m/z 2779.57 is the
C-terminal peptide (with MH++2 at m/z 1390.79) (observed as a singlet) whereas the internal
CNBr fragment (Glu66-Met80) appears as a doublet at respectively m/z 1762.92 (homoserine
lactone derivative) and m/z 1780.93 (homoserine derivative). The precursor at m/z 2779.57
was subsequently selected for MS/MS analysis, yielding a series of b- and y-ions from which the
complete C-terminal sequence could be deduced (Figure 3.3 B). For yeast alcohol dehydrogenase
we were also able to differentiate the C-terminal peptide (m/z 1678.91) from two internal peptide
fragments (Table 3.1). Interestingly, we also observed a second peptide in the fingerprint as
a singlet at m/z 1664.91. The mass difference of 14 Da can be explained by the presence of
a C-terminal isopeptide in which residue Ile 338 is replaced by Val as evidenced by MS/MS
analysis of both C-terminal peptide fragments (Figure 3.4). This confirms the presence of an
isoform with Val at position 338 as observed previously [49].
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Table 3.1: Observed CNBr fragments from test and recombinant proteins.
Proteina Mw
(kDa)
CNBr
fragmentb
Mw
calc.
(Da)c
Mw
obs.
(Da)d
Cytochrome c 11.7 Ile81-Lys104 2779.56 2779.57
Equus caballus Glu66-Met80 1762.93 1762.92
gi|119388048
Alcohol dehydrogenase 36.7 Gly76-Met98 2478.22 n.o.
Saccharomyces cerevisiae Ala169-Met193 2338.22 2338.07
gi|112491285 Glu 333-Lys347 1678.90 1678.78
Elongation factor Tu + 70.0 Leu94-Met128 3955.11 n.o.
N-term GST tag Phe132-Met365 2627.20 n.o.
Shewanella oneidensis Asp600-Ala624 2555.43 2555.40
gi|24371827 Pro344-Met365 2532.44 2532.39
Ala69-Met80 1396.76 1396.75
Leu81-Met93 1342.67 1342.65
Val371-Met382 1327.65 n.o
Asp330-Met343 1297.66 n.o
Leu154-Met164 1266.65 n.o.
Val590-Met599 1011.58 n.o.
Glycerophosphodiester 41.7 Tyr336-Lys364 3103.59 3103.73
phosphodiesterase Val209-Met230 2678.44 2678.55
Haemophilus influenza Lys2-Met26 2461.30 n.o.
Ala272-Met287 1693.81 1693.88
a NCBI Entrez entries (www.ncbi.nih.gov/Entrez/).
b The position of the CNBr fragments in the protein sequence is indicated in Arabic
numbers (numbering according to the NCBI entries).
c Mw calculated by using the residual monoisotopic values with Met ->hsl (singly pro-
tonated) (Only CNBr fragments with a Mw between 1 and 4 kDa are listed).
d Mw observed in positive mode reflectron analysis (singly protonated) (n.o.: not ob-
served); C-terminal peptides are indicated in red.
The sensitivity of our method was tested by MS analysis of a dilution series of the cytochrome
c stock solution. Therefore, 5, 2.5 and 0.5 pmol cytochrome c were cleaved with CNBr and
reacted in 10 µl 12.5 mM NH4HCO3. From this solution 0.6 µl was spotted on the MALDI plate
and analyzed by MALDI-MS analysis (triplicates). We observed a good fingerprint for the first
two fractions, containing respectively 300 and 150 fmol on the plate. No peaks were observed in
the fingerprint of the fraction with 0.5 pmol of CNBr digest, containing 30 fmol on the MALDI
plate. It should be noted that the sensitivity of our approach will not only depend on the
sensitivity of the MS used, but will also depend on the nature (amino acid composition) of the
CNBr fragment, its ionization efficiency and suppression effects in complex peptide mixtures.
Therefore, to further investigate the sensitivity of our approach, we will, after automation on
a TECAN Freedom Evo robot, perform a high-throughput study of 2D-PAGE separated proteins.
90 CHEMICAL SELECTION TECHNOLOGY
Figure 3.3: C-terminal sequence analysis of horse heart cytochrome c. Panel A: MS spectrum of the
CNBr digest after chemical opening. 15 pmol of horse heart cytochrome c was cleaved in solution.
0.6/10 µl of the reaction mixture was applied on the MALDI probe. Panel B: MS/MS spectrum of the
C-terminal peptide at m/z 2779.57. Y- and b-ions are indicated in green and red respectively. Amino
acid sequence is indicated in the one-letter code.
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Figure 3.4: MS/MS analysis of C-terminal isopeptides of alcohol dehydrogenase. Panel A: MS/MS
spectrum of the C-terminal peptide with m/z 1678.77. Panel B: MS/MS spectrum of the C-terminal
peptide with m/z 1664.76 in which Ile338 is replaced by Val. Y- and b-ions are indicated in green and
red respectively. Other fragment ions (insets) include a-ions, (a-17)-ions, (b-18)-ions, internal fragment
ions and neutral losses of ammonia (internal Arg). The amino acid sequence is indicated in the one-letter
code.
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As a proof of principle, we applied our method on two recombinant proteins currently under
study in our laboratory. In the 70 kDa recombinant TufA protein (EF-Tu), we were able to
identify the C-terminal fragment (m/z 2555.44) amongst the internal peptide fragments. Also
for the glycerophosphodiester phosphodiesterase, protein D, we were able to differentiate the
C-terminal fragment (m/z 3103.73) from the internal fragments (Table 3.1).
Chemical opening of gel purified proteins
To demonstrate the general use of our approach we also applied it to the four proteins sepa-
rated by SDS-PAGE. 50 pmol of each protein was separated on a precast gel, stained with
Coomassie blue and destained. Approximately 1/10 of the gel band was cut (±5 pmol) and
cleaved with CNBr in the gel. After extraction and drying of the pooled fraction, the CNBr
fragments were opened as indicated above. However, MS analysis (0.6/10 µl) of these fractions
indicated the presence of a 25 Da adduct (and multiplexes thereof), both on the C-terminal
fragment and the partially opened internal fragments, as observed in some of the previous
experiments. Although the exact nature of this modification remains unclear so far, we observed
that the reaction occurs only after treatment in the slightly basic buffer, as no adducts were
observed in the untreated mixtures. Furthermore, if the CNBr peptide mixture was first purified
by an additional ZipTip extraction (C18) before the chemical opening, no adducts were observed.
The success of this approach was demonstrated with the recombinant protein D. After ZipTip
and chemical opening, four peptides were observed of which only one appeared as a singlet
(Figure 3.5 A). MS/MS analysis of the precursor at m/z 3103.73 yielded the complete C-terminal
sequence of 29 amino acids (b- and y-ions) (Figure 3.5 B). However, MS/MS analysis of the C-
terminal peptide from the EF-Tu yielded no good fragmentation spectrum. This is consistent
with our previous observations that some C-terminal CNBr fragments do not fragment well
(unpublished results). It should be noted that CNBr fragments do not contain a C-terminal
Lys or Arg and that fragmentation will depend on the presence and location of internal basic
residues, and on the sequence and the amino acid composition of the peptide itself. To the best
of our knowledge, this problem has not been studied in detail so far.
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Figure 3.5: C-terminal sequence analysis of recombinant protein D. Panel A: MS spectrum of the
CNBr digest after chemical opening; 50 pmol of recombinant protein D was separated by SDS-PAGE.
Approximately 1/10 of the band was cut out of the gel and cleaved by CNBr. Panel B: MS/MS spectrum
of the C-terminal peptide at m/z 3103.73. Y- and b-ions are indicated in green and red respectively.
The amino acid sequence is indicated in the one-letter code.
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3.2.5 Conclusion
Shotgun proteomics provides the most comprehensive identification of proteins from cellular
lysates, but generally fails to characterize the N- or C-terminal sequence of the protein under
study. This is most often due to the scare detection of terminal peptides during the mass
spectrometric analysis of complex peptide mixtures and the incomplete annotation of protein
termini in protein databases. Here, we have demonstrated a novel approach allowing to discri-
minate C-terminal peptides in CNBr mixtures. The method can be applied at the low femtomol
level and can be used for the analysis of gel or gel-free purified proteins. For gel-separated
proteins we observed an adduct of 25 Da during chemical opening. Although its exact nature
remains unknown so far, this adduct is not observed if the gel fractions are desalted (ZipTip)
before the ring opening. Although some peptides had a molecular mass in the good range for
MS analysis (1-4 kDa) they were not observed during mass analysis (Table 3.1). This is most
likely due to a low ionization efficiency (depending on the sequence and amino acid composition)
or to sample suppression effects as observed previously[42, 43].
In contrast to the carboxypeptidase method, the chemical approach is suitable for the develop-
ment of a high-throughput approach, by coupling the MALDI-MS/MS analysis to a robotic
sample preparation device. For that purpose a TECAN Freedom EVO robot has recently been
introduced in our laboratory. The development of a method that allows a high-throughput
analysis of proteolytic processing at a proteomics level will be of fundamental importance to
gain a better understanding of the complex biological processes in living organisms.
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3.3 Automation of C-terminal sequence analysis of 2D-PAGE sepa-
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3.3.1 Abstract
Experimental assignment of the protein termini remains essential to define the functional
protein structure. Here, we report on the improvement of a proteomic C-terminal sequence
analysis method. The approach aims to discriminate the C-terminal peptide in a CNBr-digest
where Met-Xxx peptide bonds are cleaved in internal peptides ending at a homoserine lactone
(hsl)-derivative. pH-dependent partial opening of the lactone ring results in the formation
of doublets for all internal peptides. C-terminal peptides are distinguished as singlet peaks
by MALDI-TOF MS and MS/MS is then used for their identification. We present a fully
automated protocol established on a robotic liquid-handling station.
3.3.2 Introduction
Characterization of the exact N- or C-terminus of a protein is an essential contribution to
evidence-based gene annotation. Current prediction methods fail to provide a proper assignment
of these termini that are highly sensitive to post-translational processing events. The failure
of classical chemical protein sequencing methods to reach the throughput and sensitivity to
routinely provide this information forced us to adopt proteomic strategies typically involving
isolation of terminal peptides. Replacement of chemical protein sequencing by top-down mass
spectrometry is considered, but requires costly high resolution (FT-based) instrumentation
and intensive protein purification. Therefore, full exploitation of this approach awaits further
technical and bioinformatics improvements [50, 51].
A number of methods have been described for the specific isolation of the C-terminal peptide
of a protein, basically falling into three categories, i.e. introducing labels at certain functional
groups, chromatographic enrichment of terminal peptides and binding via functional groups to a
resin. The introduction of an isotopic label, either in the C-terminal peptide using Br-containing
reagents [52] or in the internal peptides using H2
18O during in-gel digestion [53], allows to
distinguish the C-terminal peptide by matrix-assisted laser desorption/ionization (MALDI)-MS.
Due to the difficulties to selectively target the C-terminus and/or the need for a large amount
of sample, these techniques have rarely been applied [54]. In a second strategy, N-terminally
blocked peptides and C-terminal peptides are enriched from a complex peptide mixture by strong
cation exchange (SCX) purification at low pH [48]. An example of the third strategy is the use
of immobilized anhydrotrypsin to specifically bind tryptic peptides that contain an arginine or
lysine at their C-terminus. C-terminal peptides, typically devoid of such a C-terminal basic
residue, are then recovered from the non-bound fraction [55]. Lastly, ProC-TEL uses a positive
selection approach to enrich the C-terminal peptides using the transpeptidase activity of car-
boxypeptidase Y to label the C-terminus of the protein with biotin prior to tryptic digestion [56].
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Recently two C-terminal sequencing techniques have been reported that can be applied to
complex biological samples, both combining two of the previously mentioned strategies. Based
on the COFRADIC approach, N-terminally blocked and C-terminal peptides are first enriched
in a SCX step followed by the introduction of a butyrate label on the α-amine of the C-terminal
peptides [57]. This allows identifying the latter by their altered chromatographic behavior. The
C-TAILS approach combines multiple amine and carboxyl group protection steps with a tryptic
digest to selectively bind the internal peptides to a primary amine containing resin [58]. These
methods have successfully been applied to complex samples, but require multiple derivatization
and/or separation steps making them labor intensive.
In the so-called ladder sequencing techniques, first described by Chait et al. [59], a sequence-
defining concatenated set of peptide fragments, each differing from the next by a single residue,
is generated in a controlled fashion. Subsequently the complete fragment set, the peptide ladder,
is analyzed mostly by MALDI-MS. While chemical ladder generating procedures, often based on
the Edman degradation, have mainly been developed for N-terminal approaches, proteolytic di-
gestion using carboxypeptidases (CPase) has been the preferred method for C-terminal sequence
analysis. Our group has developed an enzymatic ladder sequencing technique that enables the
systematic identification of C-termini from proteins either in-gel or in-solution [42, 43]. The
proteins are first chemically cleaved under acidic conditions with cyanogen bromide (CNBr).
CNBr hydrolyses the peptide bond C-terminal from methionine residues that are converted into
homoserine (hse). Under acidic conditions hse undergoes a cyclisation to the lactone form [1].
This homoserine lactone (hsl) residue allows to differentiate between the C-terminal peptides
and the N-terminal and internal peptides. During incubation with a CPase, only the original
C-terminal fragment (having a free carboxyl group) is accessible to enzymatic degradation and
forms a ladder. The sequence of the C-terminal peptide can then be read by measuring the
unseparated peptide mixture containing the CPase generated fragments on a MALDI-TOF MS
(Figure 3.6).
In this ladder sequencing technique, CPY and CPP are selected because of their broad amino
acid specificity [44]. However, it is known that cleavage C-terminal of Gly is slow, and also
the presence of Phe, Thr, or Lys slows down or inhibits ladder generation [60]. Additionally,
the rate of hydrolysis depends on reaction conditions such as pH, ionic strength and substrate
concentration. Due to these limitations, we observed that the reaction times required optimiza-
tion for each individual sample. Finally, it should be noted that most exopeptidases have a
Km-value in the range of 5-50 µM, which means that they are operating at 50% maximum
velocity when a protein concentration of 5 pmol/µl is used [61]. At lower concentrations (sub
pmol), the proteolytic activity toward the substrate will be minimal.
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We recently reported the modification of the technique by eliminating the use of CPase through
developing a novel chemical approach to differentiate between internal and the C-terminal
peptides without the need to separate the peptides prior to analysis [60]. In this chemical
approach, the peptide mixture, generated by digestion with CNBr, is incubated in slightly
basic buffer. This results in a partial opening of the hsl derivatives to the corresponding hse
derivative (∆m = +18 Da). All internal peptides appear as doublets in the MALDI-TOF
MS spectrum, whereas the C-terminal peptide is the only singlet present and can be selected
for MS/MS analysis (Figure 3.6). By replacing the CPase-dependent determination of the
C-terminal peptide by a chemical method, we made the technique sequence independent and
eliminated the need to optimize the protocol for each sample separately.
Figure 3.6: Schematic representation of the different steps in the two C-terminal sequencing methods.
Proteins separated by 2D-PAGE are cleaved in gel with CNBr after destaining. CNBr cleavage results in
the formation of internal fragments ending at a homoserine lactone (hsl) derivative. When the fragments
are incubated with carboxypeptidase (CPase), only the peptide containing the original C-terminal
sequence (Xxx-Yyy-Zzz) is accessible for enzymatic degradation by CPase and forms a ladder. When
chemical selection is used to differentiate internal from C-terminal peptides, the peptides are incubated
in a slightly basic buffer resulting in the partially opening of the hsl ring forming both homoserine (hse)
and hsl derivatives of the internal peptides. Hsl and hse have a mass difference of 18 Da. Both the
ladders and the hsl/hse derivatives are analyzed by MALDI analysis on a 4800 MALDI TOF/TOF
instrument. CPX represents a CPase or a mixture of CPases.
While our previous work was based on some model proteins in-gel and in-solution, we here report
the results obtained from a proof-of-concept experiment by performing the enhanced protocol
in a proteomics setup on 2D-PAGE gel separated proteins from Shewanella oneidensis MR-1.
To increase the throughput of the method, we transferred it to a liquid handling and robotic
platform. After loading the protein gel spots in a 96-well plate, the robot performs all necessary
steps of the protocol in an automated way, including sonication, heating, cooling, pipetting and
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sample clean- up using ZipTips. Multi-arm robots can move the 96-well plates between different
modules on the worktable limiting manual interference and contaminations. We compared the
results with data obtained by C-terminal sequencing using the manual CPase ladder sequencing
approach and demonstrate a significant improvement of the number of identified C-terminal
sequences.
3.3.3 Materials and methods
Materials and chemicals
HPLC-grade acetonitrile (ACN) was obtained from BioSolve (Valkenswaard, The Netherlands).
Trifluoroacetic acid (TFA) (purity >99.9%) was obtained from Beckman Instruments (Palo
Alto, CA, U.S.A.). Urea was obtained from GE Healthcare (Diegem, Belgium). ’Complete
mini’ ethylenediaminetetraacetic acid (EDTA)-free protease inhibitor mix, DNase I and RNase
came from Roche (Vilvoorde, Belgium). Coomassie Plus Bradford protein assay was purchased
from Thermo (San Jose, CA, USA). ReadyStrip IPG strips, Bio-Lyte 3-10 ampholyte and
Tris/Glycine/SDS running buffer 10x were purchased from Bio-Rad (Hercules, CA, US). The
solution of 30% (w/v) acrylamide/0.8% (w/v) bisacrylamide was purchased from National
Diagnostics (Atlanta, GE, US), whereas agarose was from Eurogentec (Liege, Belgium). Sodium
dodecyl sulfate (SDS) was obtained from Merck (Darmstadt, Germany). Sequencing-grade
CPY was obtained from Roche (Indianapolis, IN, USA). C-18 Zip-Tips were obtained from
Millipore (Billerica, MA, USA). 2 ml glass vials with screw top, PTFE/Red rubber septa
and polypropylene screw caps were obtained from Supelco (Bellefonte, PA, US). Polystyrene
V-shaped 96-well plates were obtained from Greiner Bio-one (Frickenhausen, DE). Water was
purified using a MilliQ water filtration system (Millipore). Other chemicals and reagents were
purchased from Sigma (St. Louis, MO, US).
Bacterial growth and protein extraction
S. oneidensis MR-1 was grown aerobically overnight in 1 L Luria Bertani (LB) medium on a
rotary shaker at a speed of 220 rpm at 28 ◦C until an optical density at 600 nm (OD600) of
0.6 was reached. The cells were then centrifuged and washed twice using a 50 mM TrisHCl
solution (pH 7.5). The bacterial cell pellet was dissolved in lysis buffer pH 7.5 (9 M urea,
40 mM Tris-HCl, 2% 3-[(cholamidopropyl) dimethylammonio]- 1-propanesulfonate (CHAPS),
1% dithiothreitol (DTT), 0.5 mg/ml bovine pancreas DNase I, 0.25 mg/ml bovine pancreas
RNase A, 50 mM MgCl2) containing a protease inhibitor mixture (EDTA-free). A volume of
1.5ml of this solution was added per gram of biomass and sonicated on ice using a Digital
Sonifier S-250D (Branson, Danbury, CT) for 1 min on 30% amplitude in pulses of 2 s. After
sonication the sample was kept on ice for 15 min to allow the DNase and RNase to digest
the polynucleotides. Next the sample was centrifuged at 16,000 g for 45 min and the soluble
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protein fraction was precipitated with acetone at 20 ◦C. The protein pellet was dissolved in
rehydration buffer (9 M urea, 1% DTT, 2% CHAPS, 2% Bio-Lyte 3-10 ampholyte solution).
2D-PAGE
350 µl of bacterial extract (±300 µg of protein as determined by a Bradford protein assay)
was loaded via passive in-gel rehydration [62] on a 17 cm IPG strip, pH range 4-7. The strips
were covered with mineral oil and were left for 9 h at room temperature. Isoelectric focusing
(IEF) was performed using a Protean IEF cell (Bio-Rad, Hercules, CA) at room temperature by
applying a stepwise voltage gradient up to 3500 Volt, until 35 kVh were reached. Following the
focusing step the proteins were reduced in 50 mM Tris-HCl (pH 8.8), 6 M urea, 2% SDS, 30%
glycerol, 1% DTT) and amidoacetylated (same buffer, DTT replaced by 5% Iodoacetamide
(IAA)) by shaking the strip submerged in buffer for 10 min at room temperature. For the
second dimension, the strips were placed on a 12% SDS-PAGE gel with a 0.5% agarose gel as
interface. The gels were run at 30 mA/gel until the bromophenol blue front reached the bottom
of the gel. After fixation (40% EtOH, 10% acetic acid), the gels were stained overnight with
Coomassie G. The gels were destained with 30% methanol prior to spot picking.
CNBr cleavage
CNBr cleavage of gel separated proteins was performed as described before [43, 60]. Briefly,
after visualization and destaining, the bands or spots containing the protein were excised from
the gels. Before cleavage with CNBr, the gel pieces were washed twice with 100 µl 200 mM
NH4HCO3 /50% ACN and then shrunken with 40 µl ACN and rehydrated in 5 µl MQ. CNBr
cleavage was started by adding 15 µl TFA and 5 µl 5 M CNBr in ACN. CNBr and TFA are
highly toxic and corrosive products which must, at any time, be manipulated under a fume hood,
only by skilled personnel wearing protective clothing! After incubation overnight (4 ◦C) the
supernatant was collected and the peptides were extracted twice with 30 µl 70% ACN/0.1% TFA
for 30 min at 37 ◦C. All fractions were pooled and dried in a SpeedVac (Thermo Savant, San
Jose, CA, USA). Care must be taken during sample manipulation to avoid oxidation. Oxidation
of methionine to methionine sulfoxide prevents CNBr from attaching to the sulfur atom and
initiating the cleavage reaction. Therefore, samples were submitted for gel electrophoresis as
soon as possible after cell lysis, and gels were kept in a tris(2-carboxyethyl)phosphine (TCEP)
containing solution until CNBr digestions.
Carboxypeptidase protocol
The CPase protocol was performed as described by Samyn et al. [43]. Sequencing-grade CPY
was diluted to a stock solution of 1 pmol/µl in 40 mM sodium citrate pH 6.0. For time-dependent
ladder formation the CNBr fragments were dissolved in 10 µl 10 mM ammonium acetate buffer
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pH 5.4 and mixed with CPY (enzyme to substrate ratio of 1:50 wt/wt). After 0, 1, 3, 10, 20
and 30 min 0.5 µl of this mixture and 0.5 µl of matrix were spotted on the MALDI target plate.
For concentration-dependent digestions, the CNBr fragments were dissolved in 5 µl ammonium
acetate buffer. 0.5 µl was spotted onto the MALDI target plate and incubated with 0.5 µl of 1,
0.2, 0.04, 0.008 pmol/µl CPY until solvent evaporation terminated the reaction.
Chemical derivatization
Before the chemical derivatization, the dried samples were desalted using C18 ZipTip micro
purification tips. The ZipTip protocol was performed as described by the manufacturer. A 50%
ACN/0.1% TFA solution was used as activation and elution solvent. A 0.1% TFA solution in
MQ was used as dissolving, equilibration and wash solvent. After elution the samples were
dried (in an oven) at 60 ◦C for 15 min. The partial opening of the hsl to hse was performed by
dissolving the sample in 10 µl 10 mM NH4HCO3 (pH 8.0), and incubation at 37
◦C for 30 min.
During the dissolving steps the samples were sonicated for 5 min. After incubation 0.5 µl of
the sample was spotted onto the MALDI target plate
Automation
All samples obtained from the chemical derivatization protocol were processed on a Tecan
Freedom Evo 150 platform (Figure 3.7). The custom designed robot is equipped with a robotic
manipulator arm to move 96-well plates and an 8-channel liquid handling arm. Two channels on
the liquid handling arm are set up to be used with ZipTips. Two other channels are equipped
with high internal volume stainless steel needles with sharp tips, used to pierce through the
rubber septa of the vials containing the corrosive chemicals. The last 4 channels on the liquid
handling arm are equipped with high precision Tecan Positioning System (Te-PS) fluorinated
ethylene propylene (FEP) coated stainless steel needles used for all other liquid handling. The
worktable (1.5 m) holds 96-well plate carriers, solvent trays, slots for glass vials, a heater with
six 96-well plate slots at different temperatures and a sonicator used as alternative for a vortex.
The solvents and one 96-well plate carrier were cooled to 4 degrees to slow down evaporation of
the solvents. The entire robotic platform is placed under a fume hood to protect the user from
the toxic TFA and CNBr vapors. Freedom Evoware 2 standard software serves as an interface
between the user and the platform.
The excised gel spots were collected in polystyrene V-shaped 96-well plates that are resistant to
the corrosive properties of CNBr. All steps of the chemical derivatization protocol; destaining,
chemical cleavage, extraction, ZipTip, lactone opening and spotting on the MALDI target plate
were performed by the robotic platform. The only steps that required manual handling were
covering the 96-well plate with Parafilm to prevent evaporation during the overnight incubation
with CNBr and placing the 96-well plate in the SpeedVac to dry the samples after extraction.
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Figure 3.7: Picture of the setup of the Tecan liquid handling and robotic system. Top: front view,
Bottom: top view on the reaction table.
Mass spectrometry
All mass spectrometry analysis were performed on an Applied Biosystems 4800 plus Proteomics
Analyzer with TOF/TOF optics (Applied Biosystems, Foster City, CA). This MALDI mass
spectrometer uses a 200 Hz frequency tripled Nd:YAG laser operating at a wavelength of 355
nm. For high resolution analysis of the peptides, the instrument was operated in reflector mode.
For MS/MS, ions generated by the MALDI process were accelerated at 8 kV through a grid
at 7.3 kV into a short, linear, field-free drift region. In this region, the ions passed through
a timed-ion-selector device that is able to select a peptide ion, for subsequent fragmentation
in the collision cell. The selected ions then passed through a retarding lens where they were
decelerated and allowed to enter into the collision cell, which was operated at 7 kV. The collision
energy is defined by the potential difference between the source and the collision cell (1 kV).
After passing through the collision cell, the ions (both intact peptide ions and fragments) were
accelerated in the second source region at 15 kV into the reflector, and finally, to the detector.
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Samples were prepared by applying 0.5 µl of the sample to a 384-well stainless steel target
plate and by adding 0.5 µl matrix solution (25 mM α-cyano-4-hydroxycinnamic acid + 10
mM ammonium citrate solution in 50% ACN containing 0.1% TFA). They were allowed to
air-dry at room temperature and were then inserted into the mass spectrometer and subjected
to MALDI-MS analysis. All MS and MS/MS experiments were performed twice on the same
sample (two spots) and were run in duplicate. Prior to analysis, the mass spectrometer was
externally calibrated with a mixture of Angiotensin I, Glu-fibrino-peptide B, ACTH (1-17),
and ACTH (18-39). For MS/MS experiments, the instrument was externally calibrated with
fragments of Glu-fibrinopeptide.
MS data analysis
GPS explorer (Applied Biosystems, Foster City, CA) was used to search the combined MS
and MS/MS data against the NCBI S. oneidensis MR-1 protein database [29], obtained from
www.ncbi.nih.gov/Entrez/. GPS Explorer used a local MASCOT server for protein identifi-
cations [63]. Both for PMF and MS/MS searches, the 50 most intense ions were uploaded
to the server. Search parameters were as follows: 100 ppm peptide tolerance and 0.5 Da
MS/MS tolerance. CNBr was selected as cleavage reagent and zero miss cleavages were allowed.
Conversion of methionine to hsl or hse and carbamidomethylation of cysteine were allowed as
variable modifications.
The MS/MS spectra of the C-terminal peptides were manually interpreted and the sequence tags
were searched against the NCBInr database using BLASTp (http://blast.ncbi.nlm.nih.gov/). S.
oneidensis MR-1 was selected as organism and BLOSUM 62 was selected as scoring matrix.
Additionally, to confirm the identifications, the obtained C-terminal sequence tags were searched
using MS homology (http://prospector.ucsf.edu/prospector/mshome.htm).
3.3.4 Results
Implementing the chemical derivatization protocol on a robotic platform
After optimization of our chemical method [60] we observed that it was robust and, in con-
trast with our previous CPase-based strategy, it was largely independent of the sequence of
the C-terminal peptides [42]. In order to obtain a higher throughput, we decided to trans-
fer the protocol to an automated robotic platform. Due to some limitations of the Tecan
platform and the corrosive properties of two essential chemicals (TFA and CNBr) some adap-
tations had to be made to the initial protocol (The detailed protocol can be found online at
doi:10.1016/j.euprot.2014.03.004).
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To limit the number of manual interventions, all drying and dissolving steps were performed in
an oven (60 ◦C) and in a sonicator embedded in the robot instead of being placed manually
in a SpeedVac and vortex, respectively (Figure 3.7). Only the peptide extracts obtained after
CNBr digestion were dried using the SpeedVac because of their large volume.
To protect the user and the electronics against exposure to toxic chemicals and to prevent
evaporation of the solvents and the samples during chemical degradation and incubation at
elevated temperature steps, the samples and solvents were kept cooled and sealed as much
as possible. Because the CNBr/ACN and TFA solutions degrade plastic solvent containers,
they were kept in cooled glass vials with rubber septa that can be pierced with inert needles.
The tip of the needles was cut to a 45◦ angle to allow them to easily pass through the thick
septa. The needles also have a large internal volume to prevent the CNBr and TFA containing
solutions from entering and degrading the plastic tubing of the liquid handling system. In
view of the observation that the CNBr and TFA containing solutions degraded most of the
tested glue based seals for 96-well plates, Parafilm was found to be the best alternative to avoid
evaporation during overnight chemical digestion.
Next to the vials, rubber caps, needles and seals, a large set of 96-well plates were tested
for compatibility with the solvents and recovery of peptides after drying steps. During all
these tests SDS-PAGE separated horse heart cytochrome c was used as a test protein. The
Polystyrene V-shaped 96-well plates from Greiner Bio-One were finally selected as they provided
the most reproducible results (data not shown).
Evaluation of the automated procedure on Shewanella oneidensis MR-1 2D-PAGE
gel spots
The automated method was evaluated for proteome analysis of S. oneidensis MR-1. S. onei-
densis was aerobically grown and the total protein extract was separated by 2D-PAGE. After
Coomassie blue staining, 96 of the most intense spots were selected (Figure 3.8) and loaded in a
96-well plate. The robot autonomously performed all steps from the sample preparation protocol,
starting from destaining the spots and finishing by spotting the peptides on the MALDI-plate,
in 24 h with only 2 minor manual interventions (applying Parafilm and transferring the 96-well
plate to the SpeedVac).
To illustrate our approach, we focus on the CNBr peptide map of spot 21. After incubation
with the basic buffer, an internal peptide appears as a doublet (2339.0 Da and 2357.0 Da)
with a mass difference of 18 Da in the spectrum. The C-terminal peptide appears as the most
intense singlet peak at 2089.9 Da (Figure 3.9 A). After fragmentation, a complementary b- and
y-ion series was obtained covering the entire C-terminal peptide sequence (Figure 3.9 B). The
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Figure 3.8: 2D-PAGE separated proteins from aerobically grown Shewanella oneidensis MR-1. ±300
µg of total cell extract was loaded on an IPG strip (4-7) and analyzed as described. The numbered
spots were subjected to both approaches. The spots are coloured according to the C-terminal sequence
information and protein identification obtained during chemical selection. The 24 spots marked in red
were identified only using the C-terminal sequence obtained. For the 14 spots marked in green, the
C-terminal peptide was identified, but no sequence information was obtained. No C-terminal sequence
information was obtained for the 22 spots marked in blue, but the proteins were identified by PMF
analysis. The 36 spots marked in black were not identified.
18-residue amino acid sequence was submitted to a BLAST search against the S. oneidensis
proteins in the NCBI database [29, 64] and was identified as the C-terminal peptide of a protein
annotated as an ABC-type tungstate uptake system substrate-binding component (TupA).
Out of 96 samples, 44 unique proteins from 60 different spots, with a molecular mass ranging
from 12.5 to 93 kDa, could be identified using the CNBr peptide mass peptide fingerprint
and MS/MS data (Table 3.2 and Appendix Table A.1). In 38 spots (24 proteins) thereof, we
were able to distinguish the C-terminal peptides since they appeared as singlets in the MS
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Figure 3.9: C-terminal sequence analysis of spot 21 (ABC-type tungstate uptake system substrate-
binding component TupA) using chemical selection. Panel A: MS spectrum of the CNBr digest after
chemical opening. Masses with m/z 1043, 1109 and 1300 are reoccurring contaminants. Panel B:
MS/MS spectrum of the C-terminal peptide at m/z 2089.9. Y- and b-ions are indicated in green and
red respectively. Amino acid sequence is indicated in one-letter code.
spectrum (Table 3.2). Other singlet peaks were recurrent contaminants that could be excluded.
These C-terminal peptides were selected for MS/MS analysis and after manual interpretation
of the obtained fragmentation spectra we were able to obtain sufficient C-terminal sequence
information to identify 13 proteins present in 24 spots using a BLAST search against the S.
oneidensis MR-1 protein database (Table 3.2). In 4 cases, the entire sequence of the C-terminal
peptide could be extracted from the fragmentation spectrum while in the other, a sequence
tag of minimum 6 consecutive amino acids could be determined. In one case, DNA-binding
protein H-NS family (spot 38), the C-terminal peptide contained one missed cleavage due to
the presence of an oxidized methionine.
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Evaluation of the carboxypeptidase based method for C-terminal sequencing
To benchmark the automated method we also used our previously described manual technique,
implementing CPase treatment [42], to analyze the 96 most intense spots from a 2D-PAGE
gel containing S. oneidensis MR-1 proteins. Of the 96 spots, here 45 unique proteins could be
identified by peptide mass fingerprint (PMF) analysis of the CNBr fragments and by performing
a database search on a local MASCOT server using MS/MS data. In 16 spots, a sequence ladder
could be obtained after incubation with CPase, corresponding to 8 different proteins. The length
of the obtained sequence ladder varied between only 2 and 6 amino acids. Additional sequence
information of the C-terminal peptide was generated by MS/MS. The obtained sequences were
searched against the NCBI S. oneidensis MR-1 database using two different search engines
(Table 3.3) significantly identifying 4 different proteins present in 13 spots.
To illustrate the workflow of the CPase technique we show the peptide map of cytoplasmic
peptidyl-prolyl cis-trans isomerase B (spot 88) in detail. During the time-dependent ladder
formation, samples were collected and spotted on the MALDI plate at different time points
during the incubation with CPase. The peptide mass fingerprint analysis based on the spectrum
from the sample before CPase incubation resulted in a significant protein identification score of
92 (result not shown). By combining MS spectra obtained from the concentration dependent
digests a 4 amino acid C-terminal tag SVAA could be determined originating from the C-
terminal peptide, with an m/z value of 1903.05 (Figure 3.10 A). The intact peptide was also
selected for MS/MS. Now, a somewhat larger amino acid tag could be extracted from the
spectrum, AVVIEKVS or SVKEIVVA (Figure 3.10 B). By combining this information with the
C-terminal 4 amino acid tag SVAA the direction of the tag can be determined and combined to
AVVIEKVSVAA. This sequence tag resulted in a positive identification in a BLAST search
(Table 3.3).
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Figure 3.10: C-terminal sequence analysis of spot 88 (Cytoplasmic peptidyl-prolyl cistrans isomerase
B PpiB) using carboxypeptidase (CPase) selection. Panel A: accumulated MS spectrum of the CNBr
digest after incubation with CPase at different time points. A four amino acid long sequence ladder is
formed starting at the C-terminal peptide (m/z 1903.79). Panel B: MS/MS spectrum of the C-terminal
peptide. Only b-ions are observed.
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3.3.5 Discussion
The chemical selection technique, automated on the robotic Tecan platform, outperforms our
previous CPase based method in terms of throughput. 96 samples can be prepared for MALDI
analysis starting from gel spots in 24 h (including a 12 h CNBr digest). The entire process
only asks for two manual interventions. When samples are analyzed using the manual CPase
technique a throughput of only 10 samples a day could be reached.
The MALDI data acquisition and interpretation are also faster and more straightforward when
using the chemical selection technique. There is no need to analyze the samples at multiple
time points or with multiple concentrations of CPase. This reduces the number of spots and
spectra that need to be acquired and interpreted. The C-terminal peptide can be identified
from a single MS spectrum while multiple MS spectra need to be layered to observe the ladder
formed in the CPase technique.
When the results of both experiments are compared it is clear that the chemical selection
technique has a larger number of identified and sequenced C-terminal peptides. There are two
main reasons why the chemical selection would generate better results than the CPase selection.
First, due to the selectivity of the CPase, a lot of C-terminal peptides are not efficiently digested
and no ladder will be observed for those proteins, while the chemical selection is sequence
independent. Second, when a sample is analyzed using the CPase approach the sample is
distributed over multiple fractions (concentration- and time-dependent analysis) resulting in a
lower concentration of the peptide of interest in the spot. Due to the ladder formation, the
C-terminal peptide is also present in multiple forms, lowering its detection level.
We realize that 2D-PAGE has several well characterized limitations that limit the applicability
of our technique, and that LC-MS based shotgun methods are in place [65]. However, 2D-PAGE
is still the preferred method to separate intact proteins and offers the possibility to distinguish
protein isoforms. Several proteins were identified in multiple spots, in all demonstrated cases
providing knowledge that the isoforms are not the result of C-terminal processing.
The success of our C-terminal sequence determination depends on the length, ionization capacity
and fragmentation efficiency of the CNBr fragments that are generated. In both cases the
MS analysis is performed using MALDI-TOF MS, generating predominantly singly charged
ions. The use of α-cyano-4-hydroxycinnamic acid as matrix produces chemical noise in the low
molecular weight mass range and therefore hinders the detection of C-terminal peptides with a
mass below 1 kDa. Further optimization of the MALDI sample preparation could probably
improve this. It should be realized that performing C-terminal sequence analysis of tryptic
endopeptides as obtained from typical shotgun methods theoretically results in over 70% of
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peptides smaller than 1000 Da in S. oneidensis.
On the other hand, in our experience the upper mass limit for the analysis of CPase derived
ladder sequences in MALDI-TOF MS, providing enough resolution and accuracy to identify the
amino acid sequence, was restricted to C-terminal fragments with Mw of ±4-5 kDa. Similarly,
MALDI-TOF MS/MS is typically restricted to peptides of the same length, limiting our new
approach. Indeed, when analyzing the mass distribution of the C-terminal peptides generated
by CNBr cleavage of all S. oneidensis MR-1 proteins, we calculated that 51.2% of the 4087
unique entries in the NCBI database have a C-terminal peptide mass between 1 kDa and 5.5
kDa and should be easily distinguished in a reflection MALDI-TOF MS spectrum. 70% of
the proteins that we identified based on the peptide fingerprints, but for which no C-terminus
could be obtained, have a predicted C-terminal peptide that falls outside this mass range. To
be independent from genome annotation, the C-terminal sequence should be determined by de
novo sequencing. The upper limit to generate qualitative de novo interpretable MS/MS spectra
using our 4800 TOF/TOF instrument is around 3.5 kDa. Half of the C-termini that could not
be identified by de novo sequence analysis, but were identified by a MASCOT MS/MS ion
search (7 spots out of 14) were larger. It should be commented that MASCOT is not fully
compatible with our strategy. For CNBr digested peptides, it automatically sets the C-terminal
amino acid as variable for homoserine and homoserine lactone. It would be better to allow a
fixed modification there, which would reduce the search window and result in more significant
scores. This is also the reason why we report the GPS Scores, as this groups the scores for
all fingerprint and MS/MS spectra of a particular MALDI spot analysis, providing a more
confident identification.
Overall, we were unable to identify the C-terminal peptide in 23 identified spots (21 unique
protein entries), around 70% of those C-termini were outside the 1-5.5 kDa range (Appendix
Table A.1).
3.3.6 Conclusion
The determination of the actual C-termini of proteins on a proteome-wide scale is a challenging
task. Common shotgun proteomic approaches often fail to characterize protein termini, especially
C-termini. This is most often due to the poor detection of terminal peptides during mass
spectrometric analysis of complex peptide mixtures and the incomplete annotation of protein
termini in protein databases. Verification of predicted C-termini could be performed in LC-MS
setups by generation of specific inclusion lists, based on the predicted mass of the C-terminal
peptides. Here, we present the first fully automated C-terminal sequencing approach that
can be implemented in a traditional proteomic setup. We have applied the method to 96
2D-PAGE separated S. oneidensis MR-1 proteins and show strong improvement compared to
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our previously used manual CPase ladder sequencing technique. Moreover, we were able to
identify three times more proteins using de novo sequenced C-terminal peptides. The main
limitations of the technique are intrinsic to the use of 2D-PAGE and MALDI TOF/TOF MS
as analysis tools. We have demonstrated that the technique theoretically covers 50% of the
proteome of S. oneidensis MR-1 and is at least complementary to other approaches for whole
genome C-terminal sequence determination.
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Chapter 4
Alternative cleavage reaction
4.1 Generating smaller C-terminal peptides
In the chemical selection strategy using CNBr, proteins are only cleaved C-terminal of methionine.
Since methionine only accounts for 2.59% of the amino acids in Shewanella oneidensis MR-1,
the peptides generated after CNBr cleavage are relatively large. In order for peptides to be
detected on a MALDI-TOF/TOF analyzer they need to be in the 1-5.5 kDa mass range. Our
data showed that most succesfully de novo interpreted MS/MS spectra had a parent ion with
a molecular mass below 3.5 kDa. Using CNBr as cleavage reagent, 51% of the C-terminal
peptides can be detected and only 1 out of 3 proteins generates a C-terminal peptide in the de
novo sequencing mass range. To improve the proteome coverage of the technique an alternative
cleavage reaction was optimized. When KI is added to the CNBr cleavage reaction mixture,
next to cleavage C-terminal of methionine, also cleavage C-terminal to tryptophan is observed.
Methionine is converted to a homoserine lactone (hsl), and tryptophan to a Cγ-O-spirolactone
tryptophan [1]. The structural resemblance between the reaction products of the two amino
acids, Cγ-spirolactone tryptophan being an indol-substituted homoserine lactone, suggested the
likelihood of a similar behaviour during ladder sequencing by carboxypeptidases and chemical
selection incubations. Tryptophan accounts for 1.25% of the amino acids in S. oneidensis MR-1.
By cleaving C-terminal of tryptophan and methionine 58% of the C-terminal peptides are
detectable on MALDI-TOF/TOF MS and 42% of the proteins have a C-terminal peptide in
the de novo sequencing mass range.
4.2 Trp cleavage alternatives and reaction mechanisms
4.2.1 Different Trp cleavage methods
Oxidizing and halogenating agents are widely used for modification of amino acid side chains
of proteins. [2–5] Some of these modifications were used for the non-enzymatic cleavage of
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tryptophanyl peptide bonds in peptides and proteins. The oxidation of tryptophan during
halogenation converts the indole group into oxindole and dioxindole in a combined oxidation
and cleavage reaction. The first method widely used for the modification and cleavage of
tryptophanyl peptide bonds utilized N-bromosuccinimide (NBS) as oxidant [6]. Because
NBS is an extremely reactive agent, other amino acids are also modified under tryptophan
cleavage conditions: tyrosine and histidine peptide bonds are cleaved during oxidation [7, 8],
methionine is irreversibly converted to sulfone groups [9, 10] and cysteine and proline are
oxidized [9]. In order to obtain a more selective cleavage, different strategies were used to
create more mild reaction conditions. 8 M urea was added to form bromourea as a less
reactive intermediate [11], and p-cresol and phenol were added to act as scavenger for tyrosine
oxidation [12, 13]. Also milder brominating reagents were tested; (2-(2-nitrophenylsulfenyl)-3-
methyl-3’-bromoindolenine (BNPS- skatole) [9], 2,4,6-tribromo-4-methylcyclohexadienone [14]
and tribromocresol [15]. These reagents delivered a more selective cleavage of tryptophanyl
bonds, but the other amino acids were still oxidized. Besides brominating reagents also other
halonium releasing compounds were tested. Although iodine and chlorine cations are generally
weaker oxidants than their bromine counterparts, they have sufficient potential to perform
analogous cleavage reactions. The most important reagents used are N-iodosuccinimide (NIS)
[16], N-chlorosuccinimide [10], N-chlorobenzotriazole [17], o-iodosobenzoic acid [13, 18], and
chloramine-T combined with KI, I2 and I
–
3 [19]. N-chlorosuccinimide was reported to be the
least harsh and only oxidized tryptophan and methionine [10, 20]. In 1977, Ozols et al. reported
the combined cleavage of methionyl and tryptophanyl peptide bonds by performing CNBr
cleavage in heptafluorobutyric acid [21].
4.2.2 Reaction mechanisms of Trp cleavage methods
Several slightly different reaction mechanisms for tryptophan oxidation and concomitant peptide
bond cleavage after oxidative indole halogenation at low pH have been proposed over the years
[6, 13, 14, 19]. The reaction products, stoichiometry and conversion speeds are monitored
using UV-absorption at 280 nm during titration experiments. Patchornik et al. were the
first to report the conversion of the indole spectrum in an oxindole spectrum similar to that
of bromospiro-oxindole [6]. Later, the formation of an oxolactone product was confirmed by
mass spectrometry [22, 23]. Slight differences were observed in stoichiometry between the
different halogenation reagents used, all of them requiring 2 or 3 halogenating molecules per
oxidation and cleavage reaction. The extra third halogenating molecule is used to form a
stable halogen-oxindole derivative [14, 20]. In the reaction mechanism that was proposed by
Patchornik, a bromonium intermediate is formed in the initial step. A nucleophilic attack of
the carbonyl oxygen on the C3 carbon leads to the salt of an iminolactone, which after further
oxidation gives a stable lactone (Figure 4.1) [6].
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Figure 4.1: Reaction mechanism for oxidative halogenation of Trp according to Patchornik [14].
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4.3.1 Abstract
We present the optimized protocol to chemically cleave proteins C-terminal to methionine and
tryptophan with concomitant cysteine oxidation using a CNBr and KI mixture. The charac-
teristics, mechanism and reaction products of the cleavage were evaluated and the occurrence
of possible side reaction products was studied with a panel of test peptides. Additionally, the
spiro- and homoserine lactone groups were used to chemically discriminate between C-terminal
and other peptides in the cleavage mixture. We were able to identify the C-terminal peptide
in a digestion mixture of two test proteins and extend the application range of our previously
reported C-terminal sequencing method.
4.3.2 Introduction
Contemporary proteomics is largely based on the separation of peptides or proteins followed by
mass spectrometric analysis and database searches for protein identification. Although accurate
mass determination and fragmentation of intact proteins can result in their identification [24, 25],
most approaches depend on the application of specific and reproducible methods for cleavage
of the protein into fragments of a size amenable to more routine mass spectrometric methods
including peptide mass fingerprinting or/and tandem mass spectrometry based sequencing of
peptides [26]. Proteins are therefore typically digested using endoproteases, most typically
trypsin, but also endoproteinase LysC is applied. The rationale for their application is double.
They leave a positively charged Lys or/and Arg C-terminal residue that is advantageous to
generate more complete fragment ion series in MS/MS [27]. In addition, the abundance of these
amino acid residues in proteins is moderate and, therefore, these enzymes generate peptide
sizes that are suitable for mass spectrometric methods.
However, the latter is not the case for all proteins and for proteomic and other protein chemistry
applications alternatives to these enzymes are still of interest. Enzymes with other cleavage
specificities have proven quite useful, but in addition, the nature of certain amino acid residues
has permitted the development of non-enzymatic, physical or chemical methods [28–31]. Al-
though chemical cleavage methods form an alternative for endoprotease digestions, they are
less frequently used, unless enzymes with the correct specificity are unavailable or when the use
of enzymes is undesired for other reasons.
The most commonly used method for chemical cleavage, selective cleavage of methionyl peptide
bonds with cyanogen bromide (CNBr), was first described in 1962 [32]. During the cleavage
reaction the methionine is converted to homoserine in a pH-sensitive equilibrium with its
lactone form (Figure 4.2 A), and the two forms can be quantitatively converted into each
other [33]. Today this method, given the low abundance of methionine residues in proteins
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typically resulting in larger peptides, is utilized to generate peptides for immunogenic stud-
ies [34]. Furthermore, CNBr cleavage is used to solubilize membrane proteins [35], and to
digest proteins that are inaccessible to enzymes in studies of the disulfide bonding pattern
of proteins [36, 37]. Proteins are typically cleaved with CNBr at a low pH and different
reaction mixtures including 0.1 N HCl, 70% formic acid and 70% TFA have been used. Because
formylation of side chains is avoided, the use of 70% TFA is preferred over the use of 70%
formic acid [38], resulting in a nearly 100% cleavage yield. Met-Ser and Met-Thr bonds are
cleaved less efficiently [39], but this impairment can be avoided by performing the cleavage in
solutions containing a higher percentage of water, consequently a lower concentration of acid [40].
Figure 4.2: The different amino acid derivatives that are formed after digestion of a protein using
KI/CNBr. A) After cleavage C-terminal to methionine the methionine is converted to a homoserine
lactone in equilibrium with its open lactone form. B) Cleavage C-terminal to tryptophan converts this
residue to an indol-substituted homoserine lactone, Cγ-O-spirolactone tryptophan.
In the previous chapters, we presented two C-terminal sequencing techniques using CNBr
cleaved proteins. Carboxypeptidases and a chemical selection were applied to discriminate
between the carboxylic acid ending C-terminal peptide and the peptides ending at a homoserine
lactone. We also demonstrated that the methods can be used to study proteolytical processing
events and can be performed on an automated robotic platform at a proteome-wide scale.
Recently the technique has been used to determine the terminal amino acids of recombinant
proteins [41].
During incubation with carboxypeptidases, only the C-terminal peptide is accessible to enzy-
matic degradation and forms a sequence ladder [42]. Alternatively, in the chemical approach,
incubation of the CNBr mixture in a slightly basic buffer results in a partial opening of the
homoserine lactone derivatives to the corresponding homoserine product (∆m = +18 Da).
Therefore, all internal peptides appear as doublets in the MS spectrum, whereas the C-terminal
fragment appears as the only singlet [43]. In both techniques, the C-terminal peptide can be
distinguished and selected for MS/MS to unambiguously determine the C-terminal peptide.
However, during our efforts to automate this methodology, we observed that many proteins
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have C-terminal peptides with a molecular weight that is beyond routine mass limits to obtain
good quality MS/MS data [44]. To reduce the size of C-terminal peptides, we were looking for
an additional chemical method that could be introduced in our workflows.
Apart from chemical cleavage C-terminal of methionine, tryptophanyl peptide bonds can be
cleaved by oxidative halogenation with 2-(2’-Nitrophenylsulphenyl)-3- methyl-3-bromoindoenine
(BNPS-skatole), a nowadays rarely used chemical cleavage method [9]. Other reagents used
for the cleavage of tryptophanyl peptide bond include N-bromosuccinimide, o-iodosobenzoic
acid and dimethyl sulfide or aqueous HBr in acetic acid [2, 18, 45]. These methods result in
the cleavage of the tryptophanyl peptide bond after oxidation of the tryptophan residue [13].
Contrary to the metabolic oxidation of tryptophan with reactive oxygen species [46], chemical
oxidation of tryptophan with halogenated compounds results in the cleavage of peptide bonds,
without opening the indole ring. Tryptophan is then oxidized to form Cγ-O-spirolactone tryp-
tophan, a C4 oxidized indol substituted homoserine lactone (Figure 4.2 B) [6, 22]. Essentially
the same reaction was also performed using an instrumental method: the electrochemical oxi-
dation of proteins results in cleavage of polypeptides C-terminal to tyrosine and tryptophan [47].
In 1994, an abstract by Huang and Huang described a method for the concomitant chemical
cleavage of tryptophanyl and methionyl peptide bonds using potassium iodide (KI) and CNBr.
Proteins are cleaved at both sites and the fragments used for Edman degradation or separated
by SDS-PAGE [1]. This method has been used a few times [48, 49]. It is thought that mixing
KI and CNBr generates I2, a reaction which has originally been proposed in a protocol for the
iodometric determination of bromide in solutions [50, 51], and this consequently results in the
formation of the spirolactone form of Trp and concomitant cleavage under acidic conditions
[19]. Indeed, specific cleavage C-terminal of tryptophan was attained by incubating proteins in
an excess of CNBr under oxidizing circumstances [21, 52]. Similar to what is observed in other
oxidative halogenation reactions, we hypothesized that the method simultaneously results in
the oxidation of cystine disulfides to two cysteic acid residues [14, 53].
Here, in view of applications in proteomic protocols, we optimized this procedure to cleave
proteins C-terminal to both methionine and tryptophan, with concomitant cysteine oxidation.
Using MS and MS/MS, the characteristics and mechanism of the cleavage were evaluated
and the occurrence of possible side reaction products was studied with a set of test proteins.
Additionaly, the spiro- and homoserine lactone groups were used to chemically discriminate
between C-terminal and other peptides in the cleavage mixture. We were able to identify the
C-terminal peptide in a digestion mixture of two test proteins and extend the application range
of our previously reported chemical selection method [44].
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4.3.3 Materials and methods
Materials
The four test proteins, used for optimization of the protocol, were mature avidin (Gallus gallus),
cytochrome c (horse heart) and α-lactalbumin (Bos taurus) supplied by Sigma-Aldrich (Bornem,
Belgium) and β-lactoglobulin (Bos taurus) supplied by Applied Biosystems (Framingham, MA,
USA). Organic solvents, i.e. acetonitrile (ACN), methanol (MeOH) and ethanol, were from
Biosolve (Valkenswaard, The Netherlands) and doubly deionized water was in-house purified
with a Milli-Q water filtration system from Millipore (Bedford, MA, USA), further designated
as MQ.
SDS-PAGE gel electrophoresis
The test proteins were run according to Laemmli in separate lanes on in-house casted 10 well
12% Tris-glycine gels (thickness 1 mm). Electrophoresis was carried out using a Mini-Protean 3
Cell (Bio-Rad, Nazareth, Belgium) at room temperature. 1/1 mixtures (v/v) of protein sample
with sample buffer containing β-mercaptoethanol and bromophenol blue were heated briefly
(95 ◦C, 5 min) and loaded on the gel. Electrophoresis, using 25 mM Tris base, 192 mM glycine,
0.1% SDS (w/v) as electrophoresis buffer, was carried out at 150 V until the bromophenol blue
front reached the edge of the gel. The gels were fixated (2% H3PO4/50% ethanol; 30 minutes)
and stained with Coomassie brilliant blue G-250 (0.2% in 34% MeOH/17% (NH4)2SO4/3%
phosphoric acid; 3 hours). The background of the gels was destained overnight in a 30% MeOH
solution.
Destaining, reduction and alkylation
The separated proteins were excised and washed twice with 150 µl 200 mM NH4HCO3/50%
ACN for 30 minutes at 30 ◦C and dried in a Speedvac (Thermo Savant, Holbrook, NY). The
dried gel bands were submitted to reduction/alkylation, initially by incubation with 15 µl 10
mM dithiothreitol (DTT) in 7 M guanidinium HCl/0.3 M Tris, pH 9.0 (45 minutes at 55 ◦C).
Alkylation was performed by adding 5 µl of a 10 mg/ml iodoacetamide and incubation in the
dark for an additional 45 minutes at room temperature. For the reduction and alkylation of
proteins in solution the same protocol was used, however the samples were desalted by using a
ProSorb-device (Applied Biosystems) according to the manufacturer’s instructions.
CNBr and CNBr/KI cleavage
CNBr-cleavage was performed according to a protocol previously described [42]. For CNBr
cleavage in solution, dried protein was dissolved in 5 µl Milli-Q, 15 µl trifluoroacetic acid (TFA)
(Applied Biosystems) and 5 µl 5 M CNBr in ACN (Sigma-Aldrich). After destaining and, when
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applicable, reduction/alkylation, dried gel pieces were incubated with 5 µl MQ, 15 µl TFA and
5 µl 5 M CNBr in ACN. The samples were incubated overnight at 4 ◦C, after which proteins in
solution were dried and reconstituted in 0.1% TFA in water. After incubation of gel-separated
proteins, the supernatant was sequestered and peptides extracted from the gel by two washes
with 35 µl 70% ACN/0.1% TFA, the solutions were pooled and dried. Prior to analysis the
dried extracts were dissolved in 0.1% TFA.
For cleavage of methionyl and tryptophanyl peptide bonds, 4 µl MQ, 15 µl TFA (unless other-
wise stated) and 5 µl 5 M CNBr in ACN were added to the dried protein or gel pieces. To this
1 µl of a 200 mM KI solution (unless otherwise stated) containing 4% phenol (Sigma-Aldrich)
was added, reaching a final KI concentration of 8 mM. Samples were incubated overnight at 4
◦C and further treated as described for CNBr-cleaved proteins.
To gain insight in the cleavage reaction an experiment was set up wherein horse heart cy-
tochrome c was incubated with KI/CNBr in different ratios. In order to avoid the addition of
excessive clean up steps, the concentration of CNBr was lowered and control digestions, using
CNBr alone, were done in parallel. Incubations were performed with a KI/CNBr ratio of 2, 1,
0.5, 1/32, 1/63 and with the ratio used in the optimized protocol (1/125). Linear MALDI-TOF
MS (see further) was used to analyze the results from these cleavages, for which the instrument
was externally calibrated using the singly, doubly and triply charged ions from horse heart
cytochrome c.
It must at all times be kept in mind that CNBr, TFA and phenol are toxic and corrosive
products that can only be manipulated in a fume hood by skilled personnel, wearing protective
clothing.
Incubations using other halogen salts were likewise performed, fluoro- chloro- and bromo-salts
were added in the same ratio to CNBr as for the optimized KI-protocol described above, as
were other iodo-salts.
Chemical opening
Before chemical opening of the lactone ring, the dried samples were desalted using C-18 micro
purification tips (ZipTip, Millipore). The ZipTip protocol was performed as described by
the supplier. A 50% ACN/0.1% TFA solution was used as activation and elution solvent. A
0.1% TFA solution in MQ was used as equilibration and washing solvent. After elution the
samples were dried in a SpeedVac instrument. The partial opening of the homoserine- and
Cγ-O-spirolactone was performed by dissolving the sample in 10 µl 12.5mM NH4HCO3 (pH
8.0), and incubation at 37 ◦C for 30 minutes.
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Mass spectrometry
All mass spectra were acquired on an Applied Biosystems 4700 or 4800 TOF/TOF Pro-
teomics analyzer. 0.7 µl aliquots of the samples were mixed with 0.4 µl of a 5 mg α-cyano-
4-hydroxycinnamic/700 µl 50% ACN/0.1% TFA solution and applied on the MALDI plate,
which was left to dry under ambient conditions.
For mass spectral analysis in reflectron mode, the mass spectrometer was externally calibrated
with a mixture of angiotensin I, Glu-fibrinopeptide B, ACTH (18-39), ACTH (7-38) and des-Arg-
bradykinin. For MS/MS experiments, the instrument was calibrated using Glu-fibrinopeptide
fragments. MS/MS experiments were performed with the metastable suppressor on and ‘gas off’
in the fragmentation cell. Precursor ions were manually selected to ensure the fragmentation of
those peptides of interest. For the fragmentation of peptides with a mass less than 3000 Da,
the width of the mass window was set from -1 to +4 around the precursor peptide. For larger
peptides this mass window was from -2 to +6.
Database searches were done using an in-house MASCOT platform. The cleavage-specificity
C-terminal to tryptophan and methionine was programmed. For PMF-analysis, cleavage
N-terminal to cysteic acid was neglected in the searches. Homoserine lactone and Cγ-O-
spirolactone tryptophan were defined and set as variable modifications when C-terminal of
peptides, cysteic acid was set as fixed modification.
4.3.4 Results
The aim of this study was to characterize in more detail the products obtained after a protocol
that was proposed to perform chemical cleavage of proteins C-terminal to tryptophan and
methionine simultaneously, and to implement it in our existing chemical selection technique for
C-terminal sequencing [1, 43]. Similar to other oxidative halogenation reactions, we hypothe-
sized that application of this protocol on proteins would also result in oxidation of cysteine and
cystine to cysteic acid residues [14, 53]. From initial results it was clear that this was indeed the
case, allowing the analysis of proteins after a single step, combining both cleavage of peptide
bonds and complete oxidation of disulfides.
In the original protocol, a KI-solution is added to the reaction mixture simultaneously with the
addition of CNBr. In order to avoid the missed cleavages, due to the inability of CNBr to react
with oxidized methionine, it was tried to add the KI-solution to the sample after an initial
incubation of 4 hours with CNBr alone. However, no impact of this initial incubation was
apparent from the spectra (results not shown); this step was thus omitted in later experiments
and KI was added simultaneously with CNBr. Formation of potassium-adducts was reduced by
keeping the final concentration of KI to a minimum. Solutions from 500 mM to 25 mM were
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tested and when 1 µl of a 200 mM solution was used, resulting in a final KI concentration of 8
mM, the cleavage remained optimal while the formation of K+-adducts was minimized. Further
lowering the concentration of KI resulted in missed cleavages at tryptophanyl peptide bonds.
The protocol was further modified by adding trace amounts of phenol to the reaction mixture
to avoid iodination of tyrosine. When 4% phenol was added to the halogen salt solution, the
occurrence of this side reaction was completely eliminated.
The optimized protocol was then evaluated on four test proteins for which we used MALDI-TOF
mass spectrometry (Figure 4.3). The major products are indeed peptides resulting from cleavage
C-terminal to methionine and tryptophan, respectively ending on homoserine lactone (∆m=
-48 Da) and Cγ-O-spirolactone tryptophan (∆m= +14 Da) (Figure 4.2, Table 4.1). When
cysteine is present in the sequence, this is observed as cysteic acid (∆m= +48 Da). Some side
reactions were observed, and especially oxidation of methionine or tryptophan without peptide
bond cleavage resulted in missed cleavages. A more important side reaction was the cleavage of
peptide bonds N-terminal to cysteine, when oxidized to cysteic acid. The actual chemical origin
of this side reaction is unclear as it results in an additional loss of 1 Da for the N-terminal
fragment.
Figure 4.3: MS-spectra of the test proteins incubated with CNBr/KI. Panel A: Horse heart cytochrome
c. Panel B: β-lactoglobulin (Bos taurus). Panel C: Avidin (Gallus gallus). Panel D: α-lactalbumin (Bos
taurus).
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Table 4.1: Peptides observed after CNBr + KI digestion of cytochrome c (horse heart), β-
lactoglobulin (Bos taurus), avidin (Gallus gallus) and α-lactalbumin (Bos taurus).
Mw
calc.
(Da)
Mw
obs.
(Da)
Fragment Sequence Remarks
Cytochrome c (horse heart)
1390.28 1390.31 81 104 M.IFAGIKKKTEREDLIAYLKKATNE MH++2 of 2779.57
1517.87 1516.88 1 - 13 acGDVEKGKKIFVQK X-Cys(14) cleavage
1762.93 1762.97 66 - 80 M.EYLENPKKYIPGTKM∗
2494.29 2494.37 60 - 80 W. KEETLMEYLENPKKYIPGTKM∗
2510.29 2510.40 60 - 80 W. KEETLM◦EYLENPKKYIPGTKM∗
2779.57 2779.67 81 - 104 M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
3234.17 3234.31 1 - 59 acGDVEKGKKIFVQKCAQCHTVEKGGKH-
KTGPNLHGLFGRKTGQAPGFTYTDANK-
NKGITW∗
N-term. peptide2+
β-lactoglobulin (Bos taurus)
1329.53 1329.73 8 - 19 M.KGLDIQKVAGTW∗
1367.54 1367.69 8 - 19 M.KGLDIQKVAGTW∗ K+ adduct of 1329.53
1711.89 1710.91 146-159 M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
2113.33 2113.04 146-162 M.HIRLSFNPTQLEEQCaHI C-term. peptide
2116.52 2116.16 1-19 LIVTQTMKGLDIQKVAGTW∗ N-term. peptide
2132.52 2132.17 1-19 LIVTQTM◦KGLDIQKVAGTW∗ N-term. peptide
Avidin (Gallus gallus)
1211.38 1211.51 1-10 ARKCaSLTGKW∗ N-term. peptide
1303.55 n.i.
1331.44 1330.58 71 - 82 W.KFSESTTVFTGQ X-Cys(83) cleavage
1503.60 1503.62 98 - 110 W.LLRSSVNDIGDDW∗
1873.93 n.i.
1916.68 n.i
2131.50 2131.14 111 - 128 W.KATRVGINIFTRLRTQKE C-term. peptide
α-lactalbumin (Bos taurus)
1703.84 1703.83 105 - 118 W.LAHKALCaSEKLDQW∗
1740.94 1740.92 91 - 104 M.CaVKKILDKVGINYW∗ X-Cys(91) cleavage
2408.94 n.i.
2486.22 2486.19 6 - 26 K.CaEVFRELKDLKGYGGVSLPEW∗ X-Cys(6) cleavage
3086.55 3086.58 1 - 26 EQLTKCaEVFRELKDLKGYGGVSLPEW∗ N-term. peptide
◦ Oxidation of Met of Trp.
∗ Homoserine lactone or Cγ-O-spirolactone tryptophan.
ac Acetylation.
Ca Cysteic acid.
n.i. not identified
Besides KI, other halogen salts and iodosobenzoic acid were evaluated as oxidative halogenation
reagents. As presented in Table 4.2 for bovine β-lactoglobulin only the use of iodide salts
resulted in the cleavage C-terminal to tryptophan and in the oxidation of cysteine. Although
cleavage C-terminal to methionine was not affected, no cleavage at tryptophan was observed
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when chloro- or bromo-salts were used, illustrating that I2 formation is essential for the re-
action. Although the peptide bond N-terminal to cysteic acid was sometimes cleaved, no
random peptide bond fragmentation was observed under the conditions we applied (Table
4.2 & Supplementary Table B.1). Similar results were obtained for the three other proteins
tested (Supplementary Table B.1). Because no differences were observed when using different
iodide salts, the initial salt solution, 200 mM KI in 4% phenol/MQ, was used in experiments
to establish whether using other reaction mixtures, previously used for CNBr-cleavage, could
have an impact on the results. All reaction mixtures that were used; 70% TFA, 30% TFA, 30%
formic acid, 0.1 N HCl and 0.05 N HCl, resulted in near identical spectra (results not shown).
The incubation temperature and the incubation time seemed to have little effect on the re-
sults of the cleavage reaction. The results of these experiments for avidin are shown in Table 4.3.
Table 4.2: Peptides resulting from the cleavage of β-lactoglobulin using different
halogen salts.
Fragment Sequence Remarks
KI
1 - 19 LIVTQTM◦KGLDIQKVAGTW N-term. peptide
8 - 19 M.KGLDIQKVAGTW
146 - 162 M.HIRLSFNPTQLEEQCaHI C-term. peptide
146 - 159 M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
NaI
1 - 19 LIVTQTM◦KGLDIQKVAGTW N-term.peptide
8 - 19 M.KGLDIQKVAGTW
146 - 162 M.HIRLSFNPTQLEEQCaHI C-term. peptide
146 - 159 M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
4-Iodosobenzoic acid
1 - 19 LIVTQTM◦KGLDIQKVAGTW N-term. peptide
8 - 19 M.KGLDIQKVAGTW
146 - 162 M.HIRLSFNPTQLEEQCaHI C-term. peptide
KCl/NaCl/4-chlorobenzoic acid
8 - 24 M.KGLDIQKVAGTWYSLAM
146 - 162 M.HIRLSFNPTQLEEQCHI C-term. peptide
KBr/NaBr/2-bromobenzoic acid
1 - 24 M.LIVTQTMKGLDIQKVAGTWYSLAM Trp or Met oxidation
8 - 24 M.KGLDIQKVAGTW◦YSLAM
146 - 162 M.HIRLSFNPTQLEEQCHI C-term. peptide
Terminal Met or Trp residues were observed in the homoserine- or Cγ-O-spirolactone form.
◦= Oxidation of Met of Trp.
Ca = Cysteic acid.
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Table 4.3: Peptides observed after cleavage of avidine (Gallus gallus) at different temperatures and
after incubation at 4 ◦C from 4 to 24 hours.
Mw
Obs.
Sequence Mw
Obs.
Sequence
Overnight at -20 ◦C 4 hours at 4 ◦C
1211.63 ARKCaSLTGKW 1211.61 ARKCaSLTGKW
1503.78 M.W◦LLRSSVNDIGDDW 2966.53 W.KFSESTTVFTGQCaFIDRNGKEVLKTM
1721.85 W.LLRSSVNDIGDDW 3230.60 W.KFSESTTVFTGQCaFIDRNGKEVLKTM◦W
2131.36 W.KATRVGINIFTRLRTQKE 1721.85 M.W◦LLRSSVNDIGDDW
1503.71 W.LLRSSVNDIGDDW
Overnight at 4 ◦C 2131.29 W.KATRVGINIFTRLRTQKE
1211.63 ARKCaSLTGKW
2966.62 W.KFSESTTVFTGQCaFIDRNGKEVLKTM 8 hours at 4 ◦C
3230.69 W.KFSESTTVFTGQCaFIDRNGKEVLKTM◦W 1211.61 ARKCaSLTGKW
1503.78 M.W◦LLRSSVNDIGDDW 2966.53 W.KFSESTTVFTGQCaFIDRNGKEVLKTM
1721.85 W.LLRSSVNDIGDDW 3230.60 W.KFSESTTVFTGQCaFIDRNGKEVLKTM◦W
2131.36 W.KATRVGINIFTRLRTQKE 1721.85 M.W◦LLRSSVNDIGDDW
1503.71 W.LLRSSVNDIGDDW
Overnight at 24 ◦C 2131.29 W.KATRVGINIFTRLRTQKE
1211.63 ARKCaSLTGKW
3230.69 W.KFSESTTVFTGQCaFIDRNGKEVLKTM◦W 16 hours at 4 ◦C
1503.78 M.W◦LLRSSVNDIGDDW 1211.61 ARKCaSLTGKW
1721.85 W.LLRSSVNDIGDDW 2966.53 W.KFSESTTVFTGQCaFIDRNGKEVLKTM
2131.36 W.KATRVGINIFTRLRTQKE 3230.60 W.KFSESTTVFTGQCaFIDRNGKEVLKTM◦W
1721.85 M.W◦LLRSSVNDIGDDW
1503.71 W.LLRSSVNDIGDDW
2131.29 W.KATRVGINIFTRLRTQKE
20 hours at 4 ◦C
1211.61 ARKCaSLTGKW
1503.71 W.LLRSSVNDIGDDW
2131.29 W.KATRVGINIFTRLRTQKE
24 hours at 4 ◦C
1211.61 ARKCaSLTGKW
1503.71 W.LLRSSVNDIGDDW
2131.29 W.KATRVGINIFTRLRTQKE
Terminal Met or Trp residues were observed in the modified homoserine lactone or Cγ-O-spirolactone form.
◦ Oxidation of Met of Trp.
Ca Cysteic acid.
Finally, the effects of incubation using different molar ratios of CNBr/KI were studied. The
results of these experiments for horse heart cytochrome c are discussed below in detail and are
represented in Figure 4.4 and Table 4.4. A first observation is that there is a 55 Da mass shift for
the intact protein between samples incubated with and without KI. For the apocytochrome c this
mass shift is lost (Table 4.4, experiment A1 and B1; Figure 4.4, panel B and C). This suggests
that Fe is displaced from the heme-group when KI is added to the reaction mixture. Starting
from the lowest concentration of CNBr, cleavages C-terminal to methionine can be observed,
as is illustrated by the presence of a peak at m/z 4572 corresponding to peptide 66-104 in
experiment B1 (Figure 4.4, panel B). In experiments B3-B6, where the final concentration CNBr
surpassed 16 mM, the spectra are similar and no extra peaks can be observed. No cleavages were
observed when proteins were incubated in 60% TFA/8 mM KI alone. However, the peptide bond
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C-terminal to the only tryptophan present in the protein is cleaved at equimolarity between KI
and CNBr (Figure 4.4, panel D). A first peak of very low intensity corresponding to cleavage
C-terminal to methionine is only observed when a twofold excess of CNBr is added (Result only
visible in reflector mode and not shown). At higher concentrations of CNBr, all possible cleavage
sites are attached and even a 125-fold excess of CNBr does not seem to impair the cleavage
C-terminal to tryptophan (Figure 4.4, Panel E). When the concentration of CNBr increases,
so is the oxidation of methionine when present internally in a peptide sequence [49]. This is
seen for the peptide KEETLMEYLENPKKYIPGTKMIFAGIKKKTEREDLIAYLKKATNE
(sequence 60-104; calculated average m/z 5305) observed in panel D at m/z 5304. In panel E
this peptide is dominantly present containing a single oxidized methionine and two oxidized
methionines, respectively at m/z 5320 and 5336. Similar results were obtained for the other
three test proteins (results not shown).
Figure 4.4: Linear mode MS spectra (4-15 kDa) after incubation of native horse heart cytochrome
C with different ratios of KI/CNBr. Panel A: no KI/CNBr. Panel B: only CNBr, no KI (Table 4.4
experiment B3). Panel C: KI/CNBr 2/1 (Table 4.4 experiment A1). Panel D: equimolarity (Table 4.4
experiment A2). Panel E: KI/CNBr = 1/125 (Table 4.4 experiment A6). The peaks in the spectra are
labeled with their m/z, more information on resulting peptides.
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Table 4.4: Peptides observed after incubation of native horse heart cytochrome c with different
ratio of KI/CNBr.
Mw Obs.
(Da)
Fragment Cleavage
site
Mw Obs.
(Da)
Fragment Cleavage
site
A1: 4 mM CNBr/8 mM KI B1: 4 mM CNBr
12310 holocyt-Fe / 12365 holocyt /
11743 apocyt / 11744 apocyt /
5304 60-104 W 4572 66-104 M
7754 1-65 M
A2: 8 mM CNBr/8 mM KI B2: 8 mM CNBr
7032 1-59 W 12363 holocyt /
6467 1-59 W 11744 apocyt /
5304 60-104 W 4573 66-104 M
7754 1-65 M
A3: 16 mM CNBr/8 mM KI B3: 16 mM CNBr
7032 1-59 W 7754 1-65 M
6467 1-59 W 7136 1-65 M
5304 60-104 W 4573 66-104 M
2779,83 81-104 M 2779,83 81-104 M
1763,05 66-80 M
A4: 250 mM CNBr/8 mM KI B4: 250 mM CNBr
7032 1-59 W 7754 1-65 M
6467 1-59 W 7136 1-65 M
5320 60-104 W 4573 66-104 M
4588 66-104 M 2779,83 81-104 M
2779,83 81-104 M 1763,05 66-80 M
2494,52 60-80 M
A5: 500 mM CNBr/8 mM KI B5: 500 mM CNBr
7032 1-59 W 7754 1-65 M
6467 1-59 W 7136 1-65 M
5320 60-104 W 4573 66-104 M
4588 66-104 M 2779,83 81-104 M
2779,83 81-104 M 1763,05 66-80 M
2494,52 60-80 M
1763,05 66-80 M
A6: 1000 mM CNBr/8 mM KI B6: 1000 mM CNBr
7032 1-59 W 7754 1-65 M
6467 1-59 W 7136 1-65 M
5320 60-104 W 4573 66-104 M
4588 66-104 M 2779,83 81-104 M
2779,83 81-104 M 1763,05 66-80 M
2494,52 60-80 M
Masses below 4000 Da were observed in reflector mode, masses above 4000 Da were observed in linear mode.
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In order to identify the C-terminal peptide in the CNBr/KI digest, both the homoserine lactone
and γ-spirolactone ending peptides have to be present in their lactonised and hydrolysed form
simultaneously. All internal peptides will appear as doublets (∆ mass = 18 Da) in the MALDI
MS spectrum, while the carboxyl group ending C-terminal peptides will appear as a singlet.
Different reaction conditions were tested on two test proteins that should produce a C-terminal
peptide with a molecular mass in the range of MALDI-TOF/TOF MS analysis; β-lactoglobulin
(Bos taurus) and avidin (Gallus gallus). Similar to the previously reported lactone ring opening
protocol, 12.5 mM NH4HCO3, pH 8, was used as slightly basic buffer solution [43]. The digested
samples were incubated at RT and 37 ◦C for 30 minutes, 1 hour and 24 hours. The best results
were obtained at the elevated temperature and after minimum 1 hour. Longer incubation
times resulted in a higher percentage of K+-adduct formation (+38 Da). After cleavage and
incubation with the basic buffer of the β-lactoglobulin and avidin fragments, the C-terminal
peptides (2112.86 and 2131.13 Da) and multiple internal peptides were observed in the MS
spectra (Figure 4.5, 4.6 and Table 4.5, 4.6). The only missed cleavages observed were due to
oxidized Met and Trp residues. Hsl and spirolactone ending peptides were observed in the
spectrum in the open and ring form simultaniously. The C-terminal peptide of the avidin
fragment, observed as singlet in the spectra was selected for MS/MS and de novo sequenced
(Figure 4.6). Important to note is that the C-terminus is not the only singlet present in the
spectrum. Due to the partial cleavage N-terminally of cysteic acid, a second peptide is formed
that does not end at a lactone ring structure and is observed as a singlet (1710.75 and 1330.59).
Since this side reaction is not quantitative, the intact peptide was also visible in the spectrum
(2112.86 and 2966.35). MS/MS interpretation allowed to distinguish this as the false positive
from the real C-terminal peptide.
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Figure 4.5: MALDI MS analysis of CNBr/KI digested β-lactoglobulin (Bos taurus) after partial
homoserine lactone and γ-spirolactone ring opening. The C-terminal peptide is observed at 2112.87 Da.
All peaks in the spectrum are annotated in Table 4.5.
Table 4.5: Peptides of β-lactoglobulin (Bos taurus) present after homoserinelactone and spirolactone
ringopening
Mw calc.
(Da)
Mw obs.
(Da)
Fragment Sequence Remarks
1329.53 1329.60 8 - 19 M.KGLDIQKVAGTW∗
1347.54 1347.61 8 - 19 M.KGLDIQKVAGTW∗∗
1367.62 1367.55 8 - 19 M.KGLDIQKVAGTW∗ K+ adduct of 1329.53
1385.63 1385.56 8 - 19 M.KGLDIQKVAGTW∗∗ K+ adduct of 1347.54
1711.89 1710.76 146-159 M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
1749.98 1748.72 146-159 M.HIRLSFNPTQLEEQ K+ adduct of 1711.89
1865.22 1864.86 8 - 24 M.KGLDIQKVAGTW◦YSLAM∗
1883.23 1882.83 8 - 24 M.KGLDIQKVAGTW◦YSLAM∗∗
2030.90 n.i.
2113.33 2112.87 146 - 162 M.HIRLSFNPTQLEEQCaHI C-term. peptide
2132.52 2132.00 1 - 19 LIVTQTM◦KGLDIQKVAGTW∗
2150.53 2150.00 1 - 19 LIVTQTM◦KGLDIQKVAGTW∗∗
2170.61 2169.84 1 - 19 LIVTQTM◦KGLDIQKVAGTW∗ K+ adduct of 2132.52
2188.62 2187.97 1 - 19 LIVTQTM◦KGLDIQKVAGTW∗∗ K+ adduct of 2150.53
◦ Oxidation of Met of Trp.
∗ Homoserine lactone or Cγ-O-spirolactone tryptophan.
∗∗ Homoserine or opened Cγ-O-spirolactone tryptophan.
Ca Cysteic acid.
n.i. not identified
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Figure 4.6: C-terminal sequence analysis of avidin (Gallus gallus) using partial homoserine lactone
and γ-spirolactone ringopening after CNBr/KI digest to select the C-terminal peptide. Panel A: MALDI
MS spectrum of the CNBr/KI generated avidin peptides. The C-terminal peptide is observed at 2131.13
Da and is the only singlet in the spectrum. All internal peptides are visible as doublets (∆ mass = 18
Da). Most peptides are also detected as K+ adduct (∆ mass = 38 Da). All peaks in the spectrum are
annotated in Table 4.6. Panel B: MALDI MS/MS spectrum of the C-terminal peptide at m/z 2131.13.
Y- and b-ions are indicated in green and red respectively. The amino acid sequence is indicated in the
one-letter code.
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Table 4.6: Peptides of avidin (Gallus gallus) present after homoserinelactone and spirolactone
ringopening
Mw calc.
(Da)
Mw obs.
(Da)
Fragment Sequence Remarks
1211.38 1211.51 1 10 ARKCaSLTGKW∗
1229.39 1229.52 1 10 ARKCaSLTGKW∗∗
1331.44 1330.58 71 - 82 W.KFSESTTVFTGQ X-Cys(83) cleavage
1369.53 1368.55 71 - 82 W.KFSESTTVFTGQ K+ adduct of 1330.59
1503.60 1503.62 98 - 110 W.LLRSSVNDIGDDW∗
1521.61 1521.64 98 - 110 W.LLRSSVNDIGDDW∗∗
1541.70 1541.58 98 - 110 W.LLRSSVNDIGDDW∗ K+ adduct of 1503.62
1559.71 1559.62 98 - 110 W.LLRSSVNDIGDDW∗∗ K+ adduct of 1521.64
1721.81 1721.68 97 - 110 M.W◦LLRSSVNDIGDDW∗
1739.82 1739.70 97 110 M.W◦LLRSSVNDIGDDW∗∗
2131.50 2131.14 111 - 128 W.KATRVGINIFTRLRTQKE C-term. peptide
2169.59 2169.09 111 - 128 W.KATRVGINIFTRLRTQKE K+ adduct of 2131.14
2967.40 2966.32 71 - 96 W.KFSESTTVFTGQCaFIDRNGKEVLKTM∗
2985.41 2984.31 71 96 W.KFSESTTVFTGQCaFIDRNGKEVLKTM∗∗
◦ Oxidation of Met of Trp.
∗ Homoserine lactone or Cγ-O-spirolactone tryptophan.
∗∗ Homoserine or opened Cγ-O-spirolactone tryptophan.
Ca Cysteic acid.
4.3.5 Discussion
During the application of CNBr to generate peptide fragments, it became apparent that the
low occurrence of methionine residues limits the use of the previously described protocols for
C-terminal sequencing [42, 44]. The need to include specific manipulations to ensure opening of
disulfide bonds, especially for proteins in solution or after separation with SDS-PAGE, further
complicates the protocol. These limitations prompted us to search for alternative digestion
methods with which the conversion of the C-terminal amino acid of internal peptides, to a
group that is not cleaved off by incubation with carboxypeptidases, is maintained. The chemical
cleavage C-terminally of two different residues simultaneously, namely methionine and trypto-
phan, made the use of the protocol described by Huang and Huang an attractive alternative
[1]. Furthermore, the structural resemblance between the reaction products of the two amino
acids, Cγ-spirolactone tryptophan being an indol-substituted homoserine lactone, suggested of
a similar behaviour during carboxypeptidase incubations and ring opening experiments. The
oxidative environment required for cleavage C-terminally of tryptophan was thought to be
sufficiently strong to also allow the oxidation of disulfide bonds, thereby eliminating the need
for their reduction and alkylation.
A known side reaction, halogenation of tyrosine (when using KI; ∆m= +125.9 Da) [54], was
avoided by adding phenol to the reaction mixture. Phenol has been previously used as a
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scavenger for free iodide [12]), and the addition of 4% phenol to the salt solution (final concen-
tration in the reaction mixture 0.16%) completely eliminated this side reaction. An optimal
concentration of KI was determined.
As can be seen in Figure 4.3, the number and the impact of modifications of amino acid side
chains are limited. The conditions during the KI-cleavage are strongly oxidative, resulting
in the complete oxidation of cysteine to cysteic acid when the incubation is done without
previous alkylation of the sulfhydryl-moiety (Table 4.1). Nevertheless, aside from the oxidation
of cysteine little or no oxidative damage to amino acid side chains was observed. Some of the
side reactions are probably difficult to avoid and have been observed in most studies using
chemical means to cleave peptide bonds C-terminally of tryptophan. The side reaction that is
most troublesome is the peptide bond cleavage N-terminally of cysteic acid and the concomitant
formation of uncharacterized reaction products. Although this can be avoided by protecting
the sulfhydryl-moiety prior to the chemical cleavage, the benefit of simultaneous peptide bond
cleavage and disulfide oxidation is then lost. No reference to this type of peptide bond cleavage
is known to our knowledge. To assess the possible negative impact that the oxidation of cysteine
and the side reactions have on the general applicability of the cleavage method described, more
extensive sets of data need to be obtained. Nonetheless, the described cleavage method can
be applied for general proteomic applications offering a single-incubation protocol to attain
cleavage and the opening of disulfide bridges.
Unfortunately, the implementation of the technique in standard proteomic setups is slightly
hindered by the limitations of the protein identification algorithms such as MASCOT. Cur-
rently, MASCOT does not allow to define a fixed modification at the cleavage site. Due to
the chemical mechanism of the cleavage reaction, methionine and tryptophan are converted
to respectively homoserine lactone and Cγ-O-spirolactone tryptophan. These modifications
can only be selected as variable modifications. This has several consequences: false positive
hits are created since peptides ending at an unmodified Met and Trp are allowed, multiple
modifications reduce the score of a peptide match, and multiple variable modifications increase
search times. Furthermore, the unwanted cleavage N-terminally of cysteine results in non-sense
protein identifications. Similarly, missed cleavages are mostly induced by oxidized Met and
Trp residues. Including this knowledge to restrict the MASCOT searching would improve the
quality of the protein identifications. To circumvent the current limitations, all Met and Trp
residues in the protein library can be altered into user defined amino acids that account for the
generation of these derivatives. By analyzing the samples in an acidic environment only the
closed lactone form should be present in the spectrum and identification would then be more
performant.
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When the KI-solution is added to the reaction mixture a brown-reddish color is formed. The
reaction mechanism therefore was hypothesized to commence with the reaction of CNBr with
I– leading to the formation of active iodine species, I2, and I
+, that subsequently donate iodide
to susceptible groups. The mechanism of the tryptophan oxidation and peptide bond cleavage
by active iodine species is proposed to follow a similar reaction mechanism to that proposed by
Patchornik in 1960 for cleavage of tryptophan by N-bromosuccinimide [6, 19]. It is obvious that
both KI and CNBr must be present to cleave peptide bonds C-terminal to tryptophan (Table 4.4,
exp B). Furthermore, a molar excess of CNBr must exist before initiating the cleavage at both
methionine and tryptophan residues wheras peptide bonds C- terminally of tryptophan alone
are cleaved from the moment KI is added in the presence of stoichiometric amounts of CNBr.
These reactions are independent of the solvents used to create an acidic environment, and of
the incubation temperature and of time (Table 4.3). Although we used almost exclusively KI,
identical results were obtained using other iodide-salts, including cleavage at both residues and
oxidation of cysteine-bridges. Adding identical concentrations of other halogen salts, namely
bromide- and chloride-salts, do not impair the cleavage at methionyl peptide bonds, but do not
result in cleavage after Trp (Table 4.2).
Although iodide seems to be the central element in the reactions observed, fairly little has been
published that links iodide to disulfide oxidation [14] and the concomitant cleavage N-terminally
of cysteic acid. However, it has been noted that iodination of tyrosine residues with NaI, using
chloramine T, results in the oxidation of cysteine to cysteic acid [55]. A similar oxidation was
noticed when performing CNBr-cleavages of cytochrome c after alkylation of the cysteines with
iodoacetamide [56]. Lederer and Tarin further developed the observed oxidation of cysteine to a
method for the cleavage of the heme-group from cytochrome c [56], a reaction we also observed
both with and without the addition of KI to the CNBr reaction mixture (Figure 4.4 and Table
4.4). However, contrary to cysteines involved in disulfide bridges, no complete oxidation of the
cysteines involved in binding the heme as observed.
In our previously reported chemical selection strategy using CNBr, proteins were only cleaved
C-terminal of methionine. Since methionine only accounts for 2.59% of the amino acids in
Shewanella oneidensis MR-1 (test species used), the peptides generated after CNBr cleavage
are relatively large. In order for peptides to be detected on a MALDI-TOF/TOF analyzer
they need to be in the 1-5.5 kDa mass range. Our data showed that most of the succesfully de
novo interpreted MS/MS spectra had a parent ion below 3.5 kDa. Using CNBr as cleavage
reagent, 51% of the C-terminal peptides fall in the range of efficient detection and only 1 out
of 3 proteins generates a C-terminal peptide in the de novo sequencing mass range. When
KI is added to the CNBr cleavage reaction mixture, cleavage C-terminal of methionine and
tryptophan is observed. Tryptophan accounts for 1.25% of the amino acids in S. oneidensis
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MR-1. By cleaving C-terminal of tryptophan and methionine, 58% of the C-terminal peptides
are detectable on MALDI-TOF/TOF MS and 42% of the proteins have a C-terminal peptide
in the de novo sequencing mass range. As a proof-of-concept to demonstrate the improved
proteome coverage, the chemical selection protocol was applied to the CNBr and KI cleaved
proteins avidin and β-lactoglobulin. After partial ring opening the C-terminal peptide was
clearly identified as a singlet amongst the internal peptide doublets, resp. 2131.14 and 2112.86.
MS/MS analysis of the C-terminal peptide of avidin allowed to generate a C-terminal sequence
tag.
4.3.6 Conclusions
Here we report on the refinement of a methodology to obtain chemical protein cleavage
simultaneously after Met and Trp residues, combined with disulfide bond oxidation, in a single
reaction. The need for reduction and alkylation of disulfide bridges requires laborious protocols
that are using chemical cleavage methods in recent publications [35, 42, 57]. Given the interest
that currently exists in increasing the sequence coverage during the study of proteins, and
more specifically membrane proteins that are often difficult to study using enzymatic digests
[58–60], the chemical cleavage at two residues could be of great interest. The potential proteome
coverage of the previously described C-terminal sequencing techniques is also widened [44].
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Chapter 5
C-terminal selection by piperazine
labelling
5.1 Introduction
The methodologies described in the previous chapters are only applicable to proteins separated
by gel electrophoresis. In the time frame of our project, 2D-PAGE separation in proteomics
was increasingly overtaken by LC-MS based methods. Although 2D-PAGE still has a place in
proteomics, the high reproducibility, resolution and ability to analyze hydrophobic proteins and
proteins with high and low pI values, make shotgun LC-MS a more powerful platform [1–3].
In addition, the low ionization and fragmentation efficiency of large CNBr-derived C-terminal
peptides (lacking a terminal Lys or Arg) by MALDI-TOF/TOF MS triggered us to develop
a completely new strategy to select for these peptides in a form that can be consequently
analyzed on any (LC-) MS platform using all available fragmentation techniques with high
sensitivity. The most cited methods for LC-MS based C-terminal peptide identification and
characterization are COFRADIC [4] and C-TAILS [5]. However, both methods did not truly
make it as standard methods, due to the complexity and workload of the former, and the
in-house synthesized coupling polymer of the latter. Therefore, we aimed to develop a more
simple method based on modification and enrichment of C-terminal peptides.
Unlike internal tryptic peptides, C-terminal peptides rarely end on a basic residue. Since the
ionization efficiency in MALDI is dependent on the hydrophobicity and gas-phase basicity of
the analyte, C-terminal peptides often remain undetected in a classical MALDI-TOF peptide
mass fingerprint. Similarly, maximal ESI signal responses in the positive ionization mode are
observed at solvent pH values three or more units lower than isoelectric point of the analyte [6].
Several modifications have been presented to improve the hydrophobicity, pI and gas-phase
basicity of C-terminal peptides and peptides containing a negatively charged post-translational
modification, such as phosphorylation [7–9]. Yang et al. used 1-(2-pyrimidyl) piperazine to
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modify all carboxyl groups using a carbodiimide mediated coupling at nearly 100% yield,
increasing the ionization efficiency for phosphopeptides 50-100 times in MALDI MS. The same
method allowed to determine phosphorylation sites using ESI-ETD-MS [10, 11] (Figure 5.1).
In an additional study 4 piperazines, i.e. (1-(2-pyridyl)piperazine, 1-(2-pyrimidyl)piperazine,
1-(4-pyridyl)piperazine and 1-(1-methyl-4-piperidinyl)piperazine), were compared to evaluate
their coupling efficiency and improvement of hydrophobicity and gas-phase basicity of the
modified peptides. (1-(2-pyridyl)piperazine and 1-(2-pyrimidyl)piperazine were found to be
preferable to increase the peptide signals on MALDI-TOF MS [12] (Figure 5.2).although the detailed mechanism has not been well understood,
the gas-phase basicity is believed to contribute greatly to MALDI
ionization efficiency: high gas-phase basicity results in consider-
able tendency of protonation of peptides.20 In comparison with
nonphosphopeptides, phosphopeptides bear less hydrophobicities,
lower pI values, or gas-phase basicities, which obviously results
in lower ionization efficiencies. In this study, 1-(2-pyrimidyl)
piperazine (PP) was chosen as the acidic residue derivatization
reagent to improve peptide especially phosphopeptide ionization
efficiencies in both ESI and MALDI sources, since the pyrimidyl
groups could dramatically enhance the hydrophobicities, pI values,
and gas-phase basicities.
EXPERIMENTAL SECTION
Materials and Chemicals. 1-(3-Dimethylaminopropyl)-3-eth-
ylcarbodiimide hydrochloride (EDC, 95%), 1-hydroxy-7-azabenzo-
triazole (HOAt, 95%), and all synthetic peptides (95%) were
obtained from GL Biochem (Shanghai, China). Bovine serum
albumin (BSA, 95%), 2,5-dihydroxybenzoic acid (DHB, 98%), 1-(2-
pyrimidyl) piperazine (PP, 98%), and ammonium bicarbonate
(ABC, 99.5%) were obtained from Sigma (St. Louis, MO). Aceto-
nitrile (ACN, 99.9%) and trifluoroacetic acid (TFA, 99.8%) were
purchased fromMerck (Darmstadt, Germany). DMF was obtained
from Shanghai No. 4 Reagent Company (Kunshan, China).
Phosphoric acid (85%) was purchased from Shanghai Feida
Chemical Reagents Ltd. (Shanghai, China). All these reagents
were used as received without further purification. Deionized
water (18.4 MΩ cm) used for all experiments was obtained from
a Milli-Q system (Millipore, Bedford, MA).
Synthesis of PP Derivatized Peptides. Solutions of PP (0.5%)
in DMF (6 µL), EDC (2 mg/mL) in DMF (4 µL), HOAt (2 mg/
mL) in DMF (3 µL), and TFA (0.1%) in water (3 µL) were
sequentially added to a solution of peptides or phosphopeptide-
spiked tryptic BSA (E100 ng/µL) in water (50 µL). The amount
of TFA was especially critical to this reaction and needed to be
carefully adjusted to keep the final pH between 7.5 and 7.8. After
vortexing for several seconds at room temperature, the solvents
were removed by vacuum centrifuge to terminate the PP-
derivatization reaction. The modification of PP-derivatization was
stable in water or TFA solution (E2%) for at least 48 h (Supporting
Information Figures 1-3). Extra EDC and HOAt were not able
to react with carboxy groups in the solution of water or 50%
CH3CN/0.1% TFA. PP-derivatized peptides can then be directly
applied for MALDI-MS or ESI-MS analysis without any additional
cleanup step.
MALDI Mass Spectrometry. The MALDI mass spectra were
acquired with an Applied Biosystems 4700 proteomics analyzer
instrument. The matrix solution (10 mg/mL CHCA in 50%
CH3CN/0.1% TFA, 0.5 µL) was deposited to and dried on the
MALDI probe, and the peptide solution (0.5 µL in 50% CH3CN/
0.1% TFA) was then deposited.
ESI Mass Spectrometry. LC-MS/MS of the peptide mixture
was performed on a Bruker Daltonics (Billerica, MA) HCTultra
PTM Discovery quadrupole ion trap mass spectrometer. The ion
trap mass spectrometer was coupled with a Dionex Ultimate 3000
nano-LC system (Sunnyvale, CA) through a nanoelectrospray
interface (Bruker Daltonics). The nano-LC was equipped with a
set of Dionex PepMap C18 precolumn (300 µm × 5 mm; particle
size 50 µm) and a Dionex PepMap C18 column (75 µm × 150
mm; particle size 3 µm). The peptide mixture was dissolved in
0.1% FA solution. For each LC-MS/MS run, typically 6 µL of
sample solution was loaded to the precolumn and washed with
loading buffer (0.1% FA-H2O) for 3 min before injecting into the
LC column. The buffers used for LC separation are buffer A (0.1%
FA-H2O) and buffer B (0.1% FA-ACN).The LC gradient was
conducted as follows: 3% B to 35% B in 20 min, 35% B to 95% B in
4 min, and stayed at 95% B for 8 min. The column was finally
re-equilibrated with 3% B for 15 min before the next run. The flow
was set up at 350 nL/min.
RESULTS AND DISCUSSION
A major requirement for an attractive derivatization method
is high conversion ratio of modification reaction. Following
previous literature,21 we chose peptide coupling reagents (EDC
and HOAt) to convert reactants as much as possible in the DMF
solution. However, yield as close as possible to 100% had never
been reached when following the published papers. Once the
normally used DMF was replaced with water and a certain amount
of TFA was added to adjust the pH value of the reaction system,
all carboxy groups of peptides, including the C-terminal aspartic
and glutamic acids, can be almost fully converted to their PP
derivatized cognates (Scheme 1, Figure 1). (More quantitative data
of reaction yield could be found in Table 1 in the Supporting
Information.) Our data indicates that the optimized pH value for
a complete reaction is 7.5-7.8. Moreover, the reaction time was
shortened to a few seconds. Vortexing by hand under room
temperature was enough for this reaction to complete. This
adjustment rendered the reaction prominent features to make it
a potentially powerful tool: ease of handling, rapid reaction time,
good reproducibility, no side reaction, and free of harsh treatment
like high temperature or sonication. The gentle reaction conditions
keep peptides away from any potential threat of degradation.
Furthermore, no side reaction product was found throughout the
whole process, suggesting the high reaction specificity between
PP and the carboxy group (Figure 1).
Vacuum centrifuge was adopted to terminate the reaction by
removing the solvents. The stability of the modification is rather
good in water or TFA solution (E2%) for at least 48 h (Supporting
Information Figures 1-3). Extra reagents would not react with
peptides nor be detected by MALDI-MS or ESI-MS, so no
additional cleanup step is needed before MS analysis.
(20) Dreisewerd, K. Chem. Rev. 2003, 103, 395–425.
(21) Ho, G. J.; Emerson, K. M.; Mathre, D. J. J. Org. Chem. 1995, 60, 3569–
3570.
S heme 1. Synthesis of
1-(2-Pyrimidyl)piperazine Derivatized Peptidea
a EDC ) 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hy-
drochloride, HOAt ) 1-hydroxy-7-azabenzotriazole, TFA ) trif-
luoroacetic acid.
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Figure 5.1: Synthesis of 1-(2-pyrimidyl)piperazine derivatized proteins. EDC = 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride; HOAt = 1-hydroxy-7-azabenzotriazole; TFA
= trifluoroacetic acid [10].
Figure 5.2: Different piperazines used; 1-(2-pyridyl)piperazine (Panel A), 1-(2-pyrimidyl)piperazine
(Panel B), 1-(4-pyridyl)piperazine (Panel C) and 1-(1-methyl-4-piperidinyl)piperazine (Panel D).
Here we have adapted this derivatization method towards a new technique to probe protein
C-termini that has potential to be applied both for in-gel and in-solution separated proteins. We
used the carbodiimide coupling reaction to modify all side chain carboxyl groups as well as the
C-terminus (Figure 5.1). After this modification step, the proteins are digested using trypsin.
The newly formed carboxyl groups are then captured onto a COOH-coupling matrix using the
same carbodiimide coupling chemistry as used in the first step, leaving the C-terminal peptide in
solution ready to be analyzed and sequenced using any type of mass spectrometric setup (Figure
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5.3). The piperazine derivatization does not only serve to improve the hydrophobicity and
gas-phase basicity of the C-terminal peptide, but the specific mass tag (+146.19 Da) can be used
as a positive control to distinguish it from internal peptides. The analysis on an LC-MS system
allows the use of other fragmentation techniques than MALDI (CID) MS. As demonstrated by
ETD on phosphorylated peptides by Zhang, modified C-terminal peptides should generate a
sequence-independent fragmentation behavior over the entire peptide backbone, allowing their
identification by tandem mass spectrometry [11]. We selected coupling chemistry that is well
known in peptide synthesis and bioconjugate production to prepare the piperazine derivatized
peptides. 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) was used as
coupling reagent in combination with 1-hydroxy-7-azabenzotriazole (HOAt) to avoid the O-acyl
urea rearrangement [13] and to activate the intermediate for amide formation (Figures 5.4, 5.5,
5.6). Here we present the initial results of the development and optimization of this method,
and discuss strategies for further optimization.
Figure 5.3: Schematic representation of the different steps in the C-terminal sequencing method using
piperazine modification. Step 1: All carboxyl functions in the protein are modified. Step 2: The modified
proteins are cleaved. Step 3: The new generated carboxyl functions are bound to a COOH binding
matrix using the same coupling chemistry as in step 1. Step 4: Modified C-terminal peptides with
enhanced ionization characteristics can be analyzed using any kind of (LC-)MS setup.
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5.1.1 EDC coupling
Carbodiimides are dehydration agents often used to activate carboxylic acids towards amide
or ester formation. Sheehan reported the first formation of peptide bonds using carbodi-
imides [14]. Several carbodiimides have been used in solid-phase peptide synthesis; N,N‘-
Dicyclohexylcarbodiimide (DCC), N,N’-Diisopropylcarbodiimide (DIC), 1-(3-dimethylamino-
propyl)-3-ethylcarbodiimide hydrochloride (EDC) [15–17]. Since DCC is insoluble in water and
DIC is very toxic, EDC is currently the prefered coupling reagent in amide formation.
The first step of the amide formation reaction mechanism involves the intermediate formation
of the activated O-acylisourea derivative of the carbodiimide. A subsequent nucleophilic attack
by the primary nitrogen of the amino compound brings about the formation of the wanted
amide linkage, with the release of the soluble substituted urea. Alternatively the O-acylisourea
can also be attacked by a second carboxylate to generate an anhydride, which can then be
attacked by the amine, producing the amide and regenerating one of the carboxylates [18–
21]. The formation of O-acylurea occurs optimally at pH 4-5; the primary amino group of
the nucleophile is predominantly protonated at this low pH and therefore rather unreactive
[22]. The intermediate has an extremely short half-life and rapidly undergoes hydrolysis or
rearranges to an N-acylurea adduct [23]. Adding 1-hydroxy-7-azabenzotriazole (HOAt) to
the reaction mixture minimizes the side reaction. It reacts with the instable O-acylisourea
intermediate to form a more stable insoluble activated ester that reacts with amines at ambient
temperatures to generate amides [13]. In an additional unwanted head-to-tail side reaction the
peptide N-terminus competes with the piperazine amine to form cross-linked or circular peptides.
Figure 5.4: Structure of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (ECD) (Panel
A) and 1-hydroxy-7-azabenzotriazole (HOAt) (Panel B).
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Figure 5.5: Reaction mechanism of amide bond formation using carbodiimide coupling. The first
reaction steps an O-acylisourea-derivative is formed. This intermediate can form the amide bond by
reacting with the amino group directly (left pathway) or by first reacting with a second carboxylate
group forming an anhydride intermediate. The O-acylisourea intermediate can also rearrange and form
an unwanted, stable N-acylurea adduct. 1 = Carboxyl group, 2 = O-acylisourea, 3 = amide, 4= urea,
5= acid anhydride, 6 = N-acylurea [14, 24].
Figure 5.6: Reaction mechanism of active-ester formation using 1-hydroxy-7-azabenzotriazole (HOAt).
HOAt can be added to the carbodiimide coupling reaction to limit the formation of the stable N-acylurea
adduct. HOAt rapidly reacts with the O-acylisourea to form a more stable activated ester, that in turn
reacts with an amine to generate the wanted amide bond [13, 25].
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5.2 Materials and Methods
5.2.1 Materials
Angiotensin, bradykinin, yeast alcohol dehydrogenase (gel filtration purity) and horse heart
cytochrome c (purity 99%) were purchased from Sigma (Bornem, Belgium). A part (N35
to Arg277) of the XcpQ subunit of the Type II secretion system protein D of Pseudomonas
aeruginosa (Uniprot: P35818) was expressed and purified in house [26]. Stock solutions
(0,5 nmol/µl) were prepared for all proteins and further diluted prior to use. HPLC grade
acetonitrile (ACN) was obtained from BioSolve (Valkenswaard, The Netherlands). Trifluo-
roacetic acid (TFA) (purity >99.9%) was from Applied Biosystems (Foster city, CA, U.S.A.).
Ammonium hydrogen carbonate (NH4HCO3) (purity >99.5%), dimethylformamide (DMF)
(purity >99,8%), 1-(2-pyridyl)piperazine (purity >99%), 1-(2-pyrimidyl)piperazine (purity
>98%), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide HCl (purity >99%), 0,6 M 1-hydroxy-
7-azabenzotriazole (HOAt) in DMF (purity >98%) and α-cyano-4-hydroxycinnamic acid were
purchased from Sigma. Immobilized diaminodipropylamine CarboxyLink coupling gel (Figure
5.7) was purchased from Thermo scientific (San Jose, CA, USA). Water was purified using a
Millipore MilliQ water filtration system (Billerica, MA, USA).
Figure 5.7: Structure of the immobilized diaminopropylamine coupling gel.
5.2.2 Production of piperazine derivatized peptides or proteins
A modification reagent stock solution was prepared containing 25 ml MQ; 1.5ml (2mg/ml)
HOAt in DMF; 2ml (2mg/ml) EDC in DMF; 3ml 0.5% 1-(2-pyrimidyl)piperazine (PP) in DMF.
TFA was added to the mixture until a pH between 7.5 and 7.8 was reached. 20 µl of the PP
reaction mixture was added to 5 µl peptide/protein (10 pmol/µl), vortexed and incubated at
room temperature for 1 hour. After incubation the samples are dried in the SpeedVac (Thermo
Savant) to stop the reaction. The dried modified peptides were redissolved in 50% ACN/0.1%
TFA and spotted on a MALDI plate. The modified proteins were then digested using trypsin.
Trypsin is active between pH 7 and 9, which allows to perform the cleavage outside the EDC
activity range and thus prevents immediate modification of the newly formed carboxyl functions.
The digested protein samples were cleaned up using ZipTip solid phase extraction prior to
analysis. MALDI-TOF MS sample preparation analysis was performed as previously described
[27].
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5.2.3 Coupling to CarboxyLink gel
The coupling of the peptides to the immobilized diaminodipropylamine gel was performed as
described in the instructions. A disposable polypropylene column was filled with 4 ml of the
CarboxyLink gel slurry and equilibrated with 5 column volumes of coupling solution. The
sample (2 ml in coupling solution) was added to the gel slurry and gently mixed end-over-end
for several minutes. 60 mg of EDC dissolved in 0.5 ml coupling solution was added to the gel
and gently mixed for 3 hours at room temperature. After the gel had settled, the liquid phase
and one column volume of washing solution (50% ACN/0.1% TFA) were collected containing
the non-bound peptide fraction. After further washing, the column was loaded with PBS buffer
containing 0.05% of sodium azide and stored until further use at 4 ◦C. We used 50% DMF
in water as coupling solution and 50% ACN/0.1% TFA as wash solution. According to the
supplier, anything but phosphate, acetate, tris and glycine or thiol containing buffers can be
used since they are known to react with the O-acylintermediate and/or inactivate EDC.
Remarks:
• EDC is moisture sensitive and hydrolyzes quickly when dissolved in aqueous buffers. The
stock solution needs to be made fresh every time and the EDC reagent needs to be stored
in a tightly sealed vial with dessicant.
• Although the active pH range of EDC is often reported to be between pH 4 and 6, the
best coupling results were obtained in the narrow pH range 7.5-7.8.
• All DMF needs to be evaporated before samples are redissolved and mixed with α-cyano-
4-hydroxycinnamic acid matrix mixture. Otherwise matrix peaks will appear in the higher
mass range disturbing MS interpretation.
5.3 Results and Discussion
5.3.1 Piperazine modification of test peptides
Carbodiimide mediated coupling of piperazines to carboxyl groups is not specific, all side chain
carboxyl groups and the C-terminus of the protein are thus expected to be modified. The
reaction was optimized on two test peptides, bradykinin and angiotensin, the latter containing
an N-terminal Asp side chain carboxyl group (Figures 5.8, 5.9). Analysis of samples taken
10 minutes after initiation of the reaction indicate that modification of both sites occurs
simultaneously. Indeed, MS/MS analysis of the singly modified angiotensin (1442.88 Da)
indicates that a mix of the C-terminal and side chain modified peptides is obtained (Figure
5.10 and Table 5.1). In a minor, unwanted head-to-tail side reaction the amino terminus of
the peptides competes with the PP reagents to couple to the activated-ester intermediate,
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forming cross-links between peptides (Figure 5.8). The cross-linking of both peptides was mainly
observed at higher concentrations of peptide, indicating that the phenomenon can be avoided
by reducing the peptide to PP reagent ratio. During these initial experiments, we compared
the mass spectrometric response between peptides modified with 1-(2-pyridyl)piperazine and
1-(2-pyrimidyl)piperazine. The results were comparable, but 1-(2-pyrimidyl)piperazine was
chosen as reagent for further experiments.
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Figure 5.8: Piperazine derivatization of bradykinin. Panel A: MALDI MS spectrum of bradykinin
(theoretical mass : 1060.57 Da) before incubation with PP reaction mixture. Panel B: MALDI MS
spectrum of bradykinin containing a C-terminal PP modification (theoretical mass : 1206.76 Da). Panel
C: At higher peptide/PP reagent ratio (4 times), the peptide with mass 2248.31 is formed, due to a
head-to-tail side reaction.
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Figure 5.9: Piperazine derivatization of angiotensin. Panel A: MALDI MS spectrum of angiotensin
(1296.69 Da) prior to incubation with PP reaction mixture. Panel B: MALDI MS spectrum of angiotensin
10 minutes after initiation of the reaction. The peptide with mass 1442.88 Da contains one PP
modification, either at the C-terminus or on the Asp side chain. Panel C: MALDI MS spectrum of
angiotensin containing two PP modifications (1588.07 Da).
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Figure 5.10: MS/MS spectrum of singly modified angiotensin, mass 1442.88 Da. The fragmentat ions
corresponding to the unmodified peptide are marked in black. The C-terminal modified peptide y-ions
are 146.19 Da heavier and are marked in red, the Asp side chain (N-terminal amino acid) modified
peptides are marked in blue. Both species are observed simultaneously, showing that the modification
does not discriminate the side chain and C-terminal carboxyl groups.
Table 5.1: Overview of fragment ions of singly modified angiotensin peptide.
b-ion +146.19 262.13 418.23 517.30 680.36 793.45 930.51 1027.56 1174.63 1311.69 1424.77
b-ion 116.03 272.14 371.20 534.27 647.35 784.41 881.46 1028.53 1165.59 1278.67
NH2 D R V Y I H P F H L COOH
y-ion 1296.69 1181.66 1025.56 926.49 763.43 650.35 513.29 416.23 269.16 132.10
y-ion +146.19 1442.78 1327.75 1171.65 1072.58 909.52 796.44 659.38 562.33 415.26 278.20
List of b- and y-ions of PP modified and unmodified angiotensin peptides. Observed ions in Figure 5.10
are marked in bold, C-terminal modified y-ions are shown in red, PP-modified b-ions are marked in blue.
5.3.2 Evaluation of the method on a test protein
We first evaluated the PP modification reaction by MALDI MS analysis of the modified and
unmodified protein digest. The spectra show that the peptides are present in multiple forms in
the reaction mixture and that the reaction was incomplete after 1 h of incubation (Figure 5.11).
Although some peptides are expected to have three derivatized carboxyl groups, all of them have
one or more free carboxyl groups left (Table 5.2). Given the large number of Asp and Glu present
in the peptides and the observation how few modifications each peptide has undergone, the over-
all yield of the reaction must be around 10%. The C-terminal peptide (1512.84 Da) is observed
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as unmodified, singly modified (1658.94 Da) and doubly modified species (1805.06 Da), in the
latter case carrying a PP modification on the only internal carboxylgroup and on the C-terminus.
Figure 5.11: Evaluation of the piperazine derivatization of type II secretion system D (XcpQ, N35
to Arg277) of Pseudomonas aeruginosa by tryptic peptide mass fingerprinting. Panel A: MALDI MS
spectrum of the tryptic digested protein without incubation with PP reaction mixture. Panel B: MALDI
MS spectrum of the tryptic digested protein after incubation with PP reaction mixture. The arrows
indicate the mass shifts of peptides as a result of the derivatization. For several peptides that have
negatively charged side chains (e.g. 1260.65 and 2195.11), incomplete modification is shown. The
C-terminal peptide (1512.84 Da) is observed as unmodified, singly modified (1658.94 Da) and doubly
modified peptide (1805.06 Da).
The derivatization reaction at the protein level can be sterically hindered as a result of the
tertiary and quaternary protein structure. Higher concentrations of DMF in the reaction
mixture will in most cases destabilize the folded protein, allowing the reagent to access the
internal carboxyl groups [28]. However, our results suggest that a stronger chaotrope or addition
of detergent might be needed to (partially) unfold the protein and make all carboxylgroups
accessible. Alternatively another well-known protein modification reaction can be used to
permanently destabilize the protein by chemically altering some amino acids. O-methylisourea
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modifies all lysines to homoarginine residues (∆ mass = 42 Da) [29, 30]. Homoarginine has
a higher pKa and increases the ionization efficiency of the peptide. The modification also
increases the average mass of the tryptic peptides, as trypsin is unable to cleave C-terminal
of homoarginine. Due to the reaction conditions, 65 ◦C at pH 10.6 in a 7 N NH4OH solution,
the samples will need to be desalted to lower the buffer pH prior to carbodiimide coupling.
Additional sample cleanup can cause sample contamination or sample loss and should be limited.
Alternatively, proteins can be reduced and alkylated using dithiothreitol and iodoacetamide in
guanidium HCl/Tris buffer.
Table 5.2: List of trypic peptides of Pseudomonas aeruginosa type II secretion system (Xcp)
observed
Peptide
mass
Amino
acid nr.
Sequence PP modified peptides
4302.43 113-152 VIQVQQSPVSELIPLIRPLVPQYGH-
LAAVPSANALIISDR
4448.51
3168.50 170-197 GSHDYSVINLRYGWVMDAAEVLN-
NAMSR
2195.09 29-47 EFIDQISEITGETFVVDPR 2341.18 - 2487.25 - 2633.56
1644.79 97-112 TEAGGGQSAPDRLETR 1790.88
1512.84 229-242 LVQLAQSLDTPTAR 1658.94 - 1805.06
1260.63 170-180 GSHDYSVINLR 1406.75
1099.59 202-213 GAAGAQVIADAR 1245.68
1077.68 217-226 LIILGPPQAR
The observed masses of the unmodified peptides are in red, the masses of the PP modified peptides are in
blue, missed cleavages are indicated in bold.
The most important carboxyl function to be labeled during the initial derivatization is the
C-terminal one. This label serves as a mass tag for positive identification during MS/MS. Due
to solvation kinetics and the importance of the terminal regions in protein binding in general
and in post-translational modification, most termini are positioned at the solvated surface of
the protein, well within reach of the reagents and should be modified [31–33].
5.3.3 Evaluation of capturing test peptides to the coupling matrix
A mixture of PP modified bradykinin and unmodified angiotensin was coupled to COOH-binding
matrix, simulating a very simple digest mixture of a modified protein. After the reaction, the
unbound fraction was collected, dried, redissolved in 50% ACN/0.1% TFA and analyzed on
MALDI-TOF MS. The recovery was very low, although 4 nmol of each peptide was applied
to the matrix. Besides modified bradykinin, also partially modified angiotensin was observed,
showing that not all PP reagent had been removed during the sample cleanup of the bradykinin
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mixture using ZipTips, and that coupling to the matrix was not 100% efficient. Since the gel
has an activation level of 16-20 mol amine/mL of gel, the failure to bind all carboxylgroups
was not due to overloading. In the current protocol, the composition and pH range of the
coupling solution are similar to the one used to couple the PP reagent. Other coupling buffer
compositions with different pH can be evaluated. The incomplete coupling of the internal
peptides to the resin results in more complex MS spectra, but the C-terminal peptide should
still be identified due to the specific PP mass shift in MS spectra.
5.4 Conclusions and future perspectives
We here presented a new strategy for C-terminal sequence analysis. The aim of this project was
to develop a technique to positively select the C-terminal peptide while improving its ionization
and fragmentation behavior. The protocol has to be applicable to all (LC-)MS platforms and
cover a large area of the proteome by being compatible with different kinds, or combinations of
proteases. Only the initial steps have been optimized, but the PP modification technique has
the potential to fulfill these conditions.
So far only the coupling of the PP reagent to peptides is optimized, all other steps of the
protocol still need further optimization. Several options are still available to counter some
of the observed problems; the PP-modification of internal carboxylgroups in proteins can be
improved by adding chaotropes to the reaction mixture, different buffers can be tested during
resin coupling, miniaturization of the coupling to resin, different solid phase extraction resins
and ultrafiltration tools can be compared during sample cleanup.
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Part III
Conclusion

Chapter 6
Conclusions and future perspectives
6.1 Existing methods and applications
After its important role in the determination of primary structures of proteins in early years,
protein sequencing evolved in the 1980s to a method to verify the terminal regions of recom-
binant gene products. As presented in sections 1.8 - 1.10, this has today shifted towards
large-scale structural and functional studies of the terminal regions. It has been shown that
terminal protein regions have an important function in protein stability, protein traffiking,
protein recognition and binding [1, 2]. These processes are often regulated by post-translational
modification of the terminal regions, one of the most important being proteolytical processing [3].
The widespread shotgun proteomics approaches provide the most comprehensive identification
of proteins from cellular lysates, but generally fail to characterize the N- or C-terminal sequence
of the protein under study. This is due to the limited detection of terminal peptides during
mass spectrometric analysis of complex peptide mixtures and the incomplete and incorrect
annotation of protein termini in protein databases. As presented in Chapter 2, several terminal
sequencing techniques have been developed to study protein termini. The terminal sequence
information gained from these approaches has mainly been used in two relatively new ’omics’
domains: so-called degradomics and proteogenomics.
Since Pehr Edman introduced his N-terminal sequencing technique in 1950, a lot of improve-
ments and alternative techniques have been presented to characterize the terminal regions
of proteins, but so far none of them has been successful enough to stop the demand for new
techniques. Remarkably, most of the techniques that were discussed in the introduction have
only been further exploited by the group that initially presented them. This actually means
that none of them entered into a mature state for wide scale usage, or that they require specific
skills and resources. Moreover, most of the techniques listed are based on a negative selection
of the terminal fragment and have only been applied to rather large quantities of relatively
pure protein samples. They often require multiple amino acid modifications, desalting and
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purification steps to limit side reactions and the detection of false positives.
Most methods were focussed on the determination of the protein N-termini. Although less
chemically reactive and hence more difficult, determining C-terminal sequences offers several
advantages in proteogenomics and degradomics studies over the more popular N-terminal
sequencing approaches. As many as 85% of the eukaryotic cytosolic proteins are N-terminally
acetylated and therefore not easily accessible [4]. Furthermore, protein N-termini are highly
susceptible to trimming by various aminopeptidases present in the sample, resulting in proteins
that have N-termini missing one or more N-terminal amino acids. Due to the translation
initiation mechanism, N-termini are less sequence specific, as the N-terminal amino acid is
frequently a methionine residue [5]. These drawbacks are less prominent in C-terminal sequencing
approaches, since protein C-termini are seldomly blocked [6] and are not as susceptible to
C-terminal trimming [7].
6.2 Our contribution to the field
The starting point of this project was the C-terminal sequencing technique reported in 2005
by Bart Samyn and other members of the hosting lab for this research [8]. The aim of our
work was to modify the protocol so it can be used in an automated proteome wide setup
and to simultaneously improve the proteome coverage. In the existing method, carboxypep-
tidases were used to selectively digest the C-terminal peptide. However, the cleavage rate
of these enzymes depends strongly on the amino acid sequence of the substrate: for exam-
ple, Phe, Thr, Lys and Gly are cleaved off very slowly [8, 9]. To generate a peptide sequence
ladder, the incubation times and CPase concentration had thus to be optimized for every sample.
In Chapter 3 we have addressed the drawbacks of the use of CPase by a novel chemical approach
that allows to discriminate C-terminal peptides in CNBr mixtures. The partial ring opening
of the homoserine lactone replaces the need for carboxypeptidases to identify the C-terminal
peptide and makes the protocol sequence independent [10]. The method can be used for the
analysis of gel or gel-free purified proteins at low femtomol sensitivity levels. By coupling
the MALDI-MS/MS analysis to a robotic sample preparation device, the chemical approach
proved suitable as high-throughput approach, and can be implemented in a routine proteomic
setup. The technique was successfully applied to both test proteins and 96 2D-PAGE separated
Shewanella oneidensis MR-1 proteins. The results of the 2D-PAGE experiment were com-
pared to our previously used manual CPase ladder sequencing technique and showed a strong
improvement. Moreover, we were able to identify three times more proteins using de novo
sequenced C-terminal peptides. We have demonstrated that the technique theoretically covers
50% of the proteome of S. oneidensis MR-1 and that it is at least complementary to other
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approaches for whole proteome C-terminal sequence determination [11]. The main limitations of
the technique are intrinsic to the use of 2D-PAGE and MALDI TOF/TOF MS as analysis tools.
Low ionisation efficiency of the C-terminal peptide and preferential peptide fragmentation at
positively charged residues in the C-terminal peptide often reduce the quality of the MS(/MS)
spectra and limit the identification rate.
Both in the CPase and chemical selection method, proteins are first cleaved with CNBr. Since
methionine is a relatively rare amino acid, the peptides generated after CNBr cleavage are
relatively large. In order for peptides to be efficiently detected on a MALDI-TOF/TOF analyzer
they need to be in the 1-5.5 kDa mass range. Our data showed that most succesfully de novo
interpreted MS/MS spectra had a parent ion below 3.5 kDa. This prompted us to develop
a strategy to generate smaller peptides based on a method, first described by Huang and
Huang, using CNBr combined with KI to cleave proteins C-terminally of Met and Trp [12].
We optimized the protocol, described the side reactions, the reaction products formed and the
reaction mechanism, such that it can be used in standard proteomics experiments (Chapter 4).
It proved the only protocol currently available wherein peptide bond cleavage C-terminally of
Met and Trp is combined with breaking disulfide bonds in a single incubation. The need for
reduction and alkylation of disulfide bridges requires to use elaborate protocols when using
chemical cleavage methods, as appears from recent publications [13, 14]. Using the approach
described by us, these protocols could be simplified. Because proteins are generally reduced
and alkylated between the two dimensions, the application of a KI/CNBr-cleavage will offer
less benefits for proteins separated by 2D-PAGE; nonetheless, the attained sequence coverage
is expected to be higher than after a standard CNBr-cleavage approach. Given the interest
that currently exists in increasing the sequence coverage during the study of proteins, and
more specifically of membrane proteins that are often difficult to study using enzymatic digests
[15–17], the chemical cleavage at two residues may be of great interest.
In an attempt to improve the proteome coverage of the existing technique, the optimized
CNBr and KI cleavage protocol was implemented in the chemical selection protocol for C-
terminal sequencing. We were able to distinguish the C-terminal peptides by MS and determine
a C-terminal sequence tag by MS/MS [11]. Methionine accounts for 2.59% of the amino
acids in S. oneidensis MR-1 (test species used). When CNBr is used as cleavage reagent,
51% of the C-terminal peptides can be detected and only 1 out of 3 proteins generates a
C-terminal peptide in the de novo sequencing mass range. Tryptophan accounts for 1.25% of
the amino acids in S. oneidensis MR-1. By cleaving C-terminal of tryptophan and methionine
58% of the C-terminal peptides are detectable on MALDI-TOF/TOF MS and 42% of the
proteins have a C-terminal peptide in the de novo sequencing mass range. By adding KI to
the reaction mixture we theoretically achieved thus a 10% larger proteome coverage (Chapter 4).
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In the final results chapter, Chapter 5, we presented initial work in the development of a
new MS/MS based sequencing approach. With this technique we want to overcome some of
the reoccurring limitations described above. So far, only the initial reaction steps have been
optimized, some suggestions have been made on possible solutions to the problems encountered.
At the start of this project the aim was to develop a proteome wide technique, able to determine
a large number of C-terminal sequences. In 2007 the discussion around ’2D or not 2D’ was still
ongoing; 2D-PAGE, not 2D-LC! At that time it seemed a logical choice to further develop the
existing CPase-based C-terminal sequencing technique into a variant with higher throughput.
In hindsight, the choice for a robotic platform to automate an existing technique proved not
to be the best way to answer the quest for a method of fast terminomics. The technological
improvements in the (LC-)MS field overwhelmed us, and we did not foresee to spend 2 to 3
years on implementing an existing technique on such an automated platform, that in the end
still struggles with the same limitations and lack of sensitivity as the initial technique. Several
groups, in the meantime, developed LC-MS based techniques and are able to identify several
hundreds of proteins in a single, albeit complex experiment. Therefore, the PP modification
based method is more likely to be successful as high throughput terminomics technique, once
fully optimized.
Although our techniques might not be the most suitable for high-throughput determination of
protein C-termini, they still serve a function in the proteome community. Unlike many other
terminal sequencing techniques, the protocols we developed are very straightforward. They
consist of very few steps that need optimalization and can be performed in less than 24 hours.
As there is no need for advanced and dedicated hardware, any MS-based laboratory should
be able to successfully implement our methods in their 2D-PAGE experiments. The chemical
selection technique has already been applied by others to determine the C-terminal sequence of
a recombinant protein [18].
6.3 Future perspectives
In most of the current sequencing techniques, proteins are cleaved into peptides and the C- or
N-terminal peptides are enriched or labelled. Fragmentation of a selected peptide and de novo
interpretation of the MS/MS spectra results in the terminal sequence of this peptide, hence
of the protein. Since these cleavage reactions usually occur at the site of one or more specific
amino acids, peptides of different lengths are produced. When it comes to de novo sequencing,
mass spectrometers have a restricted optimal m/z working range, hence many of the selected
peptides will not generate an interpretable MS/MS spectrum. In order to generate terminal
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peptides in this optimal range, methods will need to be developed that work in combination
with multiple proteases. Samples can then be analyzed in parallel generating complementary
data sets.
Another way to circumvent these problems is perhaps to be found in ’top-down’ proteomics, i.e.
mass spectral methods to determine the sequence starting from intact proteins. Over the last
few years several techniques have been reported to fragment proteins or peptides independent
of their amino acid sequence in so-called non-ergodic processes [19–21]. These fragmentation
methods usually generate complete series of c- and z-ions, with the post-translational modifica-
tions still intact. Since entire proteins are fragmented in top-down methods, a lot of fragment
ions are generated, resulting in very complex MS(/MS) spectra. Therefore top-down methods
will always require precise selection of a precurson ion representing the protein, without any
interference. Currently there are no methods with enough resolution to separate proteins from
a whole lysate to the necessary purity level for top-down analysis. Since proteins have very
different physicochemical properties it will be very difficult to design LC-based techniques that
can separate intact protein mixtures. LC-MS setups usually have a dynamic range of 104th
to 106th, while in vivo differences in protein expression levels of 12 orders of magnitude have
been observed [22]. Several affinity based techniques have been reported to deplete up to 20
of the most abundant proteins from blood serum samples, but even if this method is 99.9%
successful, those 20 proteins are still 109th times more abundant than many of the important
signalling proteins [23]. Not to mention that mostly a very small portion of an expressed protein
is post-translationally modified, resulting in significant differences in activity.
Due to the very diverse nature of proteins, it seems very unlikely that, in the near future
one technology will be developed that can successfully be applied to all protein samples, as
was, for example, the case for DNA with the Sanger sequencing technology. Some techniques,
like ours, focus on simple, yet sensitive and time-efficient, protocols to determine protein
sequences using limited resources. Other approaches, like COFRADIC, can be applied in
large scale studies and generate a large number of terminal sequences, but are time consuming
and typically require a lot of instrument time. At this stage, these approaches should be
regarded as complementary. Anyhow, effords to improve (high-throughput) terminal sequencing
methodology are still at place. Petrera et al. recently pointed to the large diversity of naturally
occuring carboxypeptidases. While the substrates of these peptidases are not well described,
mutations and polymorphisms in the genes coding these CPases are linked to neurological and
cardiovascular diseases. Terminal sequencing of proteins in mutant cell lines could help to
determine their natural substrates and understand their exact pathological and fysiological
function. [24].
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Table B.1: Peptides resulting from the cleavage of test peptides using different halogen salts.
Salt Sequence Remarks
Avidin (Gallus gallus)
KI ARKCaSLTGKW N-term. peptide
W.KFSESTTVFTGQCaFIDRNGKEVLKTM
M.W◦LLRSSVNDIGDDW
W.LLRSSVNDIGDDW
W.KATRVGINIFTRLRTQKE C-term. peptide
NaI ARKCaSLTGKW N-term. peptide
M.W◦LLRSSVNDIGDDW
W.LLRSSVNDIGDDW
W.KATRVGINIFTRLRTQKE C-term. peptide
2-Iodosobenzoic acid ARKCaSLTGKW N-term. peptide
W.KFSESTTVFTGQCaFIDRNGKEVLKTM
M.W◦LLRSSVNDIGDDW
W.LLRSSVNDIGDDW
W.KATRVGINIFTRLRTQKE C-term. peptide
KCl/NaCl/4-
chlorobenzoic acid
M.WLLRSSVNDIGDDWKATRVGINIFTRLRTQKE C-term. peptide
KBr/NaBr/2-
bromobenzoic acid
M.WLLRSSVNDIGDDWKATRVGINIFTRLRTQKE C-term. peptide
α-lactalbumin (Bos taurus)
KI EQLTKCaEVFRELKDLKGYGGVSLPEW N-term. peptide
K.CaEVFRELKDLKGYGGVSLPEW X-Cys(6) cleavage
W.LAHKALCaSEKLDQW
NaI EQLTKCaEVFRELKDLKGYGGVSLPEW N-term. peptide
K.CaEVFRELKDLKGYGGVSLPEW X-Cys(6) cleavage
W.LAHKALCaSEKLDQW
2-Iodosobenzoic acid W.LAHKALCaSEKLDQW
KCl/NaCl/4-
chlorobenzoic acid
/
KBr/NaBr/2-
bromobenzoic acid
/
Cytochrome c (Equus caballus)
KI acGDVEKGKKIFVQK X-Cys(14) cleavage
W.KEETLM◦EYLENPKKYIPGTKM
W.KEETLMEYLENPKKYIPGTKM
M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
continued on next page
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Table B.1: Cleavage of test peptides using different halogen salts – continued from previous page
Salt Sequence Remarks
NaI acGDVEKGKKIFVQK X-Cy(14)s cleavage
W.KEETLM◦EYLENPKKYIPGTKM
W.KEETLMEYLENPKKYIPGTKM
M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
2-Iodosobenzoic acid acGDVEKGKKIFVQK X-Cys(14) cleavage
W.KEETLM◦EYLENPKKYIPGTKM
W.KEETLMEYLENPKKYIPGTKM
M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
KCl/NaCl/4- M.EYLENPKKYIPGTKM
chlorobenzoic acid M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
KBr/NaBr/2- M.EYLENPKKYIPGTKM
bromobenzoic acid M.IFAGIKKKTEREDLIAYLKKATNE C-term. peptide
β-lactoglobulin ((Bos taurus)
KI LIVTQTM◦KGLDIQKVAGTW N-term. peptide
M.KGLDIQKVAGTW
M.HIRLSFNPTQLEEQCaHI C-term. peptide
M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
NaI LIVTQTM◦KGLDIQKVAGTW N-term. peptide
M.KGLDIQKVAGTW
M.HIRLSFNPTQLEEQCaHI C-term. peptide
M.HIRLSFNPTQLEEQ X-Cys(160) cleavage
2-Iodosobenzoic acid LIVTQTM◦KGLDIQKVAGTW N-term. peptide
M.KGLDIQKVAGTW
M.HIRLSFNPTQLEEQCaHI C-term. peptide
KCl/NaCl/4- M.KGLDIQKVAGTWYSLAM
chlorobenzoic acid M.HIRLSFNPTQLEEQCHI C-term. peptide
KBr/NaBr/2- M.LIVTQTM◦KGLDIQKVAGTWYSLAM
bromobenzoic acid M.KGLDIQKVAGTW◦YSLAM N-term. peptide
M.HIRLSFNPTQLEEQCHI C-term. peptide
All terminal Met or Trp residues were observed in the modified homoserine lactone or Cγ-O-spirolactone form.
◦= Oxidation of Met of Trp.
ac = acetylation
Ca = Cysteic acid.
